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Abstract: Fever is one of the most common reasons for healthcare seeking 
globally and the majority of human pathogens are zoonotic. We conducted a 
systematic review to describe the occurrence and distribution of zoonotic 
causes of human febrile illness reported in malaria endemic countries. 
Articles included in the review yielded data from 53 (48·2%) of 110 
malaria endemic countries. The 244 articles included described diagnosis 
of 30 zoonoses in febrile people. The majority of zoonoses were bacterial 
(n=17), with viruses (n=9), protozoa (n=3) and helminths (n=1) also 
identified. Leptospira spp. and nontyphoidal Salmonella serovars were the 
most frequently reported pathogens. Despite evidence of profound data 
gaps, this review reveals widespread distribution of a diverse range of 
zoonotic causes of febrile illness. Greater understanding of the 
epidemiology of zoonoses in different settings is needed to improve 
awareness and management of the multiple zoonotic causes of febrile 
illness. 
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 63 
Abstract 64 
Fever is one of the most common reasons for healthcare seeking globally and the majority of 65 
human pathogens are zoonotic. We conducted a systematic review to describe the occurrence 66 
and distribution of zoonotic causes of human febrile illness reported in malaria endemic 67 
countries. Articles included in the review yielded data from 53 (48·2%) of 110 malaria 68 
endemic countries. The 244 articles included described diagnosis of 30 zoonoses in febrile 69 
people. The majority of zoonoses were bacterial (n=17), with viruses (n=9), protozoa (n=3) 70 
and helminths (n=1) also identified. Leptospira spp. and nontyphoidal Salmonella serovars 71 
were the most frequently reported pathogens. Despite evidence of profound data gaps, this 72 
review reveals widespread distribution of a diverse range of zoonotic causes of febrile illness. 73 
Greater understanding of the epidemiology of zoonoses in different settings is needed to 74 
improve awareness and management of the multiple zoonotic causes of febrile illness. 75 
 76 
Introduction 77 
Fever is one of the most common symptoms prompting healthcare seeking globally.
1-3
 Fever 78 
has myriad causes and their non-specific clinical presentation means that clinical history and 79 
physical examination are often insufficient to accurately identify causal pathogens.
1
 80 
Limitations in laboratory services and available diagnostic tools further contribute to 81 
diagnostic challenges.
4
 In malaria-endemic countries, fever is often assumed to be due to 82 
malaria.
5
 The mortality and morbidity attributable to malaria remains considerable, but there 83 
is also evidence of widespread over-diagnosis within malaria-endemic areas.
6-8
 The 84 
recognized over-diagnosis of malaria together with declines in malaria incidence since the 85 
peak in global malaria deaths in 2004
9,10
 have prompted attention to non-malaria causes of 86 
fever in malaria-endemic areas.
11,12
 Zoonotic pathogens are likely to play a substantial role as 87 
causes of fever globally. Almost two-thirds of all human pathogens are zoonotic,
13
 and there 88 
is growing evidence that many zoonoses cause more cases of human febrile illness than 89 
previously appreciated.
12,14-20
 Improved understanding of the impacts and burdens of zoonotic 90 
causes of fever in malaria-endemic countries would provide the epidemiological evidence 91 
base for disease control program development and also influence diagnostic and treatment 92 
algorithms for fever, with the potential to improve clinical outcomes. The aim of this study 93 
was to systematically review the published literature to describe the occurrence and 94 
distribution of reported zoonotic causes of human febrile illness in countries where malaria is 95 
endemic. 96 
 97 
Methods 98 
Search strategy and selection criteria 99 
The target literature for this systematic review was peer-reviewed published articles that 100 
described the testing of one or more febrile person from malaria-endemic countries for one or 101 
more zoonotic pathogen using robust diagnostic testing criteria to demonstrate acute 102 
infection. Literature searches of the Medline and Embase databases were run using the 103 
OvidSP gateway. Searches were limited to English language articles published in the period 104 
2004 to 2019 inclusive, to span the period from the described peak of global malaria 105 
mortality in 2004 to present.
9
 The searches were last executed on 03 January 2019. Outputs 106 
of database searches were combined and de-duplicated using R.
21
 Additional details of 107 
searches, screening, review, and data extraction processes are given in the appendix. 108 
 109 
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Three search concepts for ‘fever,’ ‘zoonoses,’ and ‘malaria endemic countries’ were 110 
constructed. To construct the ‘fever’ concept the exploded subject heading and keywords 111 
were combined using database appropriate syntax (e.g., exp Fever/ OR fever$1.mp. OR 112 
febrile.mp.). For the ‘zoonoses’ concept, a reference list of eligible zoonotic pathogens was 113 
compiled using lists of zoonotic diseases from the World Health Organization (WHO)
22
 and 114 
World Organisation of Animal Health (OIE)
23
 as well as literature-based searches to identify 115 
frequently reported zoonotic causes of human fever. We conducted preliminary searches of 116 
Medline and Embase using the search syntax ‘(exp Fever/ OR fever.mp.) AND (exp 117 
Zoonoses/ OR zoonoses.mp OR zoonosis.mp)’ limited to humans. Additional details of 118 
search concept construction are given in the appendix. All pathogens identified through these 119 
approaches were mapped to existing subject headings and keywords at the lowest taxonomic 120 
level possible, typically genus or species. In instances where pathogen species or serovars 121 
within the same genus varied in their zoonotic status, search concepts were constructed to 122 
include all zoonotic and non-zoonotic species or serovars and articles relating to non-123 
zoonotic species were excluded at the full text stage. The candidate pathogens were classified 124 
to differentiate pathogens normatively acquired by people through direct or indirect 125 
transmission from vertebrate animals to humans, as compared to pathogens where zoonotic 126 
transmission has been recorded but where the majority of human infections are not acquired 127 
through zoonotic transmission. We classified pathogens using the stages in the process 128 
towards human endemicity defined in Wolfe et al.
24
 Pathogens classified at stages one to 129 
three (normatively acquired through zoonotic transmission) were retained (appendix). The 130 
search concept for each pathogen or disease included exploded subject headings for both the 131 
pathogen and the diseases caused in humans and terms for both pathogen and disease were 132 
also included as keywords (e.g., exp anthrax/ OR anthrax.mp. OR exp Bacillus anthracis/ OR 133 
bacillus anthracis.mp.). The list of pathogen or disease specific searches was combined using 134 
OR syntax to generate the full ‘zoonoses’ search concept (appendix). The ‘malaria endemic 135 
countries’ concept was constructed by mapping country names for countries defined as 136 
malaria endemic in the WHO global malaria reports for the years 2005 and 2016 to Medline 137 
and Embase subject headings.
10,25
 Each country was searched for using both the exploded 138 
subject heading where possible and keywords in all cases (e.g., exp Kenya/OR Kenya.mp.). 139 
The three concepts, fever,’ ‘zoonoses,’ and ‘malaria endemic countries’ were combined using 140 
AND operators and database specific syntax (appendix). 141 
 142 
Study selection and validity assessment 143 
Articles that reported the diagnosis of a zoonotic pathogen in a population from a malaria 144 
endemic country defined on the basis of febrile illness were selected for full-text review. 145 
Conference proceedings and records that did not include any abstract text or an abstract in 146 
English were excluded. Abstracts and titles were screened by two independent reviewers (two 147 
of MC, MES, KJA, GAFL, DVH, JAC, SC and MPR) using pre-defined criteria (appendix 148 
table S1). Articles were selected for inclusion if the abstract or title described clinical and/or 149 
laboratory evaluation of a group of ≥ 2 people all of whom had fever and some of whom 150 
were diagnosed of one or more pathogens from the reference list of zoonotic pathogens (table 151 
1). Abstracts referring to the use of blood culture were also retained at this stage even if a 152 
zoonosis was not explicitly mentioned in the abstract (appendix table S1). When two 153 
reviewers disagreed on article classification, a third independent reviewer (one of JEBH, MC, 154 
MES, GAFL, DVH or MPR) resolved the tiebreak. Full text articles were sought for all 155 
articles not excluded during abstract review steps. All articles were searched for using 156 
  Page 5 of 18 
PubMed, Google and the libraries of the University of Glasgow, Duke University, 157 
Washington University in St. Louis, and US Centers for Disease Control and Prevention (US 158 
CDC). Articles were excluded if a full text for the citation could not be obtained. Two 159 
independent reviewers (two of, JEBH, MC, MES, JB and MPR) evaluated full text articles 160 
using pre-defined inclusion and exclusion criteria (table 2, appendix table S2). Strict 161 
diagnostic case definitions based on WHO and US CDC guidelines ensured that only studies 162 
reporting robust and specific diagnostic methods were retained (table 2). Articles were 163 
excluded if they did not meet one or more of the study inclusion criteria or if they did meet at 164 
least one of the study exclusion criteria (table 2). In cases where reviewers disagreed on 165 
article classification, discrepancies were checked and resolved by JEBH in discussion with 166 
other reviewers.  167 
 168 
Table 1. Zoonoses included in the review, with details of species and serovars excluded 169 
where appropriate.  170 
Pathogen Species, subspecies, and serovars excluded Pathogen 
type
13
  
Alphaviruses All species excluded with the exception of Eastern 
equine encephalitis virus (EEEV) complex, 
Venezuelan equine encephalitis (VEEV) complex, and 
Western equine encephalitis (WEEV) complex 
Virus 
Anaplasma spp. - Bacteria 
Aphthoviruses All species excluded with the exception of Foot-and-
mouth disease virus 
Virus 
Avulaviruses All species excluded with the exception of Newcastle 
disease virus 
Virus 
Babesia spp. - Protozoa 
Bacillus antrhracis - Bacteria 
Bartonella spp. B. bacilliformis and B. quintana excluded Bacteria 
Borrelia spp. B. recurrentis excluded Bacteria 
Bovine 
spongiform 
encephalopathy 
- Prion 
Brucella spp. - Bacteria 
Burkholderia spp. B. cepacia complex and B. pseudomallei excluded Bacteria 
Campylobacter 
spp. 
- Bacteria 
Chlamydia spp. All species excluded with the exception of C. psittaci Bacteria 
Coxiella burnetii - Bacteria 
Cryptosporidium 
spp. 
C. hominis excluded Protozoa 
Ebolavirus - Virus 
Echinococcus spp. - Helminth 
Ehrlichia spp. - Bacteria 
Enteroviruses All species excluded with the exception of Swine 
vesicular disease virus 
Virus 
Escherichia spp. All species excluded with the exception of Shiga-toxin 
producing E. coli 
Bacteria 
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Flaviviruses All species excluded with the exception of Japanese 
encephalitis virus (JEV), West Nile virus (WNV), and 
Tick-borne-encephalitis virus.  
Virus 
Francisella spp. All species excluded with the exception of F. 
tularensis 
Bacteria 
Hantavirus - Virus 
Henipaviruses - Virus 
Lassa virus - Virus 
Leishmania spp. L. donovani excluded if detected in India Protozoa 
Leptospira spp. - Bacteria 
Listeria spp. - Bacteria 
Lyssavirus All species excluded with the exception of Rabies 
virus 
Virus 
Marburg virus - Virus 
Mycobacterium All species excluded with the exception of M. bovis 
and M. avis 
Bacteria 
Nairovirus All species excluded with the exception of Crimean-
Congo haemorrhagic fever virus 
Virus 
Orientia
1
 -  Bacteria 
Orthopox viruses All species excluded with the exception of Cowpox 
virus, Monkeypox virus, and Vaccinia virus 
Virus 
Pasteurella spp. -  Bacteria 
Phleboviruses All species excluded with the exception of Rift Valley 
fever (RVF) virus 
Virus 
Rickettsia spp.
2
 R. prowazekii excluded Bacteria 
Salmonella spp. All species, subspecies, and serovars excluded with 
the exception of nontyphoidal Salmonella serovars 
Bacteria 
Schistosoma spp. S. haematobium, S. intercalatum, and S. 
mekongi.excluded 
Helminth 
Streptobacillus 
spp. 
- Bacteria 
Streptococcus spp. All species excluded with the exception of S. canis, S. 
suis, S. equi, and S. iniae 
Bacteria 
Taenia spp.  Helminth 
Toxocara  Helminth 
Toxoplasma gondii - Protozoa 
Trichinella spp. - Helminth 
Trypanosoma spp. All species excluded with the exception of T. brucei 
rhodesiense and T. cruzi 
Protozoa 
Varicelloviruses All species excluded with the exception of 
Pseudorabies virus 
Virus 
Vesiculoviruses All species excluded with the exception of Vesicular 
Stomatitis virus 
Virus 
Yersinia spp. All species excluded with the exception of Y. pestis, Y. 
enterocolitica and Y. pseudotuberculosis 
Bacteria 
1
 Orientia was covered by search syntax for Rickettsia.  171 
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2 
For data extraction, data on Rickettsia were classified as Rickettsia (SFGR) or Rickettsia 172 
(TGR) where the data resolution allowed. When details on the species of Rickettsia were not 173 
given, these data were classified as Rickettsia spp.  174 
 175 
Table 2: Inclusion and exclusion criteria for full text review 176 
Outcome Criterion 
Inclusion:  Febrile population (≥ 2 people with a fever, defined as body temperature 
≥ 38·0°C) 
 Diagnosis of one or more zoonotic pathogens from pre-defined reference 
list of eligible aetiological agents (table 1) 
 Diagnostic test criteria:  
i) Culture of the pathogen from sample(s) collected from a febrile person 
ii) Direct detection of the pathogen (e.g., by PCR based techniques) from 
sample(s) collected from a febrile person 
iii) Serological diagnosis of acute infection based on testing of both acute 
and convalescent phase serum samples and demonstration of 
seroconversion 
iv) Diagnosis of acute infection based on detection of pathogen-specific 
antibody or antigens in a single serum sample only for selected 
pathogens, for which widely accepted case definitions deemed 
pathogen-specific antibody or antigen detection sufficiently accurate
1
  
v) IgM detection in cerebrospinal fluid (CSF) for selected pathogens for 
which widely accepted case definitions include IgM detection in CSF
2
  
Exclusion:  Failure to meet inclusion criteria described above  
 Lack of study detail e.g., number of people tested for each pathogen 
 Negative diagnostic test results in all patients  
 Study designed to evaluate diagnostic test and/or vaccine performance 
without presenting novel data on number or proportion of patients 
diagnosed with a study pathogen from a previously described population 
of febrile people.  
 Study described as a group of ≥ 2 people principally classified based on 
a shared (100% frequency) aetiological diagnosis. 
 Review 
1
The following met study criteria for valid diagnostics for pathogen detection based on single 177 
sera only: Leptospira spp. agglutination titer of ≥ 800 by microscopic agglutination test in 178 
one serum specimen 
26
; detection of Hantavirus-specific IgM in a serum sample 
27
; detection 179 
of virus-specific IgM antibodies in serum with confirmatory virus-specific neutralizing 180 
antibodies for Eastern equine encephalitis virus (EEEV), West Nile virus (WNV), Western 181 
equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) 
28
; 182 
identification of lyssavirus specific antibody by indirect fluorescent antibody test or complete 183 
rabies virus neutralization at 1:5 dilution in the serum of an unvaccinated person 
29
; detection 184 
of viral antigens in blood by enzyme-linked immunosorbent assay for Ebola 
30,31
, Marburg 185 
31,32
, Lassa 
31,33
, and Crimean-Congo haemorrhagic fever viruses 
31
; detection of Rift Valley 186 
fever antigens or IgM in blood by enzyme-linked Immunosorbent assay 
34
; and 187 
2
 IgM detection in CSF was considered a valid diagnostic for EEEV, Japanese encephalitis 188 
virus (JEV), rabies virus, WEEV, WNV and VEEV 
28,29,35
. 189 
 190 
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Data extraction and bias assessment 191 
Data extraction was conducted independently by one of two reviewers (JEBH and MC). 192 
Article-level data were extracted on the location (country and WHO regional classification), 193 
36
 study period (start and end year of data collection), and eligibility criteria used in the study. 194 
Each population was classified according to the clinical presentation as undifferentiated or 195 
differentiated. Differentiated febrile populations were further classified as: i) febrile 196 
neurologic; ii) febrile haemorrhagic; iii) febrile gastrointestinal; iv) febrile respiratory; v) 197 
specific febrile aetiology suspected; vi) febrile co-morbid group (i.e., malignancy, 198 
immunocompromise).
37-39
 Data extracted on each population included any demographic 199 
restriction of the study population, the age range of the study participants, whether the 200 
population was described as inpatient or outpatient, urban or rural, and whether data were 201 
collected during a reported disease outbreak or not. To extract data on zoonotic pathogens, 202 
every article was classified to record if the study reported looking for or diagnosing one or 203 
more febrile individuals with any of the zoonotic pathogens included in the study reference 204 
list (table 1), irrespective of the diagnostics used. Additional data were extracted when the 205 
article reported application of a diagnostic approach that met study validity criteria. For each 206 
combination of article and pathogen, details of the valid diagnostic methods used, the type 207 
and number of samples tested, and the number of positive samples were recorded (appendix 208 
table S3, S4). In instances where more than one valid diagnostic method was used in the 209 
same study for a given pathogen (e.g., culture-based and serologic case definitions), data on 210 
the total number of individuals tested and positive for each pathogen using valid methods 211 
were aggregated. Some articles contributed data on more than one pathogen but no data on 212 
participant numbers were extracted for pathogens not identified using diagnostic approaches 213 
that met study inclusion criteria. 214 
 215 
The principal source of potential bias affecting the interpretation of the findings of this study 216 
is the lack of standardization of the febrile populations included in different studies. Criteria 217 
were defined to classify potential bias in study representativeness and prevalence estimate 218 
precision (appendix table S5).
40-42
 The representativeness bias criterion was designed to 219 
classify the representativeness of the study population, relative to the general population 220 
where the study was conducted. This was based on the description of the febrile population, 221 
the restriction (if any) of the study sample to specific clinical or demographic sub-populations 222 
and the reporting of disease outbreaks at the time of data collection. Each population was 223 
classified as follows: i) populations classified as undifferentiated febrile with no demographic 224 
restriction and no clinical aetiologies excluded were classified as low risk; ii) populations 225 
classified as undifferentiated febrile with demographic restriction and/or reporting exclusion 226 
of specific aetiologies or syndromes were classified as medium risk; iii) differentiated febrile 227 
populations and those from studies reporting disease outbreaks at the time of data collection 228 
were classified as high risk. The second, outcome-level, bias criterion was designed to 229 
classify risk of bias in the estimated precision of the proportion of fevers attributed to each 230 
pathogen. Thresholds used for this criterion are the sample sizes needed to estimate 231 
proportions of 50% and 10% with 95% confidence and 0·05 precision respectively, assuming 232 
an infinite population size. Each population was classified as follows: i) proportion estimates 233 
based on a sample size of greater than or equal to 385 were classified as low risk; ii) 234 
proportion estimates based on a sample size of greater than 385 but less than 139 were 235 
classified as medium risk; iii) proportion estimates based on a sample size of less than 139 236 
were classified as high risk. 237 
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 238 
Additional potential sources of bias included variation in the pathogens tested for, and 239 
variation in the diagnostic approaches applied. For included studies, data on the pathogens 240 
tested for (with any diagnostic approach) were summarized alongside pathogens for which 241 
diagnostic test criteria were met to qualitatively evaluate the biases introduced by only 242 
extracting data on pathogens diagnosed using methods meeting study inclusion criteria.  243 
 244 
Data analysis  245 
Extracted data on the zoonotic pathogens diagnosed using valid methods, number of 246 
individuals tested for each pathogen, and number of individuals positive for each pathogen 247 
were used to estimate the proportion of fevers attributable to each pathogen for each unique 248 
pathogen and study combination. All analyses were conducted in R
21
 and plots were made 249 
using the package ggplot2.
43
 250 
 251 
Role of the funding source 252 
The funders of the study had no role in study design, data collection, data analysis, data 253 
interpretation, or writing of the report. The corresponding author had full access to all the 254 
data in the study and had final responsibility for the decision to submit for publication. 255 
 256 
Results 257 
Database searches yielded a total of 16,332 and 10,574 records through Embase and Medline, 258 
respectively, resulting in a total of 17,852 unique records following de-duplication (figure 1). 259 
A total of 4,531 (25·4%) records were excluded during pre-screening, 13,321 (74·6%) 260 
records were screened and 962 (7·2%) of these were retained after title and abstract review. 261 
In total, 718 (74·6%) articles were excluded during full text review and 244 (25·4%) articles 262 
met all study inclusion criteria and were included (figure 1, appendix table S6). 263 
 264 
Articles included in the review yielded data from 53 (48·2%) of the 110 malaria endemic 265 
countries (figure 2). The majority of articles with a single country origin (n=235) reported 266 
data from Africa (83 of 235 articles, 35·3%) or South-East Asia (81 of 235 articles, 34·5%) 267 
(appendix table S7, figure S1). One hundred and six (45·1%) of the 235 articles with a single 268 
country origin were conducted in one of six dominant countries: India (n=31), United 269 
Republic of Tanzania (n=22), Thailand, (n=20), Nepal (n=12), Bangladesh (n=11), and 270 
Nigeria (n=10). The data reported in the review were gathered between 1994 and 2017 271 
inclusive. 272 
 273 
The 244 articles included for data extraction reported looking for and diagnosing 40 and 31 274 
zoonoses, respectively, in these populations (figure 3). The number of included zoonoses was 275 
reduced to 30 after the criteria for diagnostic testing approach were applied. The 244 articles 276 
yielded data that met diagnostic test criteria for 30 zoonoses that included 17 bacterial 277 
pathogens (56·7%), nine viruses (30·0%), three protozoa (10·0%), and one helminth (3·3%). 278 
Leptospira spp., nontyphoidal Salmonella serovars (NTS) and rickettsioses were the most 279 
frequently reported bacteria, while Japanese encephalitis virus (JEV), Hantavirus, and West 280 
Nile virus (WNV) dominated among reported viruses (figures 3, 4). 281 
 282 
The number of febrile individuals included in each study population ranged from 4 to 13,845, 283 
with a median of 300 (IQR: 120 – 812). In total, 309 records of zoonotic pathogens causing 284 
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fever were extracted from the 244 articles. The proportion of fevers attributed to each 285 
pathogen reported ranged from <1·0% to 95·0% (figure 4). The risk of bias classification in 286 
the precision of the proportion of fevers attributed to each zoonosis was 136 (44·0%) of 309 287 
low risk, 79 (25·6%) of 309 medium risk, and 94 (30·4%) of 309 high risk.  288 
 289 
Of the 244 studies, 87 (35·7%) described the clinical setting as inpatient, 36 (14·8%) as 290 
outpatient, 39 (16·0%) as mixed, and 82 (33·6%) gave no clear classification of the clinical 291 
setting. Thirty (12·3%) studies described the study area as urban, 59 (24·2%) as rural, 45 292 
(18·4%) mixed or both, and 110 (45·1%) gave no clear classification of the study area. 293 
Eighteen (7·4%) studies included adult participants, 43 (17·6%) included children, 153 294 
(62·7%) included both adults and children and 30 (12·3%) gave no clear classification of the 295 
ages included. Of the 244 studies, twelve (4·9%) described a demographically restricted 296 
population, 55 (22·5%) reported some exclusions from the population, and 32 (13·1%) 297 
mentioned exclusion of malaria-infected individuals specifically (appendix table S6). Of the 298 
244 studies, 73 (29·9%) reported looking for more than one zoonosis, 43 (17·6%) diagnosing 299 
more than one zoonosis and 37 (15·2%) contributing data on more than one zoonosis. Of the 300 
244 studies, 10 (4·1%) were described as outbreak investigations and 169 (69·3%) 301 
populations were classified as undifferentiated febrile populations. Among the 75 302 
differentiated populations, 36 (48·0%) had specific febrile aetiologies suspected, 17 (22·7%) 303 
were classified as febrile neurological, eight (10·7%) as comorbid populations, eight (10·7%) 304 
as febrile haemorrhagic, five (6·7%) as febrile gastrointestinal and one (1·3%) as febrile 305 
respiratory. The associations between clinical presentation of febrile populations and the 306 
subset of 25 pathogens identified in the differentiated populations are shown in figure 5. The 307 
risk of bias classification in the representativeness of febrile populations was 121 (49·6%,) of 308 
244 low risk, 45 (18·4%,) of 244 medium risk, and 78 (32·0%,) of 244 high risk.  309 
 310 
Discussion 311 
This systematic review reveals diverse zoonoses causing febrile illness within multiple 312 
malaria-endemic countries, often at high prevalence. However, sparse and patchy reporting 313 
suggests that the prevalence of zoonoses is widely under-estimated. Knowledge of probable 314 
infecting pathogen is crucial to inform clinical management of febrile illness and there is a 315 
clear need for further investigation of the zoonotic causes of febrile illness to generate data 316 
relevant to clinicians, epidemiologists, and health policy makers globally. This study should 317 
generate greater awareness of the clinical importance of zoonoses and provide a pragmatic 318 
starting point for actions to better manage these diseases, for example through improved 319 
diagnostic and clinical treatment algorithms. These findings demonstrate the need for 320 
enhanced epidemiological understanding of multiple zoonoses to inform disease prevention. 321 
 322 
This review reveals substantial gaps in the evidence base, including a complete absence of 323 
eligible studies from more than half of the 110 countries included in the review (figure 2). 324 
There are multiple steps and biases in the processes from a patient seeking care with febrile 325 
illness to the publication of an English language scientific paper on the occurrence and 326 
prevalence of a specific zoonosis that could be included in this review. The underlying 327 
distribution and relative clinical importance of individual pathogens varies, as do patient 328 
healthcare seeking behaviour, clinical, and patient awareness of different pathogens, 329 
diagnostic capacities, and probability of publication. It is therefore not plausible to expect this 330 
review to yield data on all zoonoses in all countries. However, considering the inclusion of 331 
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110 countries and construction of searches for 50 pathogens or pathogen groups, the 332 
identification of just 244 eligible studies underscores the profound overall shortage of robust 333 
quantitative data describing the role of any zoonoses as causes of fever in most malaria-334 
endemic countries.  335 
 336 
The geographic variation in the distribution of studies by country (figure 2) and region 337 
(appendix table S7, figure S2) is likely to be strongly influenced by variation in research and 338 
publication effort. There is noticeable geographic segregation for some zoonoses, with NTS 339 
and SFGR reported more frequently in Africa, and Leptospira spp., Orientia tsutsugamushi, 340 
and typhus-group rickettsioses (TGR) reported more frequently in South-East Asia and 341 
Western Pacific regions (appendix figure S2). For viruses, Lassa virus was reported only in 342 
Africa and JEV predominantly in South-East Asia. The distribution of studies cannot be 343 
interpreted as an accurate reflection of the underlying distribution of zoonotic pathogens, 344 
their prevalence or clinical importance. The pathogens that are looked for depend on factors 345 
such as the diagnostic capacity available, existing data, and local assessment of the likely 346 
causes of febrile illness in a specific location. Once pathogens are identified in any location 347 
there will likely be increased clinical, patient, and community awareness of those pathogens, 348 
as well as improved diagnostic capacity to detect them. In this way, dogma about the ‘known’ 349 
important causes of febrile illness in specific locations can arise and contribute to the neglect 350 
of other pathogens. The findings of this review may help indicate potential gaps in what is 351 
looked for and can highlight pathogens and locations where these dogmas should be 352 
questioned. 353 
 354 
The majority of the 30 zoonotic causes of fever contributing data for this review were 355 
bacteria (56·7%). This proportion is greater than expected from the taxonomic distribution of 356 
all zoonotic pathogens, which comprise 30·1% bacteria
44
 and also contrasts with the 357 
taxonomic distribution of emerging zoonoses, which are dominated by viruses.
13
 This finding 358 
reinforces the clinical importance of endemic bacterial zoonoses. The comparisons between 359 
the number of articles that looked for, diagnosed, and contributed data for each of 40 360 
zoonoses reveals the range of zoonotic pathogens investigated and indicates the relative 361 
investigative effort used for each pathogen (figure 3). However, the figures for number of 362 
articles where a pathogen was looked for but not identified must be interpreted with caution 363 
given the high probability of reporting bias and how rarely negative results are reported. For 364 
several pathogens, the number and proportion of articles that reported a zoonotic diagnosis 365 
but did not contribute further data for analysis (because the diagnostic approaches described 366 
did not meet study quality criteria) are substantial (figure 3). This demonstrates that for 367 
many, predominantly bacterial pathogens, suboptimal diagnostic tests or imprecise case 368 
definitions are in widespread use, highlighting the challenges of accurately quantifying 369 
disease prevalence and comparing studies.  370 
 371 
Persistent challenges in the diagnosis of febrile patients include limited laboratory capacity, 372 
reliance on demonstration of seroconversion for confirmed diagnosis of many pathogens, 373 
unsustainable costs associated with more advanced diagnostic technologies, and lack of 374 
simple and affordable tests for the accurate and timely diagnosis of several zoonotic 375 
pathogens. In addition, the delays in patient presentation that are typical in many resource 376 
limited settings, low magnitude bacteraemia at presentation and, presentation of patients 377 
during the immune phase of illness, all limit the sensitivity of culture or PCR-based 378 
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diagnostic approaches when available. These challenges necessitate syndromic approaches to 379 
patient management and broad-spectrum treatment. One specific issue relates to tetracycline 380 
use. This study identified rickettsioses and O. tsutsugamushi as common causes of fever. 381 
These would benefit from treatment with tetracyclines, which are not currently included in 382 
the Integrated Management of Adolescent and Adult Illness (IMAI) algorithms for septic 383 
shock and severe respiratory distress without shock.
45
 In light of the extensive contribution of 384 
tetracycline-responsive infections to fever in malaria-endemic countries, revisions to clinical 385 
guidelines may be warranted to suggest the empirical use of tetracyclines in addition to beta-386 
lactams in scenarios where the infection with tetracycline-responsive pathogens cannot be 387 
excluded. 388 
 389 
The findings of this review show that one or more zoonotic causes of fever are likely to 390 
present a threat to health in all of the countries included in this review. Only a small 391 
proportion of the febrile populations included in the study were defined as demographically 392 
restricted and most were not clinically differentiated. Even zoonoses commonly linked with 393 
specific syndromes (e.g., Crimean-Congo haemorrhagic fever virus and JEV) were diagnosed 394 
in undifferentiated populations and should thus be considered in the differential diagnosis of 395 
undifferentiated febrile illness. Within populations at risk, it is important that aetiologic 396 
studies are followed by epidemiologic risk factor studies to determine whether certain sub-397 
groups are at higher risk for specific zoonotic diseases. Robust febrile illness surveillance 398 
systems help inform local epidemiology and febrile illness management, and are also 399 
essential for detection of disease outbreaks.
46
 400 
 401 
There are several important limitations to this study. We examined the contribution of 402 
zoonotic pathogens to febrile illness only in malaria-endemic countries and excluded articles 403 
not available in English from our analysis. The restriction of this review to English language 404 
texts will have reduced the probability that studies from French and Spanish speaking 405 
countries were included and may partially account for some gaps, such as the 23 countries in 406 
Africa and 15 in the Americas for which no eligible studies were identified. Studies reporting 407 
all negative test results were excluded. This strategy was motivated by the inevitable 408 
influence of publication bias and challenges of systematically quantifying the non-reporting 409 
of either diagnostic test performance or the non-detection of specific pathogens. Biases in 410 
testing practices for different pathogens in different locations and with different clinical 411 
febrile presentations will influence the pathogens looked for, detected and reported. The 412 
application of diagnostic criteria that are strictly comparable across pathogens is not feasible. 413 
In this study, strict diagnostic criteria were applied, preferentially including diagnostic 414 
approaches with a high specificity, to minimize the influence of false positives within the 415 
analyses. The bias assessments for study representativeness and precision in the estimates of 416 
proportion of fevers attributable to a given pathogen both reveal that the majority of data 417 
points had medium or high risk of one or both types of bias. This emphasizes the need for 418 
cautious and essentially non-quantitative interpretation of the data extracted from these 419 
studies. Many studies with risk of precision bias due to smaller sample size tended to report 420 
the highest prevalences of disease attribution to a given pathogen (figure 5); and, 421 
interestingly, these studies were often also classified as high risk for representativeness bias. 422 
Figure 5 shows clear variation in risk of representativeness bias across pathogens, potentially 423 
linked to variation in clinical presentation. For example, the majority of data points for 424 
Japanese encephalitis virus and indeed all data points for Leishmania donovanii are 425 
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classified as high risk of representativeness bias. This review focused on studies reporting 426 
diagnostic investigation of patient populations that were principally defined by fever and 427 
populations principally defined by a common aetiological diagnosis were excluded (e.g,. 428 
populations defined by presence or suspicion of one or more zoonosis, some of whom were 429 
febrile). This review therefore had an inherently low sensitivity for studies describing disease 430 
outbreaks. This focus explains, for example, the absence of studies describing the 2014-2016 431 
Ebola West Africa outbreak. The design of this review did not allow explicit investigation of 432 
co-infections, either of zoonoses with malaria or of multiple zoonoses. Co-infections are 433 
likely to be an important factor underlying both the distribution and prevalence of some 434 
zoonotic pathogens, including for example nontyphoidal Salmonella serovars.
47
 Serological 435 
diagnosis of acute infection based on testing of both acute and convalescent phase sera is 436 
central to the confirmed diagnosis of multiple pathogens included in the study. As a 437 
consequence, individuals who die prior to the collection of convalescent samples are unlikely 438 
to contribute data (in the absence of other valid test options) and the proportions of fevers 439 
attributable to pathogens with high probability of acute fatality will be under-estimated. 440 
Furthermore, no validity criteria regarding the timing of sample collection for acute and 441 
convalescent samples were imposed, leading potentially to false negative results (e.g., 442 
seroconversion not detected because of premature convalescent sampling). For these reasons, 443 
our findings are unlikely to capture the full extent of morbidity and mortality attributable to 444 
zoonoses. 445 
 446 
The data compiled in this review demonstrate the need to consider multiple zoonoses among 447 
the potential causes of febrile illnesses in malaria-endemic countries. Different zoonoses are 448 
likely to be important in different settings. Our study provides a starting point for improving 449 
awareness of first the zoonoses that are known to contribute to febrile illness in different 450 
malaria-endemic regions and second the fever-causing zoonoses with widespread distribution 451 
that should be considered in patient evaluation. The demonstration of major data gaps should 452 
encourage a more open-minded approach when considering zoonoses as a potential cause of 453 
febrile illness. Continued efforts are needed to develop multi-pathogen diagnostics, ideally 454 
with formats appropriate for point of care use. To avoid perpetuation of self-fulfilling 455 
prophesies that can arise when only pathogens tested for (and detected) are assumed to be 456 
present, the development and evaluation of such diagnostics should be informed by data 457 
describing the pathogens present in specific settings and also the wider context. Untapped 458 
sources of information on the distribution and occurrence of fever-causing zoonoses almost 459 
certainly exist, particularly in the animal health sector. One Health efforts to share data and 460 
knowledge between animal and human health sectors could help raise clinician awareness of 461 
locally relevant zoonoses, inform history taking, and guide diagnostic and management 462 
decision making. Control of disease in animal populations and prevention of transmission 463 
from animals to humans are likely to be the most effective ways to reduce human disease risk 464 
with many zoonoses, necessitating active engagement with populations at risk to develop 465 
sustainable disease control interventions. There are substantial challenges to clinicians and 466 
epidemiologists in revealing the true impacts of many zoonoses. The enormous global burden 467 
of febrile illness and scope for improvements in the diagnosis and treatment of zoonotic 468 
pathogens necessitate efforts to overcome these challenges and translate findings into 469 
important public health gains. 470 
  471 
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 625 
Figures 626 
 627 
Figure 1: Flow diagram of records and articles assessed for the review. 628 
Among the 46 articles excluded because the full text was not accessible in English, the 629 
breakdown of languages was as follows: French (13 articles); Spanish (11 articles); Turkish 630 
(9 articles); Mandarin (6 articles); Portuguese (2 articles); Hebrew (2 articles); Arabic (1 631 
article); Danish (1 article) and Russian (1 article). 632 
 633 
Figure 2: Map illustrating the malaria-endemic countries included in the study and number of 634 
articles contributing data for each country (indicated by colour shading).  635 
 636 
Figure 3: Barchart showing the number of articles that looked for, reported diagnosis of and 637 
contributed data for each of 40, 31 and 30 zoonoses respectively.  638 
These data were tabulated for all zoonoses (n=40) and articles included in the review 639 
(n=244). Bar colour indicates pathogen type and shading differentiates studies that i) 640 
contribute data meeting study diagnostic criteria (left hand bar sections with darkest shading, 641 
n=30 pathogens indicated by *), ii) report diagnosis with approaches that do not meet study 642 
diagnostic criteria (central bar sections with lighter shading, n=31 pathogens that comprised 643 
the 30 with extracted data and Escherichia coli), iii) report looking for but not diagnosing a 644 
zoonosis (right hand bar section with lightest shading, n=40 pathogens, also including 645 
Burkholderia spp. Tick borne encephalitis virus, Marburg virus, Rabies virus, Newcastle 646 
Disease virus, Mycobacterium bovis, Francisella tularensis, Ebola virus and 647 
Cryptosporidium parvum).  648 
 649 
Figure 4: Proportion of fevers attributed to each zoonosis.  650 
The plot includes one data point per study and pathogen combination. The different panels 651 
include data from different WHO regions. Point colour indicates the coding for the risk of 652 
bias for the representativeness of the febrile population and point size is proportional to the 653 
number of individuals tested. Points are jittered on the x axis and shaded to visualize 654 
overlapping points. 655 
 656 
Figure 5: Venn diagram illustrating the associations between febrile population clinical 657 
presentation and pathogens identified.  658 
Circles are scaled to the number of pathogens detected in each type of febrile population. 659 
Undifferentiated, shown in green, 23 pathogens (including pathogens also seen in other 660 
populations); febrile neurological, shown in red, four pathogens; febrile gastrointestinal, 661 
shown in blue, two pathogens; febrile respiratory, shown in purple, one pathogen, febrile 662 
haemorrhagic, shown in yellow, seven pathogens. Five pathogens are not represented in the 663 
figure as they were only detected in febrile populations classified as co-morbid (Listeria spp., 664 
Pasteurella spp. and Toxoplasma gondii) or in febrile populations with a specific febrile 665 
aetiology suspected (Leishmania donavani, and Yersinia pestis).  666 
 667 
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Zoonotic causes of febrile illness in malaria endemic countries: a systematic review 1 
Supplementary Information 2 
 3 
Zoonoses Search Concept Construction 4 
To construct a list of frequently reported zoonotic causes of human fever, we conducted preliminary searches of 5 
Medline and Embase using the search syntax ‘(exp Fever/ OR fever.mp.) AND (exp Zoonoses/ OR zoonoses.mp 6 
OR zoonosis.mp)’ limited to humans. 7 
The outputs of these searches were combined and de-duplicated in R.1 The complete list of all subject headings 8 
associated with these articles was extracted and each heading was classified by two independent reviewers to 9 
identify headings for named disease causing agents or named diseases. Headings that referred to non-specific 10 
pathogen groups e.g., ‘arboviruses’ and those that referred to non-specific clinical symptoms, signs, syndromes, 11 
or diseases e.g., ‘jaundice’ and ‘parasitic diseases’ were excluded. All headings classified as either a pathogen or 12 
disease by one or both reviewers (JEBH and PH) were matched to a list of 1,415 infectious organisms known to 13 
be pathogenic to humans2. Non-zoonotic pathogens or diseases based on the classification by Taylor et al.2 were 14 
excluded. The frequency of appearance of each zoonosis-related heading in the initial search output dataset was 15 
tabulated. Pathogen/disease subject headings that appeared in >10 references identified through the initial ‘Fever 16 
and Zoonoses’ searches were retained. 17 
 18 
For the ‘zoonoses’ concept, the list of zoonotic pathogens identified above was combined with lists of zoonotic 19 
diseases from the World Health Organization (WHO)3 and World Organisation of Animal Health (OIE)4.  20 
 21 
All identified pathogens or diseases were then classified to differentiate pathogens that are normatively acquired 22 
by people through direct or indirect transmission from vertebrate animals to humans, as compared to pathogens 23 
where zoonotic transmission has been recorded but where sustained transmission within human populations also 24 
occurs and the majority of human infections are not acquired through zoonotic transmission. This classification 25 
was made following the definitions used in Wolfe et al.5 Three reviewers (JAC, SC, and MPR) independently 26 
classified listed pathogens or diseases using the stages in the transformation of an animal pathogen into a 27 
specialized pathogen of humans described in Wolfe et al.:5 28 
• Stage 1. A microbe that is present in animals but that has not been detected in humans under natural 29 
conditions (that is, excluding modern technologies that can inadvertently transfer microbes, such as blood 30 
transfusion, organ transplants, or hypodermic needles).  31 
• Stage 2. A pathogen of animals that, under natural conditions, has been transmitted from animals to humans 32 
(‘primary infection’) but has not been transmitted between humans (‘secondary infection’).  33 
• Stage 3. Animal pathogens that can undergo only a few cycles of secondary transmission between humans, 34 
so that occasional human outbreaks triggered by a primary infection soon die out.  35 
• Stage 4. A disease that exists in animals, and that has a natural (sylvatic) cycle of infecting humans by 36 
primary transmission from the animal host, but that also undergoes long sequences of secondary 37 
transmission between humans without the involvement of animal hosts.  38 
• Stage 5. A pathogen exclusive to humans.5 39 
 40 
Tie-breaks were resolved by a fourth independent reviewer (JEBH). Pathogens classified as stages 1 to 3 were 41 
retained. Pathogens classified as stage 4 or 5, where sustained chains of transmission between humans occur, 42 
were excluded from the review.  43 
 44 
Pathogens or diseases included in the list of study zoonoses therefore included all pathogens and diseases that 45 
were: 46 
• Identified through the WHO list, OIE list or preliminary zoonoses search approach AND 47 
• Classified as a zoonoses2 AND 48 
• Classified as a stage 1, 2 or 3 zoonosis.5 49 
 50 
The search concept for each pathogen or disease included exploded subject headings for both the pathogen and 51 
the diseases caused in humans and terms for both pathogen and disease were also included as keywords (e.g., 52 
exp anthrax/ OR anthrax.mp. OR exp Bacillus anthracis/ OR bacillus anthracis.mp.). In instances where 53 
pathogen species within the same genus varied in their zoonotic status, search concepts were constructed to 54 
include all zoonotic and non-zoonotic species and articles relating to non-zoonotic species were excluded at a 55 
later stage. Finally, the list of pathogen- or disease-specific searches were combined using OR syntax to generate 56 
the full ‘zoonoses’ search concept (Medline Search Syntax and Embase Search Syntax sections below).   57 
Appendix
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 58 
Medline Search Syntax 59 
 60 
(exp Anaplasmosis/ OR anaplasmosis.mp. OR exp Anaplasma/ OR anaplasma.mp.)  [set database shortcode to 61 
'pmez'] 62 
(exp Babesiosis/ OR babesiosis.mp. OR exp Babesia/ OR babesia.mp.) 63 
(exp Anthrax/ OR anthrax.mp. OR exp Bacillus anthracis/ OR bacillus anthracis.mp.) 64 
(exp Bartonella Infections/ OR bartonellosis.mp. OR exp Bartonella/ OR bartonella.mp.) 65 
(exp Borrelia Infections/ OR borrelia Infection$1.mp. OR exp Borrelia/ OR borrelia.mp.) 66 
(exp brucellosis/ OR brucellosis.mp. OR exp Brucella/ OR brucella.mp.) 67 
(exp Burkholderia Infections/ OR glanders.mp. OR exp Burkholderia/ OR burkholderia.mp.) 68 
(exp Campylobacter Infections/ OR exp Campylobacter/ OR campylobacter$.mp.) 69 
(exp Psittacosis/ OR psittacosis.mp. OR exp Chlamydophila psittaci/ OR chlamydophila psittaci.mp.) 70 
(exp Cowpox/ OR exp Cowpox virus/ OR cowpox.mp.) 71 
(exp Q Fever/ OR q fever.mp. OR exp Coxiella/ OR coxiella.mp.) 72 
(exp Hemorrhagic Fever, Crimean/ OR crimean-congo h?emorrhagic fever.mp. OR exp Hemorrhagic Fever 73 
Virus, Crimean-Congo/ OR crimean-congo h?emorrhagic fever virus.mp.) 74 
(exp Hemorrhagic Fever, Ebola/ OR ebolavirus infection$1.mp. OR exp Ebolavirus/ OR ebola$.mp.) 75 
(exp Echinococcosis/ OR echinococcosis.mp. OR exp Echinococcus/ OR echinococcus.mp.) 76 
(exp Ehrlichiosis/ OR ehrlichiosis.mp. OR exp Ehrlichia/ OR ehrlichia.mp.) 77 
(exp Encephalomyelitis, Equine/ OR exp Encephalitis Virus, Eastern Equine/ OR exp Encephalitis Virus, 78 
Venezuelan Equine/ OR exp Encephalitis Virus, Western Equine/ OR equine encephalitis.mp. OR equine 79 
encephalomyelitis.mp.) 80 
(exp Escherichia coli Infections/ OR exp Escherichia coli/ OR escherichia coli.mp.) 81 
(exp "Foot-and-Mouth Disease"/ OR exp "Foot-and-Mouth Disease Virus"/ OR "foot and mouth disease".mp. 82 
OR "foot-and-mouth".mp.) 83 
(exp Tularemia/ OR tular?emia.mp. OR exp Francisella tularensis/ OR francisella tularensis.mp.) 84 
(exp Hantavirus Infections/ OR hantavirus infection$1.mp. OR exp Hantavirus/ OR hantavirus.mp.) 85 
(exp Henipavirus Infections/ OR exp Henipavirus/ OR hendra.mp. OR nipah.mp. OR henipavirus.mp.) 86 
(exp Encephalitis, Japanese/ OR exp Encephalitis Virus, Japanese/ OR japanese encephalitis.mp.) 87 
(exp Lassa Fever/ OR exp Lassa virus/ OR lassa.mp.) 88 
(exp Leishmaniasis/ OR leishmaniasis.mp. OR exp Leishmania/ OR leishmania.mp.) 89 
(exp Leptospirosis/ OR leptospirosis.mp. OR exp Leptospira/ OR leptospira.mp.) 90 
(exp Listeriosis/ OR listeriosis.mp. OR exp Listeria/ OR listeria.mp.) 91 
(exp Marburg Virus Disease/ OR marburg h?emorrhagic fever.mp. OR exp Marburgvirus/ OR marburg$.mp.) 92 
(exp Monkeypox/ OR exp Monkeypox virus/ OR monkeypox.mp.) 93 
(exp Tuberculosis, Bovine/ OR bovine tuberculosis.mp. OR exp Mycobacterium bovis/ OR mycobacterium 94 
bovis.mp.) 95 
(exp Paratuberculosis/ OR paratuberculosis.mp. OR exp "Mycobacterium avium subsp. paratuberculosis"/ OR 96 
mycobacterium paratuberculosis.mp.) 97 
(exp Newcastle Disease/ OR exp Newcastle disease virus/ OR newcastle disease.mp.) 98 
(exp Pasteurella Infections/ OR pasteurellosis.mp. OR exp Pasteurella/ OR pasteurella.mp.) 99 
(exp Prion Diseases/ OR exp Prions/ OR prion.mp.) 100 
(exp Rabies/ OR rabies.mp. OR exp Rabies virus/ OR rabies virus.mp.) 101 
(exp Rat-Bite Fever/ OR rat-bite.mp. OR rat bite.mp. OR exp Streptobacillus/ OR exp Spirillum/ OR 102 
streptobacillus.mp. OR spirillum.mp.) 103 
(exp Rickettsiaceae Infections/ OR rickettsiaceae infection$1.mp. OR rickettsiosis.mp. OR exp Rickettsieae/ OR 104 
rickettsia.mp.) 105 
(exp Rift Valley Fever/ OR rift valley fever.mp. OR exp Rift Valley fever virus/ OR rift valley fever virus.mp.) 106 
(exp Salmonella Infections/ OR salmonellosis.mp. OR exp Salmonella/ OR salmonella.mp.) 107 
(exp Schistosomiasis/ OR schistosomiasis.mp. OR exp Schistosoma/ OR schistosoma.mp.) 108 
(exp Streptococcal Infections/ OR streptococcal.mp. OR exp Streptococcus/ OR streptococcus.mp.) 109 
(exp Pseudorabies/ OR pseudorabies.mp. OR exp Herpesvirus 1, Suid/ OR suid herpesvirus.mp. OR 110 
aujeszky$.mp.) 111 
(exp Swine Vesicular Disease/ OR swine vesicular.mp. OR exp Enterovirus/ OR enterovirus.mp.) 112 
(exp Cysticercosis/ OR cysticercosis.mp. OR exp Taenia/ OR taenia.mp.) 113 
(exp Encephalitis, Tick-Borne/ OR tick borne encephalitis.mp. OR exp Encephalitis Viruses, Tick-Borne/ OR 114 
tick borne encephalitis virus.mp.) 115 
(exp Toxocariasis/ OR toxocariasis.mp. OR exp Toxocara/ OR toxocara.mp.) 116 
(exp Toxoplasmosis/ OR toxoplasmosis.mp. OR exp Toxoplasma/ OR toxoplasma.mp.) 117 
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(exp Trichinellosis/ OR trichinellosis.mp. OR exp Trichinella/ OR trichinella.mp.) 118 
(exp Trypanosomiasis/ OR trypanosomiasis.mp. OR exp Trypanosoma/ OR trypanosoma.mp.) 119 
(exp Vaccinia/ OR exp Vaccinia virus/ OR vaccinia.mp.) 120 
(exp Vesicular Stomatitis/ OR exp Vesiculovirus/ OR vesicular stomatitis.mp.) 121 
(exp West Nile Fever/ OR west nile fever.mp. OR exp West Nile virus/ OR west nile virus.mp.) 122 
(exp Yersinia Infections/ OR yersinia infection$1.mp. OR exp Yersinia/ OR yersinia.mp. OR plague.mp.) 123 
(exp "Georgia (Republic)"/ OR "Georgia (Republic)".mp.) 124 
(exp Afghanistan/ OR Afghanistan.mp.) 125 
(exp Algeria/ OR Algeria.mp.) 126 
(exp Angola/ OR Angola.mp.) 127 
(exp Argentina/ OR Argentina.mp.) 128 
(exp Armenia/ OR Armenia.mp.) 129 
(exp Azerbaijan/ OR Azerbaijan.mp.) 130 
(exp Bahamas/ OR Bahamas.mp.) 131 
(exp Bangladesh/ OR Bangladesh.mp.) 132 
(exp Belize/ OR Belize.mp.) 133 
(exp Benin/ OR Benin.mp.) 134 
(exp Bhutan/ OR Bhutan.mp.) 135 
(exp Bolivia/ OR Bolivia.mp.) 136 
(exp Botswana/ OR Botswana.mp.) 137 
(exp Brazil/ OR Brazil.mp.) 138 
(exp Burkina Faso/ OR Burkina Faso.mp.) 139 
(exp Burundi/ OR Burundi.mp.) 140 
(exp Cambodia/ OR Cambodia.mp.) 141 
(exp Cameroon/ OR Cameroon.mp.) 142 
(exp Cape Verde/ OR Cape Verde.mp.) 143 
(exp Central African Republic/ OR Central African Republic.mp.) 144 
(exp Chad/ OR Chad.mp.) 145 
(exp China/ OR China.mp.) 146 
(exp Colombia/ OR Colombia.mp.) 147 
(exp Comoros/ OR Comoros.mp.) 148 
(exp Congo/ OR Congo.mp.) 149 
(exp Costa Rica/ OR Costa Rica.mp.) 150 
(exp Cote d'Ivoire/ OR Cote d'Ivoire.mp.) 151 
(exp Democratic People's Republic of Korea/ OR Democratic People's Republic of Korea.mp.) 152 
(exp Democratic Republic of the Congo/ OR Democratic Republic of the Congo.mp.) 153 
(exp Djibouti/ OR Djibouti.mp.) 154 
(exp Dominican Republic/ OR Dominican Republic.mp.) 155 
(exp East Timor/ OR East Timor.mp.) 156 
(exp Ecuador/ OR Ecuador.mp.) 157 
(exp Egypt/ OR Egypt.mp.) 158 
(exp El Salvador/ OR El Salvador.mp.) 159 
(exp Equatorial Guinea/ OR Equatorial Guinea.mp.) 160 
(exp Eritrea/ OR Eritrea.mp.) 161 
(exp Ethiopia/ OR Ethiopia.mp.) 162 
(exp French Guiana/ OR French Guiana.mp.) 163 
(exp Gabon/ OR Gabon.mp.) 164 
(exp Gambia/ OR Gambia.mp.) 165 
(exp Ghana/ OR Ghana.mp.) 166 
(exp Guatemala/ OR Guatemala.mp.) 167 
(exp Guinea/ OR Guinea.mp.) 168 
(exp Guinea-Bissau/ OR Guinea-Bissau.mp.) 169 
(exp Guyana/ OR Guyana.mp.) 170 
(exp Haiti/ OR Haiti.mp.) 171 
(exp Honduras/ OR Honduras.mp.) 172 
(exp India/ OR India.mp.) 173 
(exp Indonesia/ OR Indonesia.mp.) 174 
(exp Iran/ OR Iran.mp.) 175 
(exp Iraq/ OR Iraq.mp.) 176 
(exp Jamaica/ OR Jamaica.mp.) 177 
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(exp Kenya/ OR Kenya.mp.) 178 
(exp Kyrgyzstan/ OR Kyrgyzstan.mp.) 179 
(exp Laos/ OR Laos.mp.) 180 
(exp Liberia/ OR Liberia.mp.) 181 
(exp Madagascar/ OR Madagascar.mp.) 182 
(exp Malawi/ OR Malawi.mp.) 183 
(exp Malaysia/ OR Malaysia.mp.) 184 
(exp Mali/ OR Mali.mp.) 185 
(exp Mauritania/ OR Mauritania.mp.) 186 
(exp Mauritius/ OR Mauritius.mp.) 187 
(exp Mexico/ OR Mexico.mp.) 188 
(exp Morocco/ OR Morocco.mp.) 189 
(exp Mozambique/ OR Mozambique.mp.) 190 
(exp Myanmar/ OR Myanmar.mp.) 191 
(exp Namibia/ OR Namibia.mp.) 192 
(exp Nepal/ OR Nepal.mp.) 193 
(exp Nicaragua/ OR Nicaragua.mp.) 194 
(exp Niger/ OR Niger.mp.) 195 
(exp Nigeria/ OR Nigeria.mp.) 196 
(exp Oman/ OR Oman.mp.) 197 
(exp Pakistan/ OR Pakistan.mp.) 198 
(exp Panama/ OR Panama.mp.) 199 
(exp Papua New Guinea/ OR Papua New Guinea.mp.) 200 
(exp Paraguay/ OR Paraguay.mp.) 201 
(exp Peru/ OR Peru.mp.) 202 
(exp Philippines/ OR Philippines.mp.) 203 
(exp Republic of Korea/ OR Republic of Korea.mp.) 204 
(exp Russia/ OR Russia.mp.) 205 
(exp Rwanda/ OR Rwanda.mp.) 206 
(exp Sao Tome/ OR Sao Tome.mp.) 207 
(exp Saudi Arabia/ OR Saudi Arabia.mp.) 208 
(exp Senegal/ OR Senegal.mp.) 209 
(exp Sierra Leone/ OR Sierra Leone.mp.) 210 
(exp Solomon Islands/ OR Solomon Islands.mp.) 211 
(exp Somalia/ OR Somalia.mp.) 212 
(exp South Africa/ OR South Africa.mp.) 213 
(exp Sri Lanka/ OR Sri Lanka.mp.) 214 
(exp Sudan/ OR Sudan.mp.) 215 
(exp Suriname/ OR Suriname.mp.) 216 
(exp Swaziland/ OR Swaziland.mp.) 217 
(exp Syria/ OR Syria.mp.) 218 
(exp Tajikistan/ OR Tajikistan.mp.) 219 
(exp Tanzania/ OR Tanzania.mp.) 220 
(exp Thailand/ OR Thailand.mp.) 221 
(exp Togo/ OR Togo.mp.) 222 
(exp Turkey/ OR Turkey.mp.) 223 
(exp Turkmenistan/ OR Turkmenistan.mp.) 224 
(exp Uganda/ OR Uganda.mp.) 225 
(exp Uzbekistan/ OR Uzbekistan.mp.) 226 
(exp Vanuatu/ OR Vanuatu.mp.) 227 
(exp Venezuela/ OR Venezuela.mp.) 228 
(exp Vietnam/ OR Vietnam.mp.) 229 
(exp Yemen/ OR Yemen.mp.) 230 
(exp Zambia/ OR Zambia.mp.) 231 
(exp Zimbabwe/ OR Zimbabwe.mp.) 232 
(exp Africa/ OR africa.mp) 233 
(exp Fever/ OR fever$1.mp. OR febrile.mp.) 234 
or/1-52 235 
or/53-162 236 
164 AND 165 237 
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163 AND 166 238 
..l/167 yr=2004-2019 239 
 240 
  241 
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 242 
Embase Search Syntax 243 
 244 
(exp anaplasmosis/ OR exp human granulocytic anaplasmosis/ OR anaplasmosis.mp. OR exp Anaplasma/ OR 245 
anaplasma.mp.)  [set database shortcode to 'emczd'] 246 
(exp babesiosis/ OR babesiosis.mp. OR exp Babesia/ OR babesia.mp.) 247 
(exp anthrax/ OR anthrax.mp. OR exp Bacillus anthracis/ OR bacillus anthracis.mp.) 248 
(exp bartonellosis/ OR bartonellosis.mp. OR exp Bartonella/ OR bartonella.mp.) 249 
(exp Borrelia infection/ OR borrelia Infection$1.mp. OR exp Borrelia/ OR borrelia.mp.) 250 
(exp brucellosis/ OR brucellosis.mp. OR exp Brucella/ OR brucella.mp.) 251 
(exp Burkholderia infection/ OR glanders.mp. OR exp Burkholderia/ OR burkholderia.mp.) 252 
(exp campylobacteriosis/ OR exp Campylobacter/ OR campylobacter$.mp.) 253 
(exp ornithosis/ OR psittacosis.mp. OR exp Chlamydophila psittaci/ OR chlamydophila psittaci.mp.) 254 
(exp cowpox/ OR exp Cowpox virus/ OR cowpox.mp.) 255 
(exp Q fever/ OR q fever.mp. OR exp Coxiella/ OR coxiella.mp.) 256 
(exp Crimean Congo hemorrhagic fever/ OR crimean-congo h?emorrhagic fever.mp. OR exp Nairo virus/ OR 257 
crimean-congo h?emorrhagic fever virus.mp.) 258 
(exp Ebola hemorrhagic fever/ OR ebolavirus infection$1.mp. OR exp Ebola virus/ OR ebola$.mp.) 259 
(exp echinococcosis/ OR echinococcosis.mp. OR exp Echinococcus/ OR echinococcus.mp.) 260 
(exp ehrlichiosis/ OR ehrlichiosis.mp. OR exp Ehrlichia/ OR ehrlichia.mp.) 261 
(exp Eastern equine encephalitis/ OR exp Venezuelan equine encephalitis/ OR exp Western equine encephalitis/ 262 
OR exp Eastern equine encephalomyelitis virus/ OR exp Venezuelan equine encephalomyelitis alphavirus/ OR 263 
exp Western equine encephalomyelitis alphavirus/ OR equine encephalitis.mp. OR equine 264 
encephalomyelitis.mp.) 265 
(exp Escherichia coli infection/ OR exp Escherichia coli/ OR escherichia coli.mp.) 266 
(exp "foot and mouth disease"/ OR exp "Foot and mouth disease virus"/ OR "foot and mouth disease".mp. OR 267 
"foot-and-mouth".mp.) 268 
(exp tularemia/ OR tular?emia.mp. OR exp Francisella tularensis/ OR francisella tularensis.mp.) 269 
(exp Hantavirus infection/ OR hantavirus infection$1.mp. OR exp Hantavirus/ OR hantavirus.mp.) 270 
(exp Nipah virus infection/ OR exp Hendra virus infection/ OR exp Nipah virus/ OR exp Hendra virus/ OR 271 
hendra.mp. OR nipah.mp. OR henipavirus.mp.) 272 
(exp Japanese encephalitis/ OR exp Japanese encephalitis virus/ OR japanese encephalitis.mp.) 273 
(exp Lassa fever/ OR  exp Lassa virus/ OR lassa.mp) 274 
(exp leishmaniasis/ OR leishmaniasis.mp. OR exp Leishmania/ OR leishmania.mp.) 275 
(exp leptospirosis/ OR leptospirosis.mp. OR exp Leptospira/ OR leptospira.mp.) 276 
(exp listeriosis/ OR listeriosis.mp. OR exp Listeria/ OR listeria.mp.) 277 
(exp Marburg hemorrhagic fever/ OR marburg h?emorrhagic fever.mp. OR exp Marburg virus/ OR 278 
marburg$.mp.) 279 
(exp monkeypox/ OR exp Monkeypox virus/ OR monkeypox.mp.) 280 
(exp bovine tuberculosis/ OR bovine tuberculosis.mp. OR exp Mycobacterium bovis/ OR mycobacterium 281 
bovis.mp.) 282 
(exp paratuberculosis/ OR paratuberculosis.mp. OR exp Mycobacterium paratuberculosis/ OR mycobacterium 283 
paratuberculosis.mp.) 284 
(exp Newcastle disease/ OR exp Newcastle disease paramyxovirus/ OR newcastle disease.mp.) 285 
(exp pasteurellosis/ OR pasteurellosis.mp. OR exp Pasteurella/ OR pasteurella.mp.) 286 
(exp prion disease/ OR exp prion/ OR prion.mp.) 287 
(exp rabies/ OR rabies.mp. OR exp Rabies virus/ OR rabies virus.mp.) 288 
(exp rat bite fever/ OR rat-bite.mp. OR rat bite.mp. OR exp Streptobacillus/ OR exp Spirillum/ OR 289 
streptobacillus.mp. OR spirillum.mp.) 290 
(exp Rickettsiaceae infection/ OR rickettsiaceae infection$1.mp.OR rickettsiosis.mp. OR exp Rickettsiaceae/ OR 291 
rickettsia.mp.) 292 
(exp Rift Valley fever/ OR rift valley fever.mp. OR exp Rift Valley fever bunyavirus/ OR rift valley fever 293 
virus.mp.) 294 
(exp salmonellosis/ OR exp animal salmonellosis/ OR salmonellosis.mp. OR exp Salmonella/ OR 295 
salmonella.mp.) 296 
(exp schistosomiasis/ OR schistosomiasis.mp. OR exp Schistosoma/ OR schistosoma.mp.) 297 
(exp Streptococcus infection/ OR streptococcal.mp. OR exp Streptococcus/ OR streptococcus.mp.) 298 
(exp pseudorabies/ OR pseudorabies.mp. OR exp Pseudorabies herpetovirus/ OR suid herpesvirus.mp. OR 299 
aujeszky$.mp.) 300 
(exp swine vesicular disease/ OR swine vesicular.mp. OR exp Enterovirus/ OR enterovirus.mp.) 301 
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(exp cysticercosis/ OR cysticercosis.mp. OR exp Taenia/ OR taenia.mp.) 302 
(exp tick borne encephalitis/ OR tick borne encephalitis.mp. OR exp Tick borne encephalitis flavivirus/ OR tick 303 
borne encephalitis virus.mp.) 304 
(exp toxocariasis/ OR toxocariasis.mp. OR exp Toxocara/ OR toxocara.mp.) 305 
(exp toxoplasmosis/ OR exp congenital toxoplasmosis/ OR toxoplasmosis.mp. OR exp Toxoplasma/ OR 306 
toxoplasma.mp.) 307 
(exp trichinosis/ OR trichinellosis.mp. OR exp Trichinella/ OR trichinella.mp.) 308 
(exp trypanosomiasis/ OR trypanosomiasis.mp. OR exp Trypanosoma/ OR trypanosoma.mp.) 309 
(exp vaccinia/ OR exp Vaccinia virus/ OR vaccinia.mp.) 310 
(exp vesicular stomatitis/ OR exp Vesicular stomatitis virus/ OR vesicular stomatitis.mp.) 311 
(exp West Nile fever/ OR west nile fever.mp. OR exp West Nile flavivirus/ OR west nile virus.mp.) 312 
(exp Yersinia infection/ OR yersinia infection$1.mp. OR exp Yersinia/ OR yersinia.mp. OR plague.mp.) 313 
(exp "Georgia (republic)"/ OR "Georgia (republic)".mp.) 314 
(exp "Turkey (republic)"/ OR "Turkey (republic)".mp.) 315 
(exp Afghanistan/ OR Afghanistan.mp.) 316 
(exp Algeria/ OR Algeria.mp.) 317 
(exp Angola/ OR Angola.mp.) 318 
(exp Argentina/ OR Argentina.mp.) 319 
(exp Armenia/ OR Armenia.mp.) 320 
(exp Azerbaijan/ OR Azerbaijan.mp.) 321 
(exp Bahamas/ OR Bahamas.mp.) 322 
(exp Bangladesh/ OR Bangladesh.mp.) 323 
(exp Belize/ OR Belize.mp.) 324 
(exp Benin/ OR Benin.mp.) 325 
(exp Bhutan/ OR Bhutan.mp.) 326 
(exp Bolivia/ OR Bolivia.mp.) 327 
(exp Botswana/ OR Botswana.mp.) 328 
(exp Brazil/ OR Brazil.mp.) 329 
(exp Burkina Faso/ OR Burkina Faso.mp.) 330 
(exp Burundi/ OR Burundi.mp.) 331 
(exp Cambodia/ OR Cambodia.mp.) 332 
(exp Cameroon/ OR Cameroon.mp.) 333 
(exp Cape Verde/ OR Cape Verde.mp.) 334 
(exp Central African Republic/ OR Central African Republic.mp.) 335 
(exp Chad/ OR Chad.mp.) 336 
(exp China/ OR China.mp.) 337 
(exp Colombia/ OR Colombia.mp.) 338 
(exp Comoros/ OR Comoros.mp.) 339 
(exp Congo/ OR Congo.mp.) 340 
(exp Costa Rica/ OR Costa Rica.mp.) 341 
(exp Cote d'Ivoire/ OR Cote d'Ivoire.mp.) 342 
(exp Democratic Republic Congo/ OR Democratic Republic Congo.mp.) 343 
(exp Djibouti/ OR Djibouti.mp.) 344 
(exp Dominican Republic/ OR Dominican Republic.mp.) 345 
(exp Ecuador/ OR Ecuador.mp.) 346 
(exp Egypt/ OR Egypt.mp.) 347 
(exp El Salvador/ OR El Salvador.mp.) 348 
(exp Equatorial Guinea/ OR Equatorial Guinea.mp.) 349 
(exp Eritrea/ OR Eritrea.mp.) 350 
(exp Ethiopia/ OR Ethiopia.mp.) 351 
(exp French Guiana/ OR French Guiana.mp.) 352 
(exp Gabon/ OR Gabon.mp.) 353 
(exp Gambia/ OR Gambia.mp.) 354 
(exp Ghana/ OR Ghana.mp.) 355 
(exp Guatemala/ OR Guatemala.mp.) 356 
(exp Guinea/ OR Guinea.mp.) 357 
(exp Guinea-Bissau/ OR Guinea-Bissau.mp.) 358 
(exp Guyana/ OR Guyana.mp.) 359 
(exp Haiti/ OR Haiti.mp.) 360 
(exp Honduras/ OR Honduras.mp.) 361 
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(exp India/ OR India.mp.) 362 
(exp Indonesia/ OR Indonesia.mp.) 363 
(exp Iran/ OR Iran.mp.) 364 
(exp Iraq/ OR Iraq.mp.) 365 
(exp Jamaica/ OR Jamaica.mp.) 366 
(exp Kenya/ OR Kenya.mp.) 367 
(exp Kyrgyzstan/ OR Kyrgyzstan.mp.) 368 
(exp Laos/ OR Laos.mp.) 369 
(exp Liberia/ OR Liberia.mp.) 370 
(exp Madagascar/ OR Madagascar.mp.) 371 
(exp Malawi/ OR Malawi.mp.) 372 
(exp Malaysia/ OR Malaysia.mp.) 373 
(exp Mali/ OR Mali.mp.) 374 
(exp Mauritania/ OR Mauritania.mp.) 375 
(exp Mauritius/ OR Mauritius.mp.) 376 
(exp Mexico/ OR Mexico.mp.) 377 
(exp Morocco/ OR Morocco.mp.) 378 
(exp Mozambique/ OR Mozambique.mp.) 379 
(exp Myanmar/ OR Myanmar.mp.) 380 
(exp Namibia/ OR Namibia.mp.) 381 
(exp Nepal/ OR Nepal.mp.) 382 
(exp Nicaragua/ OR Nicaragua.mp.) 383 
(exp Niger/ OR Niger.mp.) 384 
(exp Nigeria/ OR Nigeria.mp.) 385 
(exp North Korea/ OR North Korea.mp.) 386 
(exp Oman/ OR Oman.mp.) 387 
(exp Pakistan/ OR Pakistan.mp.) 388 
(exp Panama/ OR Panama.mp.) 389 
(exp Papua New Guinea/ OR Papua New Guinea.mp.) 390 
(exp Paraguay/ OR Paraguay.mp.) 391 
(exp Peru/ OR Peru.mp.) 392 
(exp Philippines/ OR Philippines.mp.) 393 
(exp Russian Federation/ OR Russian Federation.mp.) 394 
(exp Rwanda/ OR Rwanda.mp.) 395 
(exp Sao Tome and Principe/ OR Sao Tome and Principe.mp.) 396 
(exp Saudi Arabia/ OR Saudi Arabia.mp.) 397 
(exp Senegal/ OR Senegal.mp.) 398 
(exp Sierra Leone/ OR Sierra Leone.mp.) 399 
(exp Solomon Islands/ OR Solomon Islands.mp.) 400 
(exp Somalia/ OR Somalia.mp.) 401 
(exp South Africa/ OR South Africa.mp.) 402 
(exp South Korea/ OR South Korea.mp.) 403 
(exp Sri Lanka/ OR Sri Lanka.mp.) 404 
(exp Sudan/ OR Sudan.mp.) 405 
(exp Suriname/ OR Suriname.mp.) 406 
(exp Swaziland/ OR Swaziland.mp.) 407 
(exp Syrian Arab Republic/ OR Syrian Arab Republic.mp.) 408 
(exp Tajikistan/ OR Tajikistan.mp.) 409 
(exp Tanzania/ OR Tanzania.mp.) 410 
(exp Thailand/ OR Thailand.mp.) 411 
(exp Timor-Leste/ OR Timor-Leste.mp.) 412 
(exp Togo/ OR Togo.mp.) 413 
(exp Turkmenistan/ OR Turkmenistan.mp.) 414 
(exp Uganda/ OR Uganda.mp.) 415 
(exp Uzbekistan/ OR Uzbekistan.mp.) 416 
(exp Vanuatu/ OR Vanuatu.mp.) 417 
(exp Venezuela/ OR Venezuela.mp.) 418 
(exp Viet Nam/ OR Viet Nam.mp.) 419 
(exp Yemen/ OR Yemen.mp.) 420 
(exp Zambia/ OR Zambia.mp.) 421 
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(exp Zimbabwe/ OR Zimbabwe.mp.) 422 
(exp Africa/ OR africa.mp) 423 
(exp fever/ OR fever$1.mp. OR febrile.mp.) 424 
or/1-52 425 
or/53-162 426 
164 AND 165 427 
163 AND 166 428 
..l/167 yr=2004-2019 429 
 430 
  431 
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 432 
Abstract Screening 433 
Conference proceedings, records that did not include any abstract text, and records that did not have an abstract 434 
in English were excluded. Remaining records were evaluated against the criteria listed in table S1. Records that 435 
did not present data from a malaria-endemic country were also excluded. Full text articles were sought for all 436 
articles not excluded at the abstract review step. 437 
 438 
Table S1. Criteria applied for abstract screening. 439 
Criterion Guidance Outcome 
Inc1FeverPopn Does the Title/Abstract refer to clinical and/or laboratory evaluation 
of a group of two or more humans that are explicitly described using 
one or more of the of the following terms: 
Febrile / fever(s) / pyrexia(s) /temperature ≥ 38.0C / body 
temperature elevation? 
If Yes, retain and evaluate 
Inc1ZooPath. 
 
If No, exclude. 
Inc1ZooPath Does the Title/Abstract refer to diagnosis of this febrile population 
with one or more of the pathogens/diseases included in this study 
(table 1 in main paper)? 
If Yes, retain and evaluate 
Exc1PathogenFocus. 
 
If No, evaluate Inc1Bcx. 
Inc1Bcx Does the Title/Abstract refer to the use of blood culture for the 
diagnosis of this febrile population? 
If Yes, retain and evaluate 
Exc1PathogenFocus. 
 
If No, exclude. 
Exc1PathogenFocus Does the Title/Abstract refer to a group of two or more humans that 
are principally classified on the basis of a common (i.e. 100% 
frequency) aetiological diagnosis, some proportion of which may 
also have fever? 
If Yes, exclude. 
 
If No, retain for full text review.  
 440 
Full Text Review 441 
Full text articles were evaluated by two independent reviewers against the criteria listed in table S2.  442 
 443 
Table S2. Criteria applied for full text review of articles. 444 
Criterion Guidance Outcome 
Inc2FP Does the article provide details/inclusion criteria for one or more human 
population(s) (of more than one person) that explicitly includes acute 
fever/febrile illness as part of the inclusion criteria?  
If Yes, retain and evaluate 
Inc2ZP. 
 
If No, exclude. 
Inc2ZP Does the article provide data on the diagnosis of a zoonotic pathogen as 
defined on the species level list (table 1 in main paper)?  
 
If Yes, retain and evaluate 
Inc2DT. 
 
If No, exclude. 
Inc2DT Does the article provide details of one or more diagnostic test procedure(s) for 
one or more of the zoonotic pathogens included in this study that meets >1 of 
the following criteria and are used to test >1 febrile people? 
1 – culture of the pathogen from sample(s) collected from a febrile person 
2 – direct detection of the pathogen (e.g., by PCR based techniques) from 
sample(s) collected from a febrile person 
3 – serological diagnosis of acute infection based on testing of both acute and 
convalescent phase serum samples and demonstration of seroconversion 
4 – diagnosis of acute infection based on detection of pathogen-specific 
antibody or antigens in a single serum sample only for selected pathogens, for 
which widely accepted case definitions deemed pathogen-specific antibody or 
antigen detection sufficiently accurate (table 2 in main paper)  
5 – IgM detection in CSF for selected pathogens for which widely accepted 
case definitions include IgM detection in CSF (table 2 in main paper) 
If Yes, retain, record coding of 
valid tests and evaluate 
Exc2nTests. 
 
If No, exclude. 
Exc2nTests Does the article lack detail on the number of people tested for each study 
pathogen with each testing method/case definition that meets the above 
criteria? 
If Yes, exclude. 
 
If No, retain and evaluate 
Exc2AllNeg. 
Exc2AllNeg Does the article give the number of people tested for a study pathogen with a 
test method/case definition that meets the above criteria, but all tested 
individuals are negative? 
If Yes, exclude. 
 
If No, retain and evaluate 
Exc2DV. 
Exc2DV Does the article present data from a study designed to evaluate diagnostic test 
and/or vaccine performance without presenting ‘new data’ on the 
number/proportion of patients diagnosed with pathogen x from a described 
population of febrile humans? 
If Yes, exclude. 
 
If No, retain and evaluate 
Exc2Rev. 
Exc2Rev Does the article provide a review of previously published data only, without 
presenting ‘new’ primary data on the number/proportion of patients diagnosed 
with pathogen x? 
If Yes, exclude. 
 
If No, retain and evaluate 
Exc2PF. 
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Exc2PF Does the article refer to a group of two or more humans that are principally 
classified on the basis of a common (e.g., 100% frequency) aetiological 
diagnosis, some proportion of which may also have fever? 
If Yes, exclude. 
 
If No, retain and carry forward 
for data extraction. 
 445 
Data extraction 446 
Articles were excluded during data extraction if they did not meet one or more of the study inclusion criteria or 447 
did meet one or more of the exclusion criteria described above for full text review. For all included studies, data 448 
were extracted in two stages. First, article level data were extracted following the guidance given in table S3. 449 
 450 
Article level data collection on individual pathogens included the names of each of the zoonotic pathogens that 451 
the article described diagnostic methods for and the names of the zoonotic pathogens that were diagnosed in the 452 
study. These classifications record the named zoonoses that each study reported looking for and diagnosing, 453 
irrespective of the diagnostic approach used or level of detail given. 454 
 455 
At the second step, data were extracted the for each combination of zoonotic pathogen and diagnostic test 456 
approach that met study validity criteria following the guidance given in table S4. In instances where more than 457 
one diagnostic method was used for a given pathogen (e.g., culture and serology-based case definitions), data on 458 
the total number of individuals tested and positive using valid diagnostics for a given pathogen were aggregated. 459 
Data were only extracted for diagnosed pathogens and no data were extracted for pathogens not identified, even 460 
when common diagnostic approaches were used. For example, in studies conducting blood cultures the number 461 
of individuals tested and positive for each identified zoonosis were extracted but no data were extracted on the 462 
number of individuals who tested negative for other pathogens that could be identified by that blood culture. 463 
 464 
When duplicate records were identified, e.g., when two articles reported identical data on pathogen detection in 465 
the same population, the later duplicate record was removed from the dataset for analysis.  466 
 467 
Extracted data were used to classify study and outcome level attributes according to the pre-defined criteria for 468 
bias assessment given in table S5. 469 
 470 
Table S3. Data extracted for each article included in the review. 471 
Data to be extracted Guidance 
Country and WHO region Record the country or countries in which the reported study was conducted (i.e. 
the country where the febrile population was identified, and data were collected). 
Country name spellings and regional classifications are as defined by the WHO.  
Start year of data collection Record the start year for the period over which the reported study was conducted 
(i.e. the period when the febrile population was identified, and data were 
collected).  
End of data collection Record the end year for the period over which the reported study was conducted 
(i.e. the period when the febrile population was identified, and data were 
collected). 
Fever population description Record a general description of the febrile population investigated in this study. 
Fever population eligibility Record the inclusion and exclusion criteria used to define eligibility of 
participants in this study. 
Specific aetiologies excluded Record if patients with any specific aetiologies or syndromes were excluded in 
this study. Generalised exclusions such as “known causes of fever “, “obvious 
focus of infection” or ‘obvious explanations of febrile illness” were not classified 
here.  
Details of exclusions Record the details of the named aetiologies and/or syndromes excluded. 
Differentiated or undifferentiated fever Classify each study population as undifferentiated febrile population or 
differentiated febrile population according to the reported clinical presentation.  
Febrile population classification Classify differentiated febrile populations as: i) febrile neurologic presentation; ii) 
febrile haemorrhagic presentation; iii) febrile gastrointestinal presentation; iv) 
febrile respiratory presentation; v) specific febrile aetiology suspected (i.e., 
leishmaniasis, leptospirosis, plague, and rickettsiosis); vi) fever in a high specific 
co-morbid group (i.e. malignancy, immunocompromise). 
Age Record details provided about the ages of the febrile population  
Demographic restriction Record the details of any demographic restriction of the study population e.g., 
restriction of the study population to individuals meeting specific criteria for age 
or sex. 
Urban or rural population 
 
Record whether or not the study was conducted in a predominantly urban 
population, predominantly rural or mixed. 
Inpatient or outpatient population 
 
Record whether or not the febrile population described were inpatients (e.g., 
admitted to a healthcare facility), outpatients (e.g., patients seeking care at a 
healthcare facility but apparently not admitted) or if the study was population-
based. 
Outbreak Record whether or not the study reports that data collection was conducted during 
a reported outbreak or not and the disease/syndrome described if Yes. 
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Zoonotic pathogens diagnosed among febrile 
patients 
Was any proportion of the reported febrile population diagnosed with a zoonotic 
pathogen? 
Pathogens looked for For each zoonosis mentioned in the article record 1 if the article describes a 
diagnostic approach taken to identify individuals infected with that pathogen. 
Record 0 for each zoonosis where this is not the case. 
Pathogens diagnosed For each zoonosis mentioned in the article record 1 if the article reports more than 
one member of a febrile population diagnosed with this pathogen (irrespective of 
the diagnostics used). Record 0 for each zoonosis where this is not the case. 
 472 
Table S4. Data extracted for each zoonotic pathogen diagnosed by a valid method.  473 
Data to be extracted Guidance 
Zoonotic pathogen identified Record the pathogen diagnosed using valid diagnostic methods. 
Type of sample Record the details of the sample(s) tested with each specific test/approach. 
Diagnostic method used Record the type of diagnostic test(s) used for each specific test/approach. 
Number of individuals tested for that pathogen by 
valid methods 
Record the number of febrile patients tested using the valid diagnostics described 
in this row of the dataset specifically. 
Number of individuals diagnosed as positive for that 
pathogen by valid methods 
Record the number of febrile patients classified as positive using the valid 
diagnostics described in this row of the dataset specifically. 
Indicator for multiple diagnostic methods for given 
pathogen in this reference 
Record Yes (1) if there is more than one row of data for this pathogen and 
reference combination. 
 474 
Bias evaluation 475 
Each population was classified as low, medium or high risk of bias against the representativeness and precision 476 
criteria as detailed in table S5.  477 
 478 
Table S5. Criteria for bias assessment and classification of study and population level attributes. 479 
Criteria Risk of bias 
classification 
Description 
Study representativeness Low Undifferentiated febrile population with no demographic restriction 
and no aetiologies or syndromes excluded. 
 Medium Undifferentiated febrile population with demographic restriction or 
one or more aetiologies and/or syndromes excluded. 
 High Febrile population classified as differentiated (table S4) or sampled 
during an identified disease outbreak. 
Precision of percentage fevers 
attributed to zoonosis 
Low Number of individual tested > 385. 
 Medium Number of individuals tested > 139 and ≤385. 
 High Number of individuals tested ≤ 139. 
 480 
 481 
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Results 482 
 483 
Table S6: Characteristics and summary of the 244 articles and 309 records of zoonosis diagnosis included in the review. 484 
Study population abbreviations: UN = undifferentiated; D = differentiated; COMORBID  = febrile co-morbid group GI = febrile gastrointestinal; HEM = febrile 485 
haemorrhagic; NEU = febrile neurological; RESP; febrile respiratory; SP = specific febrile aetiology suspected.  486 
Diagnostics abbreviations: ELISA = enzyme linked immunosorbent assay; HI = haemagglutination inhibition test; IFA = immunofluorescence assay; IgM = IgM detection; 487 
MAT = microscopic agglutination test; PCR = polymerase chain reaction-based test; PRNT = plaque reduction neutralisation test. When multiple diagnostics used different 488 
tests are separated by “,”. 489 
An excel format version of this table, including additional data fields is accessible at: http://dx.doi.org/10.5525/gla.researchdata.890  490 
Pathogen First author, year of 
publication and 
reference 
Country Study 
Period 
Study Population 
Classification 
Diagnostics Used Number 
Tested 
Number 
Positive 
Representativeness Bias 
Coding 
Precision 
Bias Coding 
Anaplasma 
phagocytophilum 
Lee et al. (2018)6 Republic of 
Korea 
2015-
2017 
UN PCR 380 14 Medium Medium 
Anaplasma 
phagocytophilum 
Yi et al. (2017)7 Republic of 
Korea 
2003-
2012 
UN PCR 70 5 Low High 
Anaplasma 
phagocytophilum 
Zhang et al. (2011)8 China 2004-
2006 
D SP PCR, IFA 26 8 High High 
Anaplasma 
phagocytophilum 
Zhang et al. (2013)9 China 2009-
2010 
UN Culture, IFA, PCR 421 46 Low Low 
Babesia microti Zhou et al. (2013)10 China 2012-
2013 
UN PCR 449 10 Low Low 
Bartonella spp. Chaudhry et al. (2018)11 India 2012-
2016 
UN PCR 28 2 Medium High 
Bartonella spp. Faruque et al. (2017)12 Thailand 2008-
2009 
UN Culture 720 1 Medium Low 
Bartonella spp. Hercik et al. (2017)13 United Republic 
of Tanzania 
2014-
2015 
UN PCR 842 4 Low Low 
Bartonella spp. Kosoy et al. (2010)14 Thailand 2002-
2003 
UN Culture, PCR 261 14 Low Medium 
Bartonella spp. Simpson et al. (2018)15 South Africa 2012-
2013 
UN PCR 74 7 Medium High 
Bartonella spp. Sokhna et al. (2013)16 Senegal 2011-
2012 
UN PCR 440 23 Low Low 
Borrelia spp. Aarsland et al. (2012)17 Ethiopia 2009-
2010 
UN PCR 102 2 Low High 
Borrelia spp. Elhelw et al. (2014)18 Egypt 2008-
2009 
UN PCR 15 4 Medium High 
Borrelia spp. Fotso Fotso et al. 
(2015)19 
Algeria 2012-
2012 
UN PCR 257 4 Low Medium 
Borrelia spp. Mediannikov et al. 
(2014)20 
Senegal 2010-
2011 
UN PCR 1566 115 Low Low 
Borrelia spp. Nordstrand et al. 
(2007)21 
Togo 2002-
2004 
UN PCR 237 21 Low Medium 
Borrelia spp. Parola et al. (2011)22 Senegal 2008-
2009 
UN PCR 206 27 Medium Medium 
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Pathogen First author, year of 
publication and 
reference 
Country Study 
Period 
Study Population 
Classification 
Diagnostics Used Number 
Tested 
Number 
Positive 
Representativeness Bias 
Coding 
Precision 
Bias Coding 
Borrelia spp. Reller et al. (2011)23 United Republic 
of Tanzania 
NA-NA UN PCR 310 13 Low Medium 
Borrelia spp. Sarih et al. (2009)24 Morocco 2005-
2006 
UN PCR 127 23 Medium High 
Borrelia spp. Sokhna et al. (2013)16 Senegal 2011-
2012 
UN PCR 440 35 Low Low 
Borrelia spp. Toure et al. (2017)25 Mali 2012-
2012 
UN PCR 8 3 Medium High 
Brucella spp. Afifi et al. (2005)26 Egypt 1999-
2003 
D SP Culture 9883 275 High Low 
Brucella spp. Barua et al. (2016)27 India 2010-
2012 
D SP Culture 102 18 High High 
Brucella spp. Boone et al. (2017)28 Madagascar 2011-
2013 
UN PCR 1020 15 Low Low 
Brucella spp. Bouley et al. (2012)29 United Republic 
of Tanzania 
2007-
2008 
UN MAT 455 16 Low Low 
Brucella spp. Carugati et al. (2018)30 United Republic 
of Tanzania 
2007-
2014 
UN MAT 1680 45 Low Low 
Brucella spp. Cash-Goldwasser et al. 
(2018)31 
United Republic 
of Tanzania 
2012-
2014 
UN Microagglutination test 562 39 Low Low 
Brucella spp. Ciftdogan et al. (2011)32 Turkey 2003-
2008 
UN Culture 92 3 Low High 
Brucella spp. Crump et al. (2013)33 United Republic 
of Tanzania 
2007-
2008 
UN MAT 453 16 Low Low 
Brucella spp. Fadeel et al. (2006)34 Egypt 1999-
2003 
UN Culture 1177 202 Low Low 
Brucella spp. Jennings et al. (2007)35 Egypt 2002-
2003 
UN Culture 4490 115 Medium Low 
Brucella spp. Kamal et al. (2013)36 Saudi Arabia 2009-
2011 
UN PCR 101 50 Low High 
Brucella spp. Kuila et al. (2017)37 India 2013-
2015 
UN PCR 2088 88 Low Low 
Brucella spp. Manock et al. (2009)38 Ecuador 2001-
2004 
UN ELISA 275 4 Medium Medium 
Brucella spp. Mattar et al. (2017)39 Colombia 2012-
2013 
UN Rose Bengal plate test 100 1 Medium High 
Brucella spp. Migisha et al. (2018)40 Uganda 2017-
2017 
D SP Culture 235 10 High Medium 
Brucella spp. Nandagopal et al. 
(2012)41 
India 2008-
2009 
UN PCR 301 3 Low Medium 
Brucella spp. Paul et al. (2017)42 Saudi Arabia 2014-
2016 
UN Culture 377 37 Low Medium 
Brucella spp. Rahman et al. (2016)43 Bangladesh 2007-
2008 
D SP PCR 6 3 High High 
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Pathogen First author, year of 
publication and 
reference 
Country Study 
Period 
Study Population 
Classification 
Diagnostics Used Number 
Tested 
Number 
Positive 
Representativeness Bias 
Coding 
Precision 
Bias Coding 
Campylobacter spp. Ali et al. (2016)44 Pakistan 2011-
2014 
D RESP Culture 356 2 High Medium 
Campylobacter spp. Bottieau et al. (2011)45 No Specific 
Country 
2000-
2006 
D GI Stool examination, 
Culture 
512 47 High Low 
Campylobacter spp. Hogan et al. (2018)46  Ghana 2013-
2015 
UN PCR 240 21 Low Medium 
Campylobacter spp. Naheed et al. (2008)47 Bangladesh 2003-
2004 
UN Culture 867 1 Low Low 
Coxiella burnetii Angelakis et al. (2014)48 No Specific 
Country 
2008-
2012 
UN PCR 1888 7 Low Low 
Coxiella burnetii Crump et al. (2013)33 United Republic 
of Tanzania 
2007-
2008 
UN IFA 482 24 Low Low 
Coxiella burnetii Esmaeili et al. (2017)49 Iran (Islamic 
Republic of) 
2013-
2013 
UN ELISA 116 16 Medium High 
Coxiella burnetii Greiner et al. (2018)50 Thailand 2002-
2005 
UN IFA 1784 5 Medium Low 
Coxiella burnetii Hamilton et al. (2011)51 Iraq 2008-
2008 
UN PCR, IFA 18 8 Low High 
Coxiella burnetii Hercik et al. (2017)13 United Republic 
of Tanzania 
2014-
2015 
UN PCR 842 2 Low Low 
Coxiella burnetii Khalili et al. (2016)52 Iran (Islamic 
Republic of) 
2014-
2015 
UN PCR 92 7 Low High 
Coxiella burnetii Manock et al. (2009)38 Ecuador 2001-
2004 
UN ELISA 33 15 Medium High 
Coxiella burnetii Mazyad et al. (2007)53 Egypt 2006-
2006 
UN PCR 150 5 Low Medium 
Coxiella burnetii Metanat et al. (2014)54 Iran (Islamic 
Republic of) 
2011-
2011 
UN IFA 105 23 Low High 
Coxiella burnetii Njeru et al. (2016)55 Kenya 2014-
2015 
UN PCR 448 10 Low Low 
Coxiella burnetii Pradeep et al. (2017)56 India 2016-
2016 
UN PCR 72 2 Medium High 
Coxiella burnetii Ratmanov et al. (2013)57 Senegal 2008-
2011 
UN PCR 874 4 Low Low 
Coxiella burnetii Reller et al. (2016)58 Nicaragua 2008-
2009 
UN IFA 748 10 Low Low 
Coxiella burnetii Sokhna et al. (2013)16 Senegal 2011-
2012 
UN PCR 440 2 Low Low 
Coxiella burnetii Toure et al. (2017)25 Mali 2012-
2012 
UN PCR 8 1 Medium High 
Crimean-Congo 
haemorrhagic fever 
virus 
Alam et al. (2013)59 Pakistan 2008-
2008 
D HEM PCR, IgM 44 16 High High 
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Pathogen First author, year of 
publication and 
reference 
Country Study 
Period 
Study Population 
Classification 
Diagnostics Used Number 
Tested 
Number 
Positive 
Representativeness Bias 
Coding 
Precision 
Bias Coding 
Crimean-Congo 
haemorrhagic fever 
virus 
Ali et al. (2007)60 Pakistan 2001-
2001 
D HEM PCR 10 3 High High 
Crimean-Congo 
haemorrhagic fever 
virus 
Bukbuk et al. (2016)61 Nigeria 2010-
2014 
D SP PCR 380 1 High Medium 
Crimean-Congo 
haemorrhagic fever 
virus 
Kuchuloria et al. 
(2016)62  
Georgia 2008-
2011 
UN IgM 537 3 Medium Low 
Eastern equine 
encephalitis virus 
Aguilar et al. (2007)63 Peru NA-NA D NEU ELISA 153 2 High Medium 
Ehrlichia spp. Chikeka et al. (2016)64 Nicaragua NA-NA UN IFA 748 1 Low Low 
Ehrlichia spp. Ndip et al. (2009)65 Cameroon 2003-
2003 
UN PCR 118 12 Medium High 
Hantavirus Armien et al. (2013)66 Panama 2006-
2010 
D SP PCR 150 117 High Medium 
Hantavirus Castillo Ore et al. 
(2012)67 
Peru 2007-
2010 
UN IgM 5174 9 Low Low 
Hantavirus Chandy et al. (2005)68 India 2002-
2003 
D HEM ELISA 152 23 High Medium 
Hantavirus Chandy et al. (2009)69 India 2005-
2007 
UN ELISA, IFA, PCR 347 86 Low Medium 
Hantavirus Chau et al. (2017)70 Mozambique 2012-
2014 
UN ELISA 200 4 Low Medium 
Hantavirus Chen et al. (2014)71 China 2011-
2012 
D HEM PCR, IFA 85 33 High High 
Hantavirus Chrispal et al. (2010)72 India 2007-
2008 
UN ELISA 398 1 Low Low 
Hantavirus Cruz et al. (2012)73 Bolivia 
(Plurinational 
State of) 
2008-
2009 
UN PCR, IgM 372 9 Low Medium 
Hantavirus Klempa et al. (2010)74 Guinea 2001-
2005 
D HEM ELISA, Neutralization 
test 
717 8 High Low 
Hantavirus Kuchuloria et al. 
(2014)75 
Georgia 2008-
2011 
UN IgM 537 2 Low Low 
Hantavirus Liu et al. (2007)76 China 2002-
2004 
UN IFA, PCR 130 49 Low High 
Hantavirus Mattar et al. (2017)39 Colombia 2012-
2013 
UN ELISA 100 4 Medium High 
Hantavirus Suharti et al. (2009)77 Indonesia 1995-
1996 
D SP ELISA 60 5 High High 
Hantavirus Thompson et al. 
(2015)78 
Nepal 2008-
2011 
UN IgM 125 2 Low High 
Hantavirus Zhan et al. (2017)79 China 2011-
2011 
D SP IgM, PCR 141 2 High Medium 
   
 Page 17 of 42 
Pathogen First author, year of 
publication and 
reference 
Country Study 
Period 
Study Population 
Classification 
Diagnostics Used Number 
Tested 
Number 
Positive 
Representativeness Bias 
Coding 
Precision 
Bias Coding 
Japanese encephalitis 
virus 
Anga et al. (2010)80 Papua New 
Guinea 
2007-
2008 
D NEU IgM 129 2 High High 
Japanese encephalitis 
virus 
Chatterjee et al. (2004)81 India 1996-
1999 
D NEU HI 72 24 High High 
Japanese encephalitis 
virus 
Chheng et al. (2013)82 Cambodia 2009-
2010 
UN ELISA 107 6 Low High 
Japanese encephalitis 
virus 
Dias et al. (2018)83 India 2014-
2014 
UN RNA sequencing 4 1 Low High 
Japanese encephalitis 
virus 
Ellis et al. (2006)84 Thailand 1999-
2002 
UN ELISA 530 1 Low Low 
Japanese encephalitis 
virus 
Joshi et al. (2013)85 India 2007-
2007 
D NEU ELISA 152 4 High Medium 
Japanese encephalitis 
virus 
Kakoti et al. (2013)86 India 2012-
2012 
D HEM IgM 223 49 High Medium 
Japanese encephalitis 
virus 
Kumar et al. (2015)87 India NA-NA D NEU IgM 108 54 High High 
Japanese encephalitis 
virus 
Maude et al. (2016)88 Bangladesh 2012-
2012 
UN IgM 300 1 Medium Medium 
Japanese encephalitis 
virus 
Medhi et al. (2017)89 India 2012-
2014 
D NEU ELISA 1707 601 High Low 
Japanese encephalitis 
virus 
Rasul et al. (2012)90 Bangladesh 2007-
2009 
D NEU ELISA 130 2 High High 
Japanese encephalitis 
virus 
Rauf et al. (2018)91 India 2014-
2014 
D NEU IgM, PCR 54 8 High High 
Japanese encephalitis 
virus 
Rayamajhi et al. 
(2006)92 
Nepal 2000-
2001 
D NEU IgM 117 54 High High 
Japanese encephalitis 
virus 
Rayamajhi et al. 
(2007)93 
Nepal 2000-
2001 
D NEU IgM 94 54 High High 
Japanese encephalitis 
virus 
Rayamajhi et al. 
(2011)94 
Nepal 2006-
2008 
D NEU IgM 86 9 High High 
Japanese encephalitis 
virus 
Sarkar et al. (2012)95 India 2010-
2010 
D NEU IgM 43 23 High High 
Japanese encephalitis 
virus 
Singh et al. (2009)96 Nepal 2003-
2004 
D NEU IgM 107 19 High High 
Japanese encephalitis 
virus 
Singh et al. (2014)97 India 2008-
2011 
D NEU PCR 1410 10 High Low 
Japanese encephalitis 
virus 
Swami et al. (2008)98 India 2003-
2005 
D NEU IgM, PCR 40 9 High High 
Japanese encephalitis 
virus 
Taraphdar et al. (2012)99 India 2010-
2010 
UN PCR 58 23 Low High 
Lassa virus Akhuemokhan et al. 
(2017)100 
Nigeria 2009-
2010 
UN PCR 243 13 Low Medium 
Lassa virus Boisen et al. (2015)101 Sierra Leone 2012-
2012 
D SP PCR, Antigen detection 53 29 High High 
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Lassa virus Ehichioya et al. 
(2012)102 
Nigeria 2005-
2008 
D SP PCR 451 2 High Low 
Lassa virus Schoepp et al. (2014)103 Sierra Leone 2006-
2008 
D SP ELISA 253 7 High Medium 
Lassa virus Shehu et al. (2018)104 Nigeria 2016-
2016 
D SP PCR 34 11 High High 
Lassa virus Stremlau et al. (2015)105 Nigeria NA-NA D HEM Sequencing 195 104 High Medium 
Leishmania donovani Hailu et al. (2006)106 Ethiopia NA-NA D SP Microscopy, Culture 103 49 High High 
Leishmania donovani Joshi et al. (2006)107 Nepal 1998-
2002 
D SP Bone marrow 
examination 
996 284 High Low 
Leishmania donovani Mukhtar et al. (2015)108 Sudan 2012-
2014 
D SP Culture 285 191 High Medium 
Leishmania donovani Rijal et al. (2004)109 Nepal 2000-
2002 
D SP Microscopy 261 155 High Medium 
Leptospira spp. Albuquerque Filho et al. 
(2011)110 
Brazil 2009-
2009 
UN Culture 97 56 Low High 
Leptospira spp. Alia et al. (2019)111 Malaysia 2016-
2017 
D SP PCR 50 13 High High 
Leptospira spp. Barragan et al. (2016)112 Ecuador 2013-
2015 
UN PCR 668 100 Low Low 
Leptospira spp. Biggs et al. (2011)113 United Republic 
of Tanzania 
2007-
2008 
UN MAT 831 70 Low Low 
Leptospira spp. Blacksell et al. (2006)114 Lao People's 
Democratic 
Republic 
2001-
2003 
UN MAT 186 5 Medium Medium 
Leptospira spp. Boonsilp et al. (2011)115 Thailand 2001-
2002 
UN Culture, PCR 418 120 Medium Low 
Leptospira spp. Chansamouth et al. 
(2016)116 
Lao People's 
Democratic 
Republic 
2006-
2010 
UN MAT 158 1 Medium Medium 
Leptospira spp. Chheng et al. (2013)82 Cambodia 2009-
2010 
UN Culture, PCR 1179 17 Low Low 
Leptospira spp. Chiriboga et al. 
(2015)117 
Ecuador 2011-
2012 
UN PCR 210 132 Low Medium 
Leptospira spp. Cohen et al. (2007)118 Thailand 2002-
2003 
UN MAT 704 67 Low Low 
Leptospira spp. Crump et al. (2013)33 United Republic 
of Tanzania 
2007-
2008 
UN MAT 453 40 Low Low 
Leptospira spp. Dassanayake et al. 
(2009)119 
Sri Lanka 2007-
2008 
UN MAT 123 62 Low High 
Leptospira spp. Dittrich et al. (2018)120 Lao People's 
Democratic 
Republic 
2014-
2015 
D SP MAT 248 12 High Medium 
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Leptospira spp. Ellis et al. (2006)84 Thailand 1999-
2002 
UN IgM, MAT 613 107 Low Low 
Leptospira spp. Faruque et al. (2017)12 Thailand 2008-
2009 
UN Culture 720 1 Medium Low 
Leptospira spp. Gasem et al. (2009)121 Indonesia 2005-
2006 
UN PCR 137 4 Low High 
Leptospira spp. Guillebaud et al. 
(2018)122 
Madagascar 2014-
2015 
UN PCR 682 1 Low Low 
Leptospira spp. Hem et al. (2016)123 Cambodia 2007-
2009 
UN MAT 2044 17 Low Low 
Leptospira spp. Hercik et al. (2017)13 United Republic 
of Tanzania 
2014-
2015 
UN PCR 842 22 Low Low 
Leptospira spp. Hercik et al. (2018)124 United Republic 
of Tanzania 
2014-
2014 
UN PCR 191 3 Low Medium 
Leptospira spp. Ismail et al. (2006)125 Egypt 1999-
2003 
UN MAT 886 141 Low Low 
Leptospira spp. Kendall et al. (2010)126 Bangladesh 2001-
2001 
UN MAT 78 7 Low High 
Leptospira spp. Koizumi et al. (2009)127 Sri Lanka 2008-
2008 
D SP PCR 107 3 High High 
Leptospira spp. LaRocque et al. 
(2005)128 
Bangladesh 2001-
2001 
D SP PCR 359 63 High Medium 
Leptospira spp. Libraty et al. (2007)129 Thailand 1994-
1999 
UN MAT 812 14 Low Low 
Leptospira spp. Mattar et al. (2017)39 Colombia 2012-
2013 
UN ELISA, MAT 100 27 Medium High 
Leptospira spp. Matthias et al. (2008)130 Peru 2003-
2006 
UN Culture 881 45 Medium Low 
Leptospira spp. Mayxay et al. (2013)131 Lao People's 
Democratic 
Republic 
2008-
2010 
UN Culture, MAT, PCR 1932 137 Low Low 
Leptospira spp. Maze et al. (2016)132 United Republic 
of Tanzania 
2012-
2014 
UN MAT 1017 19 Low Low 
Leptospira spp. McGready et al. 
(2010)133 
Thailand 2004-
2006 
UN Culture, MAT 203 5 Medium Medium 
Leptospira spp. Mueller et al. (2014)134 Cambodia 2008-
2010 
UN PCR 1193 112 Low Low 
Leptospira spp. Murdoch et al. (2004)135 Nepal 2001-
2001 
UN PCR 26 11 Low High 
Leptospira spp. Murray et al. (2011)136 Egypt 2005-
2007 
UN Culture 2441 47 Low Low 
Leptospira spp. Natarajaseenivasan et al. 
(2004)137 
India 2000-
2000 
D SP MAT, Culture 29 7 High High 
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Leptospira spp. Natarajaseenivasan et al. 
(2012)138 
India 2009-
2009 
D SP PCR 75 71 High High 
Leptospira spp. Phimda et al. (2007)139 Thailand 2003-
2005 
D SP Culture, MAT 296 55 High Medium 
Leptospira spp. Rafizah et al. (2013)140 Malaysia NA-NA UN MAT 999 53 Medium Low 
Leptospira spp. Rao et al. (2005)141 India NA-NA D SP ELISA 70 2 High High 
Leptospira spp. Ravindar et al. (2018)142 India 2016-
2017 
UN PCR 100 13 Low High 
Leptospira spp. Reller et al. (2014)143 Nicaragua 2008-
2009 
UN PCR 748 17 Low Low 
Leptospira spp. Ribeiro et al. (2017)144 Mozambique 2012-
2015 
UN ELISA, MAT 373 3 Low Medium 
Leptospira spp. Ricapa-Antay et al. 
(2018)145 
Peru 2016-
2016 
UN PCR 139 16 Medium Medium 
Leptospira spp. Rubbo et al. (2018)146 Central African 
Republic 
2012-
2015 
UN MAT 32 2 Medium High 
Leptospira spp. Sengupta et al. (2017)147 India 2012-
2014 
UN PCR 150 5 Medium Medium 
Leptospira spp. Suttinont et al. (2006)148 Thailand 2001-
2002 
UN Culture, MAT, IFA 845 293 Medium Low 
Leptospira spp. Thipmontree et al. 
(2014)149 
Thailand 2001-
2012 
UN Culture, IFA, PCR 726 118 Medium Low 
Leptospira spp. Waggoner et al. 
(2017)150 
Kenya 2014-
2015 
UN PCR 385 1 Low Low 
Leptospira spp. Wuthiekanun et al. 
(2007)151 
Thailand 2001-
2002 
UN Culture 989 83 Low Low 
Leptospira spp. Zida et al. (2018)152 Burkina Faso 2014-
2015 
UN PCR 781 1 Low Low 
Listeria spp. El-Mahallawy et al. 
(2005)153 
Egypt 1999-
1999 
D COMORBID Culture 1135 1 High Low 
Nipah virus Chadha et al. (2006)154 India 2001-
2001 
D NEU PCR 6 5 High High 
Orientia 
tsutsugamushi 
Blacksell et al. (2007)155 Nepal 2002-
2004 
UN IFA 103 5 Low High 
Orientia 
tsutsugamushi 
Blacksell et al. (2010)156 Lao People's 
Democratic 
Republic 
2003-
2007 
D SP IFA 1030 101 High Low 
Orientia 
tsutsugamushi 
Blacksell et al. (2016)157 Thailand 2006-
2007 
UN IFA, PCR, Culture 152 37 Medium Medium 
Orientia 
tsutsugamushi 
Blacksell et al. (2016)158 Thailand 2007-
2008 
UN PCR, Culture 135 22 Medium High 
Orientia 
tsutsugamushi 
Chansamouth et al. 
(2016)116 
Lao People's 
Democratic 
Republic 
2006-
2010 
UN IFA, Culture, PCR 217 16 Medium Medium 
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Orientia 
tsutsugamushi 
Chen et al. (2014)71 China 2011-
2012 
D HEM PCR 85 1 High High 
Orientia 
tsutsugamushi 
Chheng et al. (2013)82 Cambodia 2009-
2010 
UN PCR, IFA 1179 17 Low Low 
Orientia 
tsutsugamushi 
Jung et al. (2015)159 Democratic 
People's Republic 
of Korea 
2009-
2013 
UN IFA 382 3 Low Medium 
Orientia 
tsutsugamushi 
Kingston et al. (2018)160 Bangladesh 2014-
2015 
UN PCR 416 45 Low Low 
Orientia 
tsutsugamushi 
Kocher et al. (2017)161 Peru 2013-
2013 
UN ELISA 1124 1 Low Low 
Orientia 
tsutsugamushi 
Kumar et al. (2014)162  India 2011-
2012 
UN PCR 199 48 Low Medium 
Orientia 
tsutsugamushi 
Liu et al. (2007)76 China 2002-
2004 
UN IFA, PCR 130 46 Low High 
Orientia 
tsutsugamushi 
Maude et al. (2015)163 Bangladesh 2012-
2012 
UN PCR 300 1 Low Medium 
Orientia 
tsutsugamushi 
Mayxay et al. (2013)131 Lao People's 
Democratic 
Republic 
2008-
2010 
UN Culture, PCR 1871 170 Low Low 
Orientia 
tsutsugamushi 
McGready et al. 
(2010)133 
Thailand 2004-
2006 
UN Culture, PCR, IFA 203 11 Medium Medium 
Orientia 
tsutsugamushi 
Mueller et al. (2014)134 Cambodia 2008-
2010 
UN PCR 1193 47 Low Low 
Orientia 
tsutsugamushi 
Paris et al. (2011)164 Thailand 2007-
2008 
UN IFA, Culture, PCR 138 26 Medium High 
Orientia 
tsutsugamushi 
Phimda et al. (2007)139 Thailand 2003-
2005 
D SP IFA 230 34 High Medium 
Orientia 
tsutsugamushi 
Reller et al. (2012)165 Sri Lanka 2007-
2007 
UN ELISA 883 17 Low Low 
Orientia 
tsutsugamushi 
Saisongkorh et al. 
(2004)166 
Thailand NA-NA UN PCR 36 9 Medium High 
Orientia 
tsutsugamushi 
Sonthayanon et al. 
(2006)167 
Thailand 2000-
2001 
UN IFA 722 183 Low Low 
Orientia 
tsutsugamushi 
Srinivasan et al. 
(2017)168 
India 2014-
2015 
D SP PCR 68 6 High High 
Orientia 
tsutsugamushi 
Thipmontree et al. 
(2016)169 
Thailand 2011-
2012 
UN IFA 495 98 Low Low 
Orientia 
tsutsugamushi 
Tshokey et al. (2018)170 Bhutan 2014-
2015 
UN PCR 1044 7 Medium Low 
Pasteurella spp. Bengre et al. (2012)171 India 2009-
2011 
D COMORBID Culture 50 1 High High 
Pasteurella spp. El-Mahallawy et al. 
(2005)153 
Egypt 1999-
1999 
D COMORBID Culture 1135 6 High Low 
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Rickettsia (SFGR) Aarsland et al. (2012)17 Ethiopia 2009-
2010 
UN PCR 102 4 Low High 
Rickettsia (SFGR) Bouchaib et al. (2018)172 Algeria 2013-
2015 
UN PCR 166 57 Low Medium 
Rickettsia (SFGR) Chowdhury et al. 
(2017)173 
Bangladesh 2015-
2016 
D SP PCR 414 81 High Low 
Rickettsia (SFGR) Crump et al. (2013)33 United Republic 
of Tanzania 
2007-
2008 
UN IFA 450 36 Low Low 
Rickettsia (SFGR) dos Santos et al. 
(2012)174 
Brazil 2009-
2010 
D HEM PCR 110 36 High High 
Rickettsia (SFGR) Eremeeva et al. 
(2013)175 
Guatemala 2007-
2007 
UN PCR, IFA 17 1 High High 
Rickettsia (SFGR) Faruque et al. (2017)12 Thailand 2008-
2009 
UN PCR 360 1 Medium Medium 
Rickettsia (SFGR) Gaowa et al. (2018)176 China 2015-
2016 
UN PCR 261 6 Medium Medium 
Rickettsia (SFGR) Hidalgo et al. (2013)177 Colombia 2010-
2011 
D SP IFA 26 7 High High 
Rickettsia (SFGR) Kingston et al. (2018)160 Bangladesh 2014-
2015 
UN PCR 416 2 Low Low 
Rickettsia (SFGR) Kuloglu et al. (2012)178 Turkey 2003-
2009 
D SP PCR, IFA 126 97 High High 
Rickettsia (SFGR) Liu et al. (2016)179 China 2014-
2014 
D SP PCR 733 56 High Low 
Rickettsia (SFGR) Maina et al. (2012)180 Kenya 2008-
2010 
UN PCR 699 50 Low Low 
Rickettsia (SFGR) Manock et al. (2009)38 Ecuador 2001-
2004 
UN ELISA 214 6 Medium Medium 
Rickettsia (SFGR) Mattar et al. (2017)39 Colombia 2012-
2013 
UN IFI 100 2 Medium High 
Rickettsia (SFGR) Mayxay et al. (2013)131 Lao People's 
Democratic 
Republic 
2008-
2010 
UN PCR 1849 2 Low Low 
Rickettsia (SFGR) Mediannikov et al. 
(2010)181 
Senegal 2008-
2009 
UN PCR 204 8 Medium Medium 
Rickettsia (SFGR) Mediannikov et al. 
(2013)182 
No Specific 
Country 
2010-
2012 
UN PCR 2612 321 Low Low 
Rickettsia (SFGR) Mongkol et al. (2018)183 Thailand 2012-
2014 
D SP PCR 168 8 High Medium 
Rickettsia (SFGR) Mourembou et al. 
(2015)184 
Gabon 2011-
2012 
UN PCR 793 8 Low Low 
Rickettsia (SFGR) Mourembou et al. 
(2015)185 
Gabon 2013-
2014 
UN PCR 410 42 Low Low 
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Rickettsia (SFGR) Ndip et al. (2004)186 Cameroon 2003-
2003 
UN PCR 118 7 Medium High 
Rickettsia (SFGR) Prakash et al. (2012)187 India 2006-
2008 
D SP PCR 58 34 High High 
Rickettsia (SFGR) Reller et al. (2012)165 Sri Lanka 2007-
2007 
UN IFA 883 108 Low Low 
Rickettsia (SFGR) Reller et al. (2016)58 Nicaragua 2008-
2009 
UN IFA 748 6 Low Low 
Rickettsia (SFGR) Richards et al. (2010)188 Kenya 2006-
2008 
UN PCR 163 6 Medium Medium 
Rickettsia (SFGR) Sokhna et al. (2013)16 Senegal 2011-
2012 
UN PCR 440 28 Low Low 
Rickettsia (SFGR) Sothmann et al. 
(2017)189 
Ghana 2012-
2012 
UN PCR 431 6 Medium Low 
Rickettsia (TGR) Blacksell et al. (2007)155 Nepal 2002-
2004 
UN IFA 103 9 Low High 
Rickettsia (TGR) Blacksell et al. (2010)156 Lao People's 
Democratic 
Republic 
2003-
2007 
D SP IFA 1030 183 High Low 
Rickettsia (TGR) Chansamouth et al. 
(2016)116 
Lao People's 
Democratic 
Republic 
2006-
2010 
UN IFA, Culture, PCR 217 15 Medium Medium 
Rickettsia (TGR) Chen et al. (2014)71 China 2011-
2012 
D HEM IFA 85 1 High High 
Rickettsia (TGR) Chheng et al. (2013)82 Cambodia 2009-
2010 
UN PCR, IFA 1179 5 Low Low 
Rickettsia (TGR) Chowdhury et al. 
(2017)173 
Bangladesh 2015-
2016 
D SP PCR 414 1 High Low 
Rickettsia (TGR) Crump et al. (2013)33 United Republic 
of Tanzania 
2007-
2008 
UN IFA 450 2 Low Low 
Rickettsia (TGR) Faruque et al. (2017)12 Thailand 2008-
2009 
UN PCR 720 1 Medium Low 
Rickettsia (TGR) Gasem et al. (2009)121 Indonesia 2005-
2006 
UN IFA 137 4 Low High 
Rickettsia (TGR) Hidalgo et al. (2008)190 Colombia 2005-
2005 
UN IFA 120 14 Low High 
Rickettsia (TGR) Hidalgo et al. (2013)177 Colombia 2010-
2011 
D SP IFA 26 2 High High 
Rickettsia (TGR) Kingston et al. (2018)160 Bangladesh 2014-
2015 
UN PCR 416 24 Low Low 
Rickettsia (TGR) Manock et al. (2009)38 Ecuador 2001-
2004 
UN ELISA 255 8 Medium Medium 
Rickettsia (TGR) Maude et al. (2015)163 Bangladesh 2012-
2012 
UN PCR 300 2 Low Medium 
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Rickettsia (TGR) Mayxay et al. (2013)131 Lao People's 
Democratic 
Republic 
2008-
2010 
UN PCR 1849 12 Low Low 
Rickettsia (TGR) McGready et al. 
(2010)133 
Thailand 2004-
2006 
UN Culture, PCR, IFA 203 14 Medium Medium 
Rickettsia (TGR) Mongkol et al. (2018)183 Thailand 2012-
2014 
D SP PCR 168 3 High Medium 
Rickettsia (TGR) Pradhan et al. (2012)191 Nepal 2006-
2007 
UN PCR 1039 22 Low Low 
Rickettsia (TGR) Reller et al. (2012)165 Sri Lanka 2007-
2007 
UN IFA 883 61 Low Low 
Rickettsia (TGR) Reller et al. (2016)58 Nicaragua 2008-
2009 
UN IFA 748 1 Low Low 
Rickettsia (TGR) Thompson et al. 
(2015)78 
Nepal 2008-
2011 
UN IFA 125 21 Low High 
Rickettsia (TGR) Zimmerman et al. 
(2008)192 
Nepal 2001-
2001 
UN PCR 756 50 Low Low 
Rickettsia spp. Hercik et al. (2017)13 United Republic 
of Tanzania 
2014-
2015 
UN PCR 842 2 Low Low 
Rickettsia spp. Kingston et al. (2018)160 Bangladesh 2014-
2015 
UN PCR 416 3 Low Low 
Rickettsia spp. Mongkol et al. (2018)183 Thailand 2012-
2014 
D SP PCR 168 15 High Medium 
Rickettsia spp. Mueller et al. (2014)134 Cambodia 2008-
2010 
UN PCR 1193 2 Low Low 
Rickettsia spp. Ricapa-Antay et al. 
(2018)145 
Peru 2016-
2016 
UN PCR 139 9 Medium Medium 
Rift Valley fever virus Baudin et al. (2016)193 Sudan 2011-
2012 
UN IgM 130 17 Medium High 
Rift Valley fever virus Guillebaud et al. 
(2018)122 
Madagascar 2014-
2015 
UN PCR 682 1 Low Low 
Rift Valley fever virus Schoepp et al. (2014)103 Sierra Leone 2006-
2008 
D SP ELISA 253 5 High Medium 
Rift Valley fever virus Sow et al. (2016)194 Senegal 2009-
2013 
UN PCR 13845 1 Low Low 
Salmonella (non-
Typhi) 
Akinyemi et al. 
(2007)195 
Nigeria 2004-
2005 
D GI Culture 235 16 High Medium 
Salmonella (non-
Typhi) 
Akinyemi et al. 
(2015)196 
Nigeria 2010-
2011 
UN Culture 135 2 Low High 
Salmonella (non-
Typhi) 
Al-Emran et al. 
(2016)197 
No Specific 
Country 
2011-
2013 
UN Culture 8161 28 Low Low 
Salmonella (non-
Typhi) 
Al-Emran et al. 
(2016)198 
No Specific 
Country 
NA-NA UN Culture 10636 77 Low Low 
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Salmonella (non-
Typhi) 
Andualem et al. 
(2014)199 
Ethiopia 2010-
2011 
D SP Culture 270 7 High Medium 
Salmonella (non-
Typhi) 
Bello et al. (2018)200 Nigeria NA-NA D COMORBID Culture 225 10 High Medium 
Salmonella (non-
Typhi) 
Biggs et al. (2014)201 United Republic 
of Tanzania 
2006-
2008 
UN Culture 4106 163 Low Low 
Salmonella (non-
Typhi) 
Bilman et al. (2017)202 Turkey 2014-
2014 
D GI Culture 48 10 High High 
Salmonella (non-
Typhi) 
Brooks et al. (2005)203 Bangladesh 2000-
2001 
UN Culture 888 2 Low Low 
Salmonella (non-
Typhi) 
Brown et al. (2017)204 Nigeria 2013-
2014 
D COMORBID Culture 116 1 High High 
Salmonella (non-
Typhi) 
Chheng et al. (2013)82 Cambodia 2009-
2010 
UN Culture 1180 1 Low Low 
Salmonella (non-
Typhi) 
Crump et al. (2011)205  United Republic 
of Tanzania 
2007-
2008 
UN Culture 224 2 Low Medium 
Salmonella (non-
Typhi) 
Crump et al. (2011)206 United Republic 
of Tanzania 
2007-
2008 
UN Culture 139 1 Low Medium 
Salmonella (non-
Typhi) 
D'Acremont et al. 
(2014)207 
United Republic 
of Tanzania 
2008-
2008 
UN Culture 424 1 Low Low 
Salmonella (non-
Typhi) 
Davies et al. (2016)208 Nigeria NA-NA UN Culture 129 15 Low High 
Salmonella (non-
Typhi) 
Dong et al. (2014)209 China 2009-
2011 
UN Culture 2529 3 Low Low 
Salmonella (non-
Typhi) 
Eibach et al. (2016)210 Ghana 2007-
2012 
UN Culture 7172 215 Low Low 
Salmonella (non-
Typhi) 
Gordon et al. (2010)211 Malawi NA-NA UN Culture 355 70 Low Medium 
Salmonella (non-
Typhi) 
Hercik et al. (2017)13 United Republic 
of Tanzania 
2014-
2015 
UN PCR 842 4 Low Low 
Salmonella (non-
Typhi) 
Hogan et al. (2018)46 Ghana 2013-
2015 
UN Culture 1238 28 Low Low 
Salmonella (non-
Typhi) 
Saha et al. (2017)212 Bangladesh 2012-
2016 
UN Culture 5185 1 Medium Low 
Salmonella (non-
Typhi) 
Jeon et al. (2018)213 No Specific 
Country 
2010-
2014 
UN Culture 13431 94 Low Low 
Salmonella (non-
Typhi) 
Kibuuka et al. (2015)214 Uganda 2012-
2012 
UN Culture 250 11 Medium Medium 
Salmonella (non-
Typhi) 
Kiemde et al. (2018)215 Burkina Faso 2015-
2015 
UN Culture 684 31 Low Low 
Salmonella (non-
Typhi) 
Ley et al. (2009)216 United Republic 
of Tanzania 
2008-
2009 
UN Culture 1680 49 Low Low 
Salmonella (non-
Typhi) 
Mahende et al. (2014)217 United Republic 
of Tanzania 
2013-
2013 
UN Culture 808 2 Low Low 
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Salmonella (non-
Typhi) 
Marks et al. (2017)218 No Specific 
Country 
2010-
2014 
UN Culture 13431 94 Low Low 
Salmonella (non-
Typhi) 
Meremo et al. (2012)219 United Republic 
of Tanzania 
NA-NA UN Culture 346 12 Low Medium 
Salmonella (non-
Typhi) 
Moon et al. (2013)220 Mozambique 2012-
2012 
D COMORBID Culture 258 28 High Medium 
Salmonella (non-
Typhi) 
Mourembou et al. 
(2016)221 
Gabon NA-NA UN PCR 410 3 Low Low 
Salmonella (non-
Typhi) 
Mtove et al. (2010)222 United Republic 
of Tanzania 
2008-
2009 
UN Culture 1502 45 Low Low 
Salmonella (non-
Typhi) 
Mtove et al. (2011)223 United Republic 
of Tanzania 
2006-
2010 
UN Culture 6836 232 Low Low  
Salmonella (non-
Typhi) 
Mtove et al. (2011)224 United Republic 
of Tanzania 
2009-
2010 
UN Culture 965 1 Medium Low 
Salmonella (non-
Typhi) 
Nadjm et al. (2010)225 United Republic 
of Tanzania 
NA-NA UN Culture 3639 160 Low Low 
Salmonella (non-
Typhi) 
Nadjm et al. (2012)226 United Republic 
of Tanzania 
2007-
2007 
UN Culture 198 5 Low Medium 
Salmonella (non-
Typhi) 
Ochaya et al. (2018)227 Uganda 2013-
2013 
D COMORBID Culture 256 3 High Medium 
Salmonella (non-
Typhi) 
Onchiri et al. (2016)228 Kenya 2012-
2014 
UN Culture 1496 19 Low Low 
Salmonella (non-
Typhi) 
Onyango et al. (2008)229 Kenya 2004-
2005 
D GI Culture 20 18 High High 
Salmonella (non-
Typhi) 
Onyango et al. (2009)230 Kenya 2004-
2005 
D GI Culture 40 20 High High 
Salmonella (non-
Typhi) 
Park et al. (2016)231 No Specific 
Country 
2010-
2014 
UN Culture 13431 73 Low Low 
Salmonella (non-
Typhi) 
Peters et al. (2004)232 Malawi 2000-
2000 
UN Culture 352 44 Low Medium 
Salmonella (non-
Typhi) 
Pradhan et al. (2012)191 Nepal 2006-
2007 
UN Culture 1039 2 Low Low 
Salmonella (non-
Typhi) 
Preziosi et al. (2015)233 Mozambique 2011-
2014 
UN Culture 841 10 Low Low 
Salmonella (non-
Typhi) 
Sothmann et al. 
(2015)234 
Ghana 2012-
2012 
UN Culture 2306 24 Low Low 
Salmonella (non-
Typhi) 
Tezcan et al. (2006)235 Turkey 1996-
2004 
D COMORBID Culture 621 1 High Low 
Salmonella (non-
Typhi) 
Wiersinga et al. 
(2015)236 
Gabon 2012-
2013 
UN Culture 941 5 Low Low 
Schistosoma mansoni Degarege et al. (2012)237 Ethiopia 2010-
2011 
UN Microscopy 702 82 Low Low 
Streptococcus spp. Hinjoy et al. (2017)238 Thailand 2015-
2015 
UN Culture 70 1 Medium High 
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Toxoplasma gondii Adurthi et al. (2008)239 India NA-NA D COMORBID PCR 162 21 High Medium 
Venezuelan Equine 
Encephalitis virus 
Forshey et al. (2010)240 No Specific 
Country 
2000-
2007 
UN Culture, PCR, ELISA 13259 250 Low Low 
Venezuelan Equine 
Encephalitis virus 
Kocher et al. (2016)241 Peru 2013-
2014 
UN PCR 2054 22 Low Low 
Venezuelan Equine 
Encephalitis virus 
Manock et al. (2009)38 Ecuador 2001-
2004 
UN Culture, IgM, IFA, PCR 229 2 Medium Medium 
Venezuelan Equine 
Encephalitis virus 
Morrison et al. (2008)242 Peru 2005-
2006 
UN IFA, PCR 1136 34 High Low 
West Nile virus Boisen et al. (2015)101 Sierra Leone 2012-
2012 
D SP PCR 23 4 High High 
West Nile virus Chinikar et al. (2012)243 Iran (Islamic 
Republic of) 
2008-
2009 
D NEU PCR 249 3 High Medium 
West Nile virus Elyan et al. (2014)244 Afghanistan 2008-
2010 
UN PRNT 277 24 Medium Medium 
West Nile virus Hercik et al. (2017)13 United Republic 
of Tanzania 
2014-
2015 
UN PCR 842 1 Low Low 
West Nile virus Kumar et al. (2014)245 India 2009-
2010 
UN PCR 105 27 High High 
West Nile virus Rutvisuttinunt et al. 
(2014)246 
Nepal 2009-
2010 
D SP PCR 14 2 High High 
West Nile virus Tigoi et al. (2015)247 Kenya 2009-
2012 
UN PRNT 379 47 Low Medium 
West Nile virus Williams et al. (2018)248 United Republic 
of Tanzania 
2013-
2014 
UN Sequencing 12 2 Medium High 
Yersinia pestis Sinyange et al. (2016)249 Zambia 2015-
2015 
D SP PCR 12 6 High High 
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 492 
Table S7: Summary of number of studies from each global region represented in the study dataset. 493 
WHO Region Number (%) of malaria endemic countries 
contributing data 
Number (%) of studies 
contributing data (n=2351) 
Africa 21 of 44 (47·7%) 83  (35·3%) 
Americas 8 of 23 (34·8%) 21  (8·9%) 
Eastern Mediterranean 8 of 14 (57·1%) 22  (9·4%) 
Europe 2 of 9 (22·2%) 6  (2·6%) 
South-East Asia 8 of 10 (80·0%) 81  (34·5%) 
Western Pacific 6 of 10 (60·0%) 22  (9·4%) 
1Table includes data from 235 of 244 articles included in the review, excluding 9 articles reporting data from 494 
multiple countries excluded for this analysis. 495 
 496 
 497 
 498 
 499 
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 500 
Figure S1: Barchart showing the number of articles contributing data for each country included in the study, displayed by country and WHO region. 501 
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 506 
Figure S2: Barcharts showing number of articles from each global region contributing data for each of 30 507 
zoonoses. 508 
Plot panels indicate the WHO defined global region and bar colour indicates type of pathogen. 509 
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Title: Zoonotic causes of febrile illness in malaria endemic countries: a systematic review 
 
Dear editor 
 
We would like to thank the three anonymous reviewers and the editor for their comments on 
this manuscript, and the opportunity to resubmit this revision of our paper.  We have worked 
through and documented our point-by-point responses (shown in italics) to all of the 
comments made and these are detailed in the text below.  The principal update made is to re-
run the searches at the start of 2019 to bring this review fully up to date.  We hope that this 
update and our responses to the other points raised will provide all of the information needed 
for resubmission.   
 
Best wishes 
Jo Halliday 
 
Notes from the editor (general editorial points follow the reviewers' comments): 
 
* When revising your manuscript in response to the comments below, please ensure that you 
do not exceed the limits of 4500 words and 150 references (for detailed guidance see our 
instructions for authorshttps://www.thelancet.com/pb/assets/raw/Lancet/authors/tlid-info-for-
authors.pdf) 
In correspondence with the deputy editor Dr Sekkides on 25 March 2019 it was advised that 
we include details of the references that are only cited in the appendix table (that provides 
details of all articles included in the review), in the appendix.   
We count the article length as 4420 words and 47 references in the main file.  
 
* It is essential that you bring your search up to date 
We have updated the review to include all references documented before 03 January 2019 
when the update searches for this resubmission were run. This date is included in the revised 
submission (line 106)  
 
* Owing to the limited space available we only allow seven non-text items. I suggest that you 
move tables 1 and 3 to your appendix and any other two tables, figures, or both (maybe 
figures 3 and 4). Given table 1 is largely the same as the one in your appendix, retain the 
version you had in the manuscript, as this contains more information 
 
We have updated the paper and retained only 7 non-text items in the main text file.  These are 
included as follows: 
1 – Table 1 - Pathogens included in the study – this combines the content from the main file 
and appendix, and the redundant version in the appendix has been dropped 
2 – Table 2 – Inclusion and exclusion criteria – retained in the main text 
(NB – to ensure that the references included in the figures compile into the reference list in 
the appropriate order we have retained the tables in the main text file). 
*Reply to Reviewers Comments
3 - Figure 1: Flow diagram of records and articles assessed for the review 
4 - Figure 2: Map illustrating the malaria-endemic countries included in the study and 
number of articles contributing data for each country.  
5 - Figure 3: Barchart showing number of articles where each pathogen was looked for 
diagnosed and had data extracted 
6 - Figure 4: Proportion of fevers attributed to each zoonosis.  
7 - Figure 5: Venn diagram illustrating the associations between febrile population clinical 
presentation and pathogens identified.  
 
The remaining tables and figures are now either omitted from the revision or included in the 
in appendix file. 
 
The table giving details of all of the studies included in the review is now included (with its 
own standalone bibliography in the appendix – table S6).The appendix file also includes a 
link to a DOI where an excel format version of the table can be accessed (this will be 
activated as/when the paper is ready for publication) 
 
* A paper of this type does not require a research in context panel. Move this into the main 
text or omit entirely if this information is already presented 
This section has been removed from the revised submission 
 
* Please submit ICMJE forms completed by all 
authors(https://www.thelancet.com/pb/assets/raw/Lancet/authors/icmje-coi-form.zip)  
We have uploaded ICMJE forms for all authors 
 
Reviewers' comments: 
 
Reviewer #1:  
 
1. The authors mention co-endemicity but there is no mention of co-infection and that the 
possibility of co-infection with malaria and another pathogen is real and what the probability 
of this could be 
We have updated the manuscript to include data on the number of studies that 
reported exclusion of some pathogens/syndromes and malaria specifically.  
We have also added some additional results on the number of zoonotic 
pathogens that the studies looked for, diagnosed and contributed data for. 
Lines 396-300 now read: 
“Of the 244 studies, twelve (4·9%) described a demographically restricted population, 55 
(22·5%) reported some exclusions from the population, and 32 (13·1%) mentioned exclusion 
of malaria-infected individuals specifically (appendix table S6). Of the 244 studies, 73 
(29·9%) reported looking for more than one zoonosis, 43 (17·6%) diagnosing more than one 
zoonosis and 37 (15·2%) contributing data on more than one zoonosis.” 
 
We have also added content on this point to the discussion (lines 432-435), 
which now reads: 
“The design of this review did not allow explicit investigation of co-infections, 
either of zoonoses with malaria or of multiple zoonoses. Co-infections are 
likely to be an important factor underlying both the distribution and 
prevalence of some zoonotic pathogens, including for example nontyphoidal 
Salmonella serovars.[1] 
 
2. This paper describes how in many malaria endemic settings; differential diagnosis of 
zoonotic pathogens is under-recognized/diagnosed. It is a shame that such a piece of in depth 
research did not include other languages besides English e.g. Russia. When one looks at the 
map of distribution it is also clear that there is research bias for examples with countries that 
have many research projects like Tanzania featuring high. There is also no real discussion 
about zoonoses often not being a blanket problem but a problem in high risk areas/ 
populations. This would enhance the paper. 
With the exception of the franco-phone in West Africa, for most malaria-
endemic countries, English is the primary language for biomedical science. 
However, we do agree with the limitations identified by the reviewer here and 
have addressed some of these points in the discussion content and limitations 
paragraph specifically as follows: 
Lines 404:407 
“The restriction of this review to English language texts will have reduced the 
probability that studies from French and Spanish speaking countries were 
included and may partially account for some gaps, such as the 23 countries in 
Africa and 15 in the Americas for which no eligible studies were identified.” 
 
We have added a comment in the discussion to clarify the point about the 
dominance of a small number of countries in the data set (lines 337-345), that 
read:  
“The geographic variation in the distribution of studies by country (figure 2) 
and region (appendix table S7, figure S2) is likely to be strongly influenced by 
variation in research and publication effort. There is noticeable geographic 
segregation for some zoonoses, with NTS and SFGR reported more frequently 
in Africa, and Leptospira spp., Orientia tsutsugamushi, and typhus-group 
rickettsioses (TGR) reported more frequently in South-East Asia and Western 
Pacific regions (appendix figure S2). For viruses, Lassa virus was reported 
only in Africa and JEV predominantly in South-East Asia. The distribution of 
studies cannot be interpreted as an accurate reflection of the underlying 
distribution of zoonotic pathogens, their prevalence or clinical importance..” 
 
We have also added more detail to the flowchart (Figure 1) to clearly show 
the number of abstracts and full texts excluded on the basis of language in the 
figure (n=48 of 13,321 records) and we give the breakdown of articles by 
language excluded in the figure caption. 
 
To address the comment about zoonoses not being a blanket problem we have 
added the following content in the discussion (lines 396-400): 
“Within populations at risk, it is important that aetiologic studies are followed by 
epidemiologic risk factor studies to determine whether certain sub-groups are at higher risk 
for specific zoonotic diseases. Robust febrile illness surveillance systems help inform local 
epidemiology and febrile illness management, and are also essential for detection of disease 
outbreaks.[2].” 
 
3. Results highlight (line 353...) It is not about patient awareness only and about early seeking 
and diagnosis but also about awareness in populations at risk (occupations, communities, 
geographical high risk areas etc ) , behavior change, prevention in Animals and relation to 
WASH.. This could be addressed a little in discussion. 
 
We have address this point in two locations. 
Lines 347-349 have been updated and these now read: 
”Once pathogens are identified in any location there will likely be increased clinical, patient, 
and community awareness of those pathogens, as well as improved diagnostic capacity to 
detect them” 
 
Later in the discussion we have update content on actions that can be taken to tackle and 
reduced the burden of zoonotic diseases. Lines 460-466 now read: 
“One Health efforts to share data and knowledge between animal and human health sectors 
could help raise clinician awareness of locally relevant zoonoses, inform history taking, and 
guide diagnostic and management decision making. Control of disease in animal populations 
and prevention of transmission from animals to humans are likely to be the most effective 
ways to reduce human disease risk with many zoonoses, necessitating active engagement with 
populations at risk to develop sustainable disease control interventions.” 
 
4. In discussion: POC test are expensive and scarce, these should include pathogen panels in 
the future. There is a need for Target product profiles to guide diagnostic developers. 
We agree that accurate POC tests are scarce, and that etiologic research can 
and should inform diagnostic developers. Accordingly we have added to the 
(lines 454-458): 
“Continued efforts are needed to develop multi-pathogen diagnostics, ideally with formats 
appropriate for point of care use. To avoid perpetuation of self-fulfilling prophesies that can 
arise when only pathogens tested for (and detected) are assumed to be present, the 
development and evaluation of such diagnostics should be informed by data describing the 
pathogens present in specific settings and also the wider context.”  
 
5. In discussion some space should be given to the argument that strong systems detecting 
febrile illness could bolster detection of epidemic of unknown origin or other causes. 
We have updated the discussion to include a point addressing this comment.  
Lines 396 to 400 now read: 
“Within populations at risk, it is important that aetiologic studies are followed 
by epidemiologic risk factor studies to determine whether certain sub-groups 
are at higher risk for specific zoonotic diseases. Robust febrile illness 
surveillance systems help inform local epidemiology and febrile illness 
management, and are also essential for detection of disease outbreaks.[2].” 
 
6. The last search was conducted in Aug 2016, 2 years ago, in the meantime 
there are more publications that would potentially reinforce the strength of the 
paper. This should be assessed by authors to identify whether worth updating 
the study. 
We have updated the review to include all references documented before 03 
January 2019 when the update searches for this resubmission were run. 
 
Some text editing may improve readibility on phrase : 190-2, 266-8, 288, etc 
  
We have updated the text in these identified locations as follows: 
190-192 (now lines 202-205) now reads: 
“To extract data on zoonotic pathogens, every article was classified to record if the study 
reported looking for or diagnosing one or more febrile individuals with any of the zoonotic 
pathogens included in the study reference list (table 1), irrespective of the diagnostics used” 
 
266-268 (now lines 302-306) now reads: 
“Among the 75 differentiated populations, 36 (48·0%) had specific febrile aetiologies 
suspected, 17 (22·7%) were classified as febrile neurological, eight (10·7%) as comorbid 
populations, eight (10·7%) as febrile haemorrhagic, five (6·7%) as febrile gastrointestinal 
and one (1·3%) as febrile respiratory” 
 
288-289 (now lines 285-286) now reads: 
“The proportion of fevers attributed to each pathogen reported ranged from <1·0% to 95·0% 
(figure 4)” 
 
Reviewer #3: This is a high quality systematic review on globally important clinical problem: 
In malaria-endemic countries, febrile patients receive frequently empiric-malaria treatment or 
empiric antibiotics -mostly beta-lactams- against typical bacterial pathogens. Both are usually 
not active against many zoonosis (e.g. coxiella, brucella etc) - resulting in a high proportion 
in inadequate empiric treatment in regions where zoonoses are frequent. 
This article summaries the available evidence in a very structured, comprehensive and 
systematic way. These data will be extremely helpful to design e.g. molecular POCT panels 
for certain regions. I am very enthusiastic about the research question and the approach, and I 
was indeed looking for an article like this but did not found it yet. 
There are only minor issues: 
 
1. Table 3: please add the used diagnostics approaches and the enrolled syndromes 
(gastrointestinal, neurological et.c) (you can use the coding from the inclusion criteria) 
We have added information on the febrile population classification and diagnostic tests used 
to the summary table which is now Table S6 in the appendix material. The bias coding of 
each population has also been included in the update. 
In addition, we will make a search and sortable excel copy of the full dataset accessible via a 
DOI (included in the appendix file) at Glasgow University that can be linked to the 
publication and made public on acceptance. 
 
2. Sort table 3 by pathogen or provide an interactive table online that allows the reader to sort 
by region, pathogen, syndrome, year etc. 
The Table S6 in the appendix material is now sorted by pathogen (then Author last name).  In 
addition, we will make a search and sortable excel copy of the full dataset accessible. 
 
3. Please mention, how many papers you omitted because of language reasons - this may be 
critical, since Spanish and French is frequently the main language in many of the addressed 
countries. 
Two abstracts and 46 full texts were excluded on the basis of language. These 
numbers are now clearly shown in figure 1.  
 
4. How many articles do you omit because no full text was available? 
Twenty-six articles were omitted because pdfs could not be obtained through 
the searches and library systems searched.  
To address these two points, we have updated figure 1 to clearly show the 
number of abstracts and full text excluded on the grounds of language and 
PDF availability.  The breakdown of number of excluded references written in 
different languages is given in the caption for the figure.  
 
5. Why did you stop you research in 2016? This is 2 years ago? 
We have updated the review to include all references documented before 03 
January 2019 when the update searches for this resubmission were run. 
 
Reviewer #5: Overview and general recommendation: 
 
The present study makes a valuable contribution to the knowledge about the main zoonoses 
that may be explaining the causes of febrile syndromes in non-malarial patients from endemic 
areas for several infectious diseases. Likewise, the importance of overcoming the challenge 
of malaria overdiagnosis in febrile patients is highlighted, as documenting the presence of 
other etiological agents leads to a targeted treatment preventing complications and deaths. 
Similarly, the contribution of elements for the construction of diagnostic and treatment 
algorithms for febrile syndromes would reduce the burden of infant mortality in these 
endemic areas for malaria. I also emphasize the good writing, the scientific rigor and the 
proper use of the bibliographical references, nevertheless, some suggestions are made on 
some aspects of the manuscript. 
 
Minor comments: 
 Abstract 
 
Is complete; It has an introduction, objectives, methods, results and conclusions. 
 
Introduction 
 
It is well elaborated, it is pertinent, accurate and well documented bibliographically. 
 
Methodology Results and Discussion 
 
The study is well planned as a systematic review, very detailed in terms of trying to capture 
all peer-reviewed articles, written in English and visible in the databases that they consulted. 
However, there are some observations related to the following aspects: 
 
I suggest a better clarification of how they analyzed the risks of biases, because what's 
reported (lines: 211-214) is not systematic in this.  
We have substantially updated the content on bias assessment in the manuscript.  This is 
done in a revised section now titled “Data extraction and bias assessment”(Pg 8), with 
specific additional content on the methods used in lines 216-236.  
This content reads: 
“The principal source of potential bias affecting the interpretation of the findings of this 
study is the lack of standardization of the febrile populations included in different studies. 
Criteria were defined to classify potential bias in study representativeness and prevalence 
estimate precision (appendix table S5).[3-5] The representativeness bias criterion was 
designed to classify the representativeness of the study population, relative to the general 
population where the study was conducted. This was based on the description of the febrile 
population, the restriction (if any) of the study sample to specific clinical or demographic 
sub-populations and the reporting of disease outbreaks at the time of data collection. Each 
population was classified as follows: i) populations classified as undifferentiated febrile with 
no demographic restriction and no clinical aetiologies excluded were classified as low risk; 
ii) populations classified as undifferentiated febrile with demographic restriction and/or 
reporting exclusion of specific aetiologies or syndromes were classified as medium risk; iii) 
differentiated febrile populations and those from studies reporting disease outbreaks at the 
time of data collection were classified as high risk. The second, outcome-level, bias criterion 
was designed to classify risk of bias in the estimated precision of the proportion of fevers 
attributed to each pathogen. Thresholds used for this criterion are the sample sizes needed to 
estimate proportions of 50% and 10% with 95% confidence and 0·05 precision respectively, 
assuming an infinite population size. Each population was classified as follows: i) proportion 
estimates based on a sample size of greater than or equal to 385 were classified as low risk; 
ii) proportion estimates based on a sample size of greater than 385 but less than 139 were 
classified as medium risk; iii) proportion estimates based on a sample size of less than 139 
were classified as high risk.” 
 
We have revised the lines referred to here to retain the point made but clearly distinguish this 
from more formal bias assessment steps. This content is now included in lines 235-243 which 
now read: 
“Additional potential sources of bias included variation in the pathogens tested for, and 
variation in the diagnostic approaches applied. For included studies, data on the pathogens 
tested for (with any diagnostic approach) were summarized alongside pathogens for which 
diagnostic test criteria were met to qualitatively evaluate the biases introduced by only 
extracting data on pathogens diagnosed using methods meeting study inclusion criteria.” 
 
The results of this bias coding are summarised in the results section (lines 286-288 and 307-
309).  The bias coding (representativeness and precision) of all studies and prevalence 
estimates are shown in appendix table S6.  The representativeness bias coding of all 
prevalence estimates obtained from extracted data is shown in the revision of figure 4 and 
interpretation of the influence of these biases upon the key study findings is given in the 
discussion in lines 416 to 426.  
 
I suggest to detail more accurately the risk assessment of bias in the individual studies; and to 
deepen the explanation of Figure 7 considering that and the characteristics of each study, 
which is currently very focused on the bibliometric analysis.  
We have revised and updated Figure 7 (now Figure 4) to include representation of the 
representativeness bias assessment for each data point. The bias coding for all study 
populations included in the review are also show in the appendix Table S6 and these data are 
summarised in the results section (lines 286-288 and 307-309) and discussion sections (lines 
416 to 426).  
 
There is a bias in the selection of studies for restricting the language, which is enunciated by 
the authors. 
There is a good bibliometric analysis (analysis of the publications) of Table 4 and of Figures 
2, 3, 4 and 5, which is important to understand the dynamics of publication in an area. 
However, it would also be important to inform a little more about the occurrence or 
distribution of the causes of febrile illness. This way, it wouldn't be interpreted as a selection 
bias due to language restriction. 
Due to limitations on the number of tables and figures that can be included in the main 
manuscript file (7 in total) Table 4 (now Table S7 in the appendix) and Figure 2 (now Figure 
S1 in the appendix) have been moved to the appendix content.  
Due to the biases inherent in this dataset we are reluctant to over-interpret these data and 
feel that graphical representation of the data extracted in these figures and discussion of 
these patterns in the text is appropriate. In the discussion text we do refer to the geographical 
variation in number of studies on different pathogens (lines 337-345): 
“The geographic variation in the distribution of studies by country (figure 2) and region 
(appendix table S7, figure S2) is likely to be strongly influenced by variation in research and 
publication effort. There is noticeable geographic segregation for some zoonoses, with NTS 
and SFGR reported more frequently in Africa, and Leptospira spp., Orientia tsutsugamushi, 
and typhus-group rickettsioses (TGR) reported more frequently in South-East Asia and 
Western Pacific regions (appendix figure S2). For viruses, Lassa virus was reported only in 
Africa and JEV predominantly in South-East Asia. The distribution of studies cannot be 
interpreted as an accurate reflection of the underlying distribution of zoonotic pathogens, 
their prevalence or clinical importance.” 
 
We hope that the update of figure 4 to include separate panels for different WHO regions and 
provision of the study dataset in excel format will enable further investigation of these 
patterns by readers interested in specific regions.  
 
The mean and median of the proportions reported in the included studies could make some 
untrained readers think that this is a measure of synthesis. 
We have removed this quantitative summary of the proportion data from the results section 
(lines 285-286) which now includes only the description of the range and reads: 
“The proportion of fevers attributed to each pathogen reported ranged from <1·0% to 95·0% 
(figure 4).” 
 
In addition, we have included content in the discussion (lines 416-422) to highlight the 
caution needed in interpreting these data ‘quantitatively’ as follows: 
“The bias assessments for study representativeness and precision in the estimates of 
proportion of fevers attributable to a given pathogen both reveal that the majority of data 
points had medium or high risk of one or both types of bias. This emphasizes the need for 
cautious and essentially non-quantitative interpretation of the data extracted from these 
studies. Many studies with risk of precision bias due to smaller sample size tended to report 
the highest prevalences of disease attribution to a given pathogen (figure 5); and, 
interestingly, these studies were often also classified as high risk for representativeness 
bias.” 
 
The results are consistent with the objectives of the proposal and they explain the frequency 
of 29 zoonoses, prioritized according to the review of articles that met selection criteria. 
The discussion is well posed, and it reveals the diagnostic difficulty for some pathologies 
such as leptospirosis and the diagnostic limitations within the scope of the first levels of care. 
The limitations of the study are adequately described. A complete review of the selected 
articles was made and fidelity was verified with the definition of infection by zoonotic 
pathogens. 
 
Conclusion 
 
It is consistent with the purpose of the study. 
 
References, Tables and figures 
There is a good handling of the references; All references are cited within the manuscript and 
are relevant to support the different statements, purposes or citations. Regarding the figures, 
some data on hemorrhagic fevers and some numbers that should coincide with the text of the 
manuscript should be unified. 
Apologies for these errors in the previous figure and text versions – see below for our 
responses to each specific point identified  
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 66 
Abstract 67 
Fever is one of the most common reasons for healthcare seeking globally and the 68 
majority of human pathogens are zoonoseszoonotic. We conducted a systematic 69 
review to describe the occurrence and distribution of zoonotic causes of human febrile 70 
illness reported in malaria endemic countries. Articles included in the review yielded 71 
data from 46 (41·853 (48·2%) of the 110 malaria endemic countries included in 72 
searches.. The 181244 articles included described diagnosis of 2930 zoonoses in 73 
febrile people from 46 countries.. The majority of zoonoses were bacterial (n=1617), 74 
with viruses (n=9), protozoa (n=3) and helminths (n=1) also identified. Leptospira 75 
spp. and nontyphoidal Salmonella serovars were the most frequently reported 76 
pathogens. Despite evidence of profound data gaps, this review reveals widespread 77 
distribution of a diverse range of zoonotic causes of febrile illness. ImprovedGreater 78 
understanding of the epidemiology of zoonoses in different settings is needed to 79 
improve awareness and management of the multiple zoonotic causes of febrile illness. 80 
 81 
Introduction 82 
Fever is one of the most common syndromessymptoms prompting healthcare seeking 83 
globally (1-3)..
1-3
 Fever has myriad causes and thetheir non-specific clinical 84 
presentation means that clinical history and physical examination are often 85 
unableinsufficient to accurately suggest theidentify causal pathogen (1).pathogens.
1
 86 
Limitations in laboratory services and available diagnostic tools further contribute to 87 
diagnostic challenges (4)..
4
 In malaria-endemic countries, fever is often assumed to be 88 
due to malaria (5)..
5
 The mortality and morbidity attributable to malaria remains 89 
considerable, but there is also evidence of widespread over-diagnosis (6,7) and indeed 90 
globally within malaria-endemic areas (8)..
6-8
 The recognized over-diagnosis of 91 
malaria together with declines in malaria incidence since the peak in global malaria 92 
deaths in 2004 (
9,10
) have prompted attention to non-malaria causes of fever in these 93 
malaria-endemic areas .(
11,12
). Zoonotic pathogens are likely to play a substantial role 94 
globally as causes of fever globally. Almost two-thirds of all human pathogens are 95 
zoonotic (13),,
13
 and there is growing evidence that many zoonoses cause more cases 96 
of human febrile illness than previously appreciated .(
12,14-20
). Improved 97 
understanding of the impacts and burdens of zoonotic causes of fever in malaria-98 
endemic countries would provide the epidemiological evidence base to enablefor 99 
disease control program development and also influence diagnostic and treatment 100 
algorithms for fever, with the potential to improve clinical outcomes. The aim of this 101 
study was to systematically review the published literature to describe the occurrence 102 
and distribution of reported zoonotic causes of human febrile illness in countries 103 
where malaria is endemic. 104 
 105 
Methods 106 
Search strategy and selection criteria 107 
The target literature for this systematic review was peer-reviewed published articles 108 
that described the testing of one or more febrile peopleperson from malaria-endemic 109 
countries for one or more zoonotic pathogenspathogen using robust diagnostic testing 110 
criteria to demonstrate acute infection. Literature searches of the Medline and Embase 111 
databases were run using the OvidSP gateway. Searches were limited to English 112 
language articles published in the period 2004 to 20162019 inclusive, to span the 113 
period from the described peak of global malaria mortality in 2004 (9).to present.
9
 114 
The searches were last executed on 26 August 2016.03 January 2019. Outputs of 115 
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database searches were combined and de-duplicated in R (21). Fullusing R.
21
 116 
Additional details of searches, screening, review, and data extraction processes are 117 
given in the Supplementary Information (SI).appendix. 118 
 119 
We constructed threeThree search concepts for ‘Fever’, ‘Zoonoses’, and ‘Malaria 120 
Endemic Countries’.fever,’ ‘zoonoses,’ and ‘malaria endemic countries’ were 121 
constructed. To construct the ‘Fever’fever’ concept the exploded subject heading and 122 
keywords were combined using database appropriate syntax (e.g.., exp Fever/ OR 123 
fever$1.mp. OR febrile.mp.). For the ‘Zoonoses’zoonoses’ concept, a reference list of 124 
eligible zoonotic pathogens was compiled using lists of zoonotic diseases from the 125 
World Health Organization (WHO) (22) and World Organisation of Animal Health 126 
(OIE) (23))
22
 and World Organisation of Animal Health (OIE)
23
 as well as literature-127 
based searches to identify frequently reported zoonotic causes of human fever. We 128 
conducted preliminary searches of Medline and Embase using the search syntax ‘(exp 129 
Fever/ OR fever.mp.) AND (exp Zoonoses/ OR zoonoses.mp OR zoonosis.mp)’ 130 
limited to humans. FullAdditional details of these three preliminary searchessearch 131 
concept construction are given in the SIappendix. All pathogens identified through 132 
these approaches were mapped to existing subject headings and keywords at the 133 
lowest appropriate taxonomic level possible, typically genus or species. In instances 134 
where pathogen species or serovars within the same genus varied in their zoonotic 135 
status, search concepts were constructed to include all zoonotic and non-zoonotic 136 
species or serovars and articles relating to non-zoonotic species were excluded at the 137 
full text stage. The candidate pathogens were classified to differentiate pathogens 138 
normatively acquired by people through direct or indirect transmission from 139 
vertebrate animals to humans, as compared to pathogens where zoonotic transmission 140 
has been recorded but where the majority of human infections are not acquired 141 
through zoonotic transmission. We classified pathogens using the stages in the 142 
process towards human endemicity defined in Wolfe et al (24). Pathogens classified 143 
as stages 1 to 3 were retained and full details are given in the SI..
24
 Pathogens 144 
classified at stages one to three (normatively acquired through zoonotic transmission) 145 
were retained (appendix). The search concept for each pathogen or disease included 146 
exploded subject headings for both the pathogen and the diseases caused in humans 147 
and terms for both pathogen and disease were also included as keywords (e.g.., exp 148 
anthrax/ OR anthrax.mp. OR exp Bacillus anthracis/ OR bacillus anthracis.mp.). The 149 
list of pathogen- or disease- specific searches was combined using OR syntax to 150 
generate the full ‘zoonoses’ search concept (Table 1 & SIappendix). The ‘Malaria 151 
Endemic Countries’malaria endemic countries’ concept was constructed by mapping 152 
country names for countries defined as malaria endemic in the WHO global malaria 153 
reports for the years 2005 and 2016 to Medline and Embase subject headings (10,25). 154 
Each country was searched for using both the exploded subject heading where 155 
available and keywords in all cases (e.g., exp Kenya/OR Kenya.mp.). All three 156 
concepts, Fever’, ‘Zoonoses’, and ‘Malaria Endemic Countries’ were combined using 157 
AND operators and database specific syntax gateway (SI).
10,25
 Each country was 158 
searched for using both the exploded subject heading where possible and keywords in 159 
all cases (e.g., exp Kenya/OR Kenya.mp.). The three concepts, fever,’ ‘zoonoses,’ and 160 
‘malaria endemic countries’ were combined using AND operators and database 161 
specific syntax (appendix). 162 
 163 
Study selection and validity assessment 164 
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Articles that reported the diagnosis of a zoonotic pathogen in a population from a 165 
malaria endemic country defined principally on the basis of febrile illness were 166 
selected for full-text review. Conference proceedings and records that did not include 167 
any abstract text or an abstract in English were excluded. Abstracts and titles were 168 
screened by two independent reviewers (two of DVH, GL, MC, and MES, KJA, 169 
GAFL, DVH, JAC, SC and MPR) using pre-defined criteria (SI Table S2appendix 170 
table S1). Articles were selected for inclusion if the abstract or title described clinical 171 
and/or laboratory evaluation of a group of ≥ 2 people with aall of whom had fever and 172 
diagnosissome of whom were diagnosed of one or more pathogens from the reference 173 
list of zoonotic pathogens (Tabletable 1). Abstracts referring to the use of blood 174 
culture were also retained at this stage even if a zoonosis was not explicitly mentioned 175 
in the abstract (SI Table S2). Conference proceedings were excluded.appendix table 176 
S1). When two reviewers disagreed on article classification, a third independent 177 
reviewer (DVH, GLone of JEBH, MC, MES, GAFL, DVH or MPR) resolved the 178 
tiebreak. Full text articles were sought for all articles not excluded at the screening 179 
stepduring abstract review steps. All articles were searched for using PubMed, Google 180 
and the libraries of the University of Glasgow, Duke University, Washington 181 
University in St. Louis, and US Centers for Disease Control and Prevention (US 182 
CDC). Articles were excluded if a full- text for the citation could not be obtained. 183 
Two independent reviewers (two of, JEBH, MPR, JBMC, MES, JB and MCMPR) 184 
evaluated full text articles using pre-defined inclusion and exclusion criteria 185 
(Tabletable 2)., appendix table S2). Strict diagnostic case definitions were used based 186 
on WHO and US CDC guidelines to ensureensured that only studies reporting robust 187 
and specific diagnostic methods were retained (Tabletable 2). Articles were excluded 188 
if they metdid not meet one or more of the study exclusioninclusion criteria or failed 189 
toif they did meet at least one of the study inclusion criterion (Tableexclusion criteria 190 
(table 2). In cases where reviewers disagreed on article classification, discrepancies 191 
were checked and resolved by JEBH in discussion with other reviewers.  192 
 193 
Table 1. Zoonoses included in the review, with details of species and serovars 194 
excluded where appropriate.  195 
Pathogen Species, subspecies, and serovars excluded Pathogen 
type
13
  
Alphaviruses All species excluded with the exception of 
Eastern equine encephalitis virus (EEEV) 
complex, Venezuelan equine encephalitis (VEEV) 
complex, and Western equine encephalitis 
(WEEV) complex 
Virus 
Anaplasma spp. - Bacteria 
Aphthoviruses All species excluded with the exception of Foot-
and-mouth disease virus 
Virus 
Avulaviruses All species excluded with the exception of 
Newcastle disease virus 
Virus 
Babesia spp. - Protozoa 
Bacillus 
antrhracis 
- Bacteria 
Bartonella spp. B. bacilliformis and B. quintana excluded Bacteria 
Borrelia spp. B. recurrentis excluded Bacteria 
Bovine 
spongiform 
- Prion 
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encephalopathy 
Brucella spp. - Bacteria 
Burkholderia 
spp. 
B. cepacia complex and B. pseudomallei excluded Bacteria 
Campylobacter 
spp. 
- Bacteria 
Chlamydia spp. All species excluded with the exception of C. 
psittaci 
Bacteria 
Coxiella burnetii - Bacteria 
Cryptosporidium 
spp. 
C. hominis excluded Protozoa 
Ebolavirus - Virus 
Echinococcus 
spp. 
- Helminth 
Ehrlichia spp. - Bacteria 
Enteroviruses All species excluded with the exception of Swine 
vesicular disease virus 
Virus 
Escherichia spp. All species excluded with the exception of Shiga-
toxin producing E. coli 
Bacteria 
Flaviviruses All species excluded with the exception of 
Japanese encephalitis virus (JEV), West Nile 
virus (WNV), and Tick-borne-encephalitis virus.  
Virus 
Francisella spp. All species excluded with the exception of F. 
tularensis 
Bacteria 
Hantavirus - Virus 
Henipaviruses - Virus 
Lassa virus - Virus 
Leishmania spp. L. donovani excluded if detected in India Protozoa 
Leptospira spp. - Bacteria 
Listeria spp. - Bacteria 
Lyssavirus All species excluded with the exception of Rabies 
virus 
Virus 
Marburg virus - Virus 
Mycobacterium All species excluded with the exception of M. 
bovis and M. avis 
Bacteria 
Nairovirus All species excluded with the exception of 
Crimean-Congo haemorrhagic fever virus 
Virus 
Orientia
1
 -  Bacteria 
Orthopox viruses All species excluded with the exception of 
Cowpox virus, Monkeypox virus, and Vaccinia 
virus 
Virus 
Pasteurella spp. -  Bacteria 
Phleboviruses All species excluded with the exception of Rift 
Valley fever (RVF) virus 
Virus 
Rickettsia spp.
2
 R. prowazekii excluded Bacteria 
Salmonella spp. All species, subspecies, and serovars excluded 
with the exception of nontyphoidal Salmonella 
serovars 
Bacteria 
Schistosoma spp. S. haematobium, S. intercalatum, and S. Helminth 
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mekongi.excluded 
Streptobacillus 
spp. 
- Bacteria 
Streptococcus 
spp. 
All species excluded with the exception of S. 
canis, S. suis, S. equi, and S. iniae 
Bacteria 
Taenia spp.  Helminth 
Toxocara  Helminth 
Toxoplasma 
gondii 
- Protozoa 
Trichinella spp. - Helminth 
Trypanosoma 
spp. 
All species excluded with the exception of T. 
brucei rhodesiense and T. cruzi 
Protozoa 
Varicelloviruses All species excluded with the exception of 
Pseudorabies virus 
Virus 
Vesiculoviruses All species excluded with the exception of 
Vesicular Stomatitis virus 
Virus 
Yersinia spp. All species excluded with the exception of Y. 
pestis, Y. enterocolitica and Y. pseudotuberculosis 
Bacteria 
1
 Orientia was covered by search syntax for Rickettsia.  196 
2 
For data extraction, data on Rickettsia were classified as Rickettsia (SFGR) or 197 
Rickettsia (TGR) where the data resolution allowed. When details on the species of 198 
Rickettsia were not given, these data were classified as Rickettsia spp.  199 
 200 
Table 2: Inclusion and exclusion criteria for full text review 201 
Outcome Criterion 
Inclusion:  Febrile population (≥ 2 people with a fever, defined as body 
temperature ≥ 38·0°C) 
 Diagnosis of one or more zoonotic pathogens from pre-defined 
reference list of eligible aetiological agents (table 1) 
 Diagnostic test criteria:  
i) Culture of the pathogen from sample(s) collected from a febrile 
person 
ii) Direct detection of the pathogen (e.g., by PCR based techniques) 
from sample(s) collected from a febrile person 
iii) Serological diagnosis of acute infection based on testing of both 
acute and convalescent phase serum samples and demonstration of 
seroconversion 
iv) Diagnosis of acute infection based on detection of pathogen-
specific antibody or antigens in a single serum sample only for 
selected pathogens, for which widely accepted case definitions 
deemed pathogen-specific antibody or antigen detection 
sufficiently accurate
1
  
v) IgM detection in cerebrospinal fluid (CSF) for selected pathogens 
for which widely accepted case definitions include IgM detection in 
CSF
2
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Exclusion:  Failure to meet inclusion criteria described above  
 Lack of study detail e.g., number of people tested for each 
pathogen 
 Negative diagnostic test results in all patients  
 Study designed to evaluate diagnostic test and/or vaccine 
performance without presenting novel data on number or 
proportion of patients diagnosed with a study pathogen from a 
previously described population of febrile people.  
 Study described as a group of ≥ 2 people principally classified 
based on a shared (100% frequency) aetiological diagnosis. 
 Review 
1
The following met study criteria for valid diagnostics for pathogen detection based 202 
on single sera only: Leptospira spp. agglutination titer of ≥ 800 by microscopic 203 
agglutination test in one serum specimen 
26
; detection of Hantavirus-specific IgM in a 204 
serum sample 
27
; detection of virus-specific IgM antibodies in serum with 205 
confirmatory virus-specific neutralizing antibodies for Eastern equine encephalitis 206 
virus (EEEV), West Nile virus (WNV), Western equine encephalitis virus (WEEV), 207 
and Venezuelan equine encephalitis virus (VEEV) 
28
; identification of lyssavirus 208 
specific antibody by indirect fluorescent antibody test or complete rabies virus 209 
neutralization at 1:5 dilution in the serum of an unvaccinated person 
29
; detection of 210 
viral antigens in blood by enzyme-linked immunosorbent assay for Ebola 
30,31
, 211 
Marburg 
31,32
, Lassa 
31,33
, and Crimean-Congo haemorrhagic fever viruses 
31
; 212 
detection of Rift Valley fever antigens or IgM in blood by enzyme-linked 213 
Immunosorbent assay 
34
; and 214 
2
 IgM detection in CSF was considered a valid diagnostic for EEEV, Japanese 215 
encephalitis virus (JEV), rabies virus, WEEV, WNV and VEEV 
28,29,35
. 216 
 217 
Data extraction and bias assessment 218 
Data extraction was conducted independently by one of two reviewers (JEBH and 219 
MC). Article-level data were extracted on the location (country and WHO regional 220 
classification (26)),), 
36
 study period (start and end year of data collection)), and 221 
eligibility criteria used in the study. Data extracted on the study population included 222 
whether the population was described inpatient or outpatient and urban or rural. Each 223 
population reported was classified according to the clinical presentation as 224 
undifferentiated febrile or differentiated febrile. Differentiated febrile populations 225 
were further classified as: i) febrile neurologic; ii) febrile hemorrhagichaemorrhagic; 226 
iii) febrile gastrointestinal; iv) febrile respiratory; v) specific febrile aetiology 227 
suspected (27-29). Articles were also classified to record if the; vi) febrile co-morbid 228 
group (i.e., malignancy, immunocompromise).
37-39
 Data extracted on each population 229 
included any demographic restriction of the study population, the age range of the 230 
study participants, whether the population was described as inpatient or outpatient, 231 
urban or rural, and whether data were collected during a reported disease outbreak or 232 
not. To extract data on the zoonotic pathogens included in each study, every included 233 
article was first classified to record if the study reported looking for diagnosedor 234 
diagnosing one or more febrile individuals with eachany of the zoonotic pathogens 235 
included in the study reference list (Tabletable 1), irrespective of the diagnostics used. 236 
Second, forAdditional data were extracted when the article reported application of a 237 
diagnostic approach that met study validity criteria. For each combination of article 238 
and pathogen, details of the valid diagnostic methods used, the type and number of 239 
samples tested, and the number of positive samples were recorded. (appendix table 240 
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S3, S4). In instances where more than one valid diagnostic method was used in the 241 
same study for a given pathogen (e.g.., culture-based and serologic case definitions), 242 
data on the total number of individuals tested and positive for each pathogen were 243 
aggregated. Data on the number of individuals tested and number positive were only 244 
extracted for zoonotic pathogens diagnosed using methods that met study inclusion 245 
criteria.using valid methods were aggregated. Some articles contributed data on more 246 
than one pathogen but no data on participant numbers were extracted for pathogens 247 
not identified using diagnostic approaches that met study inclusion criteria. 248 
 249 
The principal source of potential bias affecting the interpretation of the findings of 250 
this study is the lack of standardization of the febrile populations included in different 251 
studies. Criteria were defined to classify potential bias in study representativeness and 252 
prevalence estimate precision (appendix table S5).
40-42
 The representativeness bias 253 
criterion was designed to classify the representativeness of the study population, 254 
relative to the general population where the study was conducted. This was based on 255 
the description of the febrile population, the restriction (if any) of the study sample to 256 
specific clinical or demographic sub-populations and the reporting of disease 257 
outbreaks at the time of data collection. Each population was classified as follows: i) 258 
populations classified as undifferentiated febrile with no demographic restriction and 259 
no clinical aetiologies excluded were classified as low risk; ii) populations classified 260 
as undifferentiated febrile with demographic restriction and/or reporting exclusion of 261 
specific aetiologies or syndromes were classified as medium risk; iii) differentiated 262 
febrile populations and those from studies reporting disease outbreaks at the time of 263 
data collection were classified as high risk. The second, outcome-level, bias criterion 264 
was designed to classify risk of bias in the estimated precision of the proportion of 265 
fevers attributed to each pathogen. Thresholds used for this criterion are the sample 266 
sizes needed to estimate proportions of 50% and 10% with 95% confidence and 0·05 267 
precision respectively, assuming an infinite population size. Each population was 268 
classified as follows: i) proportion estimates based on a sample size of greater than or 269 
equal to 385 were classified as low risk; ii) proportion estimates based on a sample 270 
size of greater than 385 but less than 139 were classified as medium risk; iii) 271 
proportion estimates based on a sample size of less than 139 were classified as high 272 
risk. 273 
 274 
Additional potential sources of bias included variation in the pathogens tested for, and 275 
variation in the diagnostic approaches applied. For included studies, data on the 276 
pathogens tested for (with any diagnostic approach) were summarized alongside 277 
pathogens for which diagnostic test criteria were met to qualitatively evaluate the 278 
biases introduced by only extracting data on pathogens diagnosed using methods 279 
meeting study inclusion criteria.  280 
 281 
Data analysis  282 
Extracted data on the zoonotic pathogens diagnosed using valid methods, number of 283 
individuals tested for each pathogen, and number of individuals positive for each 284 
pathogen were used to estimate the proportion of fevers attributable to each pathogen 285 
for each unique pathogen and study combination. All analyses were conducted in R 286 
(21) and plots were made using the package ggplot2 (30).
21
 and plots were made 287 
using the package ggplot2.
43
 288 
 289 
Role of the funding source 290 
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The funders of the study had no role in study design, data collection, data analysis, 291 
data interpretation, or writing of the report. The corresponding author had full access 292 
to all the data in the study and had final responsibility for the decision to submit for 293 
publication. 294 
 295 
The principal sources of potential bias identified in the course of this study are the 296 
lack of standardization of the febrile populations included in different studies, 297 
variation in the pathogens tested for, and variation in the diagnostic approaches 298 
applied. Data enabling the characterization of study populations (e.g. location, 299 
outbreak or not, inpatient or outpatient, rural or urban etc.) were collected to enable 300 
assessment of the influence of these factors on reported outcomes. Data on the 301 
pathogens looked for in included studies with any diagnostic approach were 302 
summarized alongside pathogens for which diagnostic test criteria were met to 303 
qualitatively evaluate the biases introduced by only extracting data on pathogens 304 
diagnosed using methods meeting study inclusion criteria. Publication bias is likely to 305 
strongly influence the outputs from this review, but it was not possible to 306 
systematically evaluate this as publication of negative findings is rare, diagnostic 307 
practices are highly variable and no robust methodology exists to estimate the 308 
expected occurrence of the multiple pathogens included in this review. The review 309 
was designed to document only data on the reported presence of zoonotic causes of 310 
febrile illness in populations that were principally defined by the presence of fever. 311 
The application of diagnostic criteria that are strictly comparable across pathogens is 312 
not feasible. We applied strict diagnostic criteria, erring towards high specificity but 313 
reduced sensitivity to minimize the influence of this source of bias. The implications 314 
of these likely biases for the interpretation of study data are discussed.  315 
 316 
Results 317 
Database searches yielded a total of 12,27716,332 and 8,06510,574 records through 318 
Embase and Medline, respectively, resulting in a total of 12,92717,852 unique records 319 
following de-duplication (Figurefigure 1). English language abstracts were available 320 
for 10,927A total of 4,531 (25·4%) records and 687were excluded during pre-321 
screening, 13,321 (74·6%) records were screened and 962 (7·2%) of these were 322 
retained after title and abstract review. In total, 506718 (74·6%) articles were 323 
excluded during full text review (Figure 1). Finally, 181and 244 (25·4%) articles met 324 
all study inclusion criteria and were included in this review (Figure 1 and Table 3). 325 
(figure 1, appendix table S6). 326 
 327 
Articles included in the review yielded data from 46 (41·853 (48·2%) of the 110 328 
malaria endemic countries included in searches. Seven (figure 2). The majority of 329 
articles with a single country origin (n=235) reported data from multiple countries. 330 
The distributionAfrica (83 of the remaining 174235 articles by country and WHO 331 
region is shown in Figures 2 and 3, and Table 4. Sixty-seven (37·0%) of the 181 332 
studies included in the review, 35·3%) or South-East Asia (81 of 235 articles, 34·5%) 333 
(appendix table S7, figure S1). One hundred and six (45·1%) of the 235 articles with a 334 
single country origin were conducted in one of foursix dominant countries: India 335 
(n=23), Thailand, (n=1731), United Republic of Tanzania (n=15), and 22), Thailand, 336 
(n=20), Nepal (n=12).), Bangladesh (n=11), and Nigeria (n=10). The data reported in 337 
included studiesthe review were gathered frombetween 1994 to 2015and 2017 338 
inclusive. 339 
 340 
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The 181The 244 articles included for data extraction reported looking for and 341 
diagnosing 40 and 31 zoonoses, respectively, in these populations (figure 3). The 342 
number of included zoonoses was reduced to 30 after the criteria for diagnostic testing 343 
approach were applied. The 244 articles yielded data that met diagnostic test criteria 344 
for a total of 2930 zoonoses. The 29 pathogens for which diagnostic data were 345 
extracted that included 1617 bacterial pathogens (55·2%), 956·7%), nine viruses 346 
(3130·0%), 3three protozoa (10·30%), and 1one helminth (3·4%). Nontyphoidal3%). 347 
Leptospira spp., nontyphoidal Salmonella serovars (NTS), Leptospira spp.) and 348 
rickettsioses were the most frequently reported bacteria, while Japanese encephalitis 349 
virus (JEV), Hantavirus, and West Nile virus (WNV) dominated among viruses 350 
(Figures 4, 5 and 7). Before applying diagnostic test validity criteria, the 181 articles 351 
reported looking for and diagnosing 36 and 35 zoonoses respectively in these 352 
populations. This list of zoonoses was reduced to 29 after the criteria for diagnostic 353 
testing approach were applied (Figure 4). The breakdown of articles contributing data 354 
on different pathogens in different WHO regions is shown in Figure 5.reported 355 
viruses (figures 3, 4). 356 
 357 
The number of febrile individuals included in each study population ranged from 4 to 358 
13,845, with a median of 300 (IQR: 120 – 812). In total, 309 records of zoonotic 359 
pathogens causing fever were extracted from the 244 articles. The proportion of 360 
fevers attributed to each pathogen reported ranged from <1·0% to 95·0% (figure 4). 361 
The risk of bias classification in the precision of the proportion of fevers attributed to 362 
each zoonosis was 136 (44·0%) of 309 low risk, 79 (25·6%) of 309 medium risk, and 363 
94 (30·4%) of 309 high risk.  364 
 365 
Of the 181244 studies, 75 (41·487 (35·7%) described the clinical setting as inpatient, 366 
28 (15·536 (14·8%) as outpatient, 22 (12·239 (16·0%) as mixed, and for 56 367 
(30·9%),82 (33·6%) gave no clear classification of the clinical setting was given. 368 
Twenty-five (13·8%) . Thirty (12·3%) studies described the study area as urban, 43 369 
(23·859 (24·2%) as rural, 24 (13·345 (18·4%) mixed or both, and for 89 (49·2%)110 370 
(45·1%) gave no clear classification of the study area was given. Of the 181 febrile 371 
study. Eighteen (7·4%) studies included adult participants, 43 (17·6%) included 372 
children, 153 (62·7%) included both adults and children and 30 (12·3%) gave no clear 373 
classification of the ages included. Of the 244 studies, twelve (4·9%) described a 374 
demographically restricted population, 55 (22·5%) reported some exclusions from the 375 
population, and 32 (13·1%) mentioned exclusion of malaria-infected individuals 376 
specifically (appendix table S6). Of the 244 studies, 73 (29·9%) reported looking for 377 
more than one zoonosis, 43 (17·6%) diagnosing more than one zoonosis and 37 378 
(15·2%) contributing data on more than one zoonosis. Of the 244 studies, 10 (4·1%) 379 
were described as outbreak investigations and 169 (69·3%) populations, 41 were 380 
classified as undifferentiated febrile populations. Among the 75 differentiated 381 
populations, 36 (48·0%) had specific febrile aetiologies suspected, 17 (22·7%) were 382 
classified as differentiated, 95 (52·5febrile neurological, eight (10·7%) as 383 
undifferentiated, and 45 (24·9%) were mixed. Among the differentiatedcomorbid 384 
populations 4 (9·8%) were, eight (10·7%) as febrile haemorrhagic, five (6·7%) as 385 
febrile gastrointestinal, 5 (12·2%) febrile haemorrhagic, 17 (41·5%) febrile 386 
neurological, 12 (29·3%) had specific febrile aetiologies suspected, and the remaining 387 
3 (7· and one (1·3%) were mixed populations (including patients with as febrile 388 
respiratory symptoms).. The associations between clinical presentation of febrile 389 
populations and the 29subset of 25 pathogens identified in the different groups 390 
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differentiated populations are shown in Figure 6. All 6 pathogens identified in febrile 391 
haemorrhagic populations were also detected in undifferentiated patient groups. 392 
Eastern Equine Encephalitis virus (EEEV) and Nipah virus were only detectedfigure 393 
5. The risk of bias classification in febrile neurological populations and 394 
Campylobacter spp. was only detected in athe representativeness of febrile 395 
gastrointestinal population (Figure 6).  396 
 397 
In total, 9 (5·0%) of 181 studies included were described as outbreak investigations. 398 
These 9 studies included data from 7 countries and 8 pathogens, describing outbreaks 399 
of Crimean-Congo Haemorrhagic Fever (CCHF) virus in Pakistan, JEV in Thailand, 400 
Leptospira spp. in Bangladesh and Thailand, Nipah virus in India, spotted-fever group 401 
rickettsioses (SFGR) in Guatemala, Venezuelan Equine Encephalitis virus (VEEV) in 402 
Peru, WNV in India (2 studies), and Yersinia pestis in Zambia.  403 
 404 
The number of febrile individuals included in each study population ranged from 6 to 405 
13,840 individuals, with a median of 291populations was 121 (49·6%,) of 244 low 406 
risk, 45 (18·4%,) of 244 medium risk, and mean of 922. In total, 226 records of 407 
zoonotic pathogens causing fever were extracted from the 181 articles. Figure 7 plots 408 
the proportion of fevers attributed to each pathogen reported in the included studies. 409 
The proportion of fevers attributed of a given pathogen ranged from <1% to 95%, 410 
median 5.5% and mean 13.5%.78 (32·0%,) of 244 high risk.  411 
 412 
Discussion 413 
The findings of thisThis systematic review reveal areveals diverse group of zoonoses 414 
causing febrile illness within multiple malaria-endemic countries, often at high 415 
prevalence. Zoonoses are documented as a cause of fever in all regions included in 416 
this study and many different zoonoses contribute to clinical burdens. However, 417 
sparse and patchy reporting suggests that the clinical burdenprevalence of zoonoses is 418 
likely to be widely under-estimated. As knowledgeKnowledge of probable infecting 419 
pathogen is paramountcrucial to inform the clinical management and prevention of 420 
febrile illness, and there is a clear need for further investigation of the zoonotic causes 421 
of febrile illness globally to generate data relevant to clinicians, epidemiologists, and 422 
health policy makers. Our study highlights the clinical importance of several 423 
pathogens, including some that occur across a wide range of areas and at high 424 
prevalence. The globally. This study should generate greater awareness aboutof the 425 
clinical importance of zoonotic pathogenszoonoses and provide a pragmatic starting 426 
point for actions to better manage these diseases, for example through improved 427 
diagnostic and clinical treatment algorithms, as well as. These findings demonstrate 428 
the need for enhanced epidemiological understanding that is neededof multiple 429 
zoonoses to inform disease prevention.  430 
 431 
This review reveals substantial gaps in the evidence base, including a complete 432 
absence of eligible studies from more than half of the majority, 64 (58·2%) of 110 433 
countries, included in the review (Figurefigure 2). There are multiple steps and biases 434 
in the processes from a patient seeking care with febrile illness to the publication of 435 
an English language scientific paper on the occurrence and prevalence of a specific 436 
zoonosis that could be included in this review. The underlying distribution and 437 
relative clinical importance of individual pathogens will varyvaries, as well asdo 438 
patient healthcare seeking behaviorbehaviour, clinical, and patient awareness of 439 
different pathogens, diagnostic capacities, and probability of publication. It is 440 
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therefore not plausible to expect this review to yield data on each zoonosisall 441 
zoonoses in all countries. However, considering the inclusion of 110 countries and 442 
construction of searches for 4850 pathogens or pathogen groups, the identification of 443 
just 181244 eligible studies underscores the profound overall shortage of robust 444 
quantitative data describing the role of any zoonoses as causes of fever in most 445 
malaria-endemic countries. The geographic variation in the distribution of studies by 446 
country and region (Table 4) is likely to be strongly influenced by variation in 447 
research and publication effort on the topic of non-malaria febrile illness and cannot 448 
be interpreted as an accurate reflection of the underlying distribution of zoonotic 449 
pathogens or their clinical importance. The restriction of this review to English 450 
language texts will also have reduced the probability that studies from French and 451 
Spanish speaking countries were included and may partially account for some specific 452 
gaps, such as the 27 countries in Africa and 15 in the Americas for which no eligible 453 
studies were identified (Figure 2, Table 4).  454 
 455 
We extracted data on 29 zoonotic causes of fever in malaria-endemic countries. 456 
Among these, the majority (55·2%) were bacteria. The proportion of bacteria is 457 
significantly greater than expected from the taxonomic distribution of all zoonotic 458 
pathogens, which comprise 30.1% bacteria (2 = 26·4, d.f. = 1, p<0·001, data from 459 
(31)) and also contrasts with the taxonomic distribution of emerging zoonoses, which 460 
are dominated by viruses (13). While this study is unlikely to accurately reflect the 461 
true taxonomic distribution of all fever-causing zoonoses, this finding does reinforce 462 
the clinical importance of endemic bacterial zoonoses and need for greater awareness 463 
of these zoonoses, particularly given the availability of effective treatments that could 464 
substantially mitigate these disease burdens. 465 
 466 
The geographic variation in the distribution of studies by country (figure 2) and 467 
region (appendix table S7, figure S2) is likely to be strongly influenced by variation in 468 
research and publication effort. There is noticeable geographic segregation for some 469 
zoonoses, with NTS and SFGR reported more frequently in Africa, and Leptospira 470 
spp., Orientia tsutsugamushi, and typhus-group rickettiosesrickettsioses (TGR) 471 
reported more frequently in South-East Asia (Figure 5).and Western Pacific regions 472 
(appendix figure S2). For viruses, Lassa virus was reported only in Africa and JEV 473 
onlypredominantly in South-East Asia. These geographic differences in the reporting 474 
patterns will only partially reflect the true The distribution of studies cannot be 475 
interpreted as an accurate reflection of the underlying distribution andof zoonotic 476 
pathogens, their prevalence of each pathogen. Diagnostic testing behavior is not 477 
uniform and theor clinical importance. The pathogens that are looked for also 478 
dependsdepend on factors such as the diagnostic capacity available, existing data, and 479 
local assessment of the likely causes of febrile illness in a specific location. The data 480 
generated in this review cannot be used to formally quantify the under or over 481 
representation of different pathogens in different countries but may help indicate 482 
potential gaps in what is looked for. Once specificOnce pathogens are identified in 483 
specific locations,any location there will likely be improvedincreased clinical and, 484 
patient, and community awareness of those pathogens, as well as improved diagnostic 485 
capacity to detect them. In this way, dogma about the ‘known’ important causes of 486 
febrile illness in specific locations can arise and contribute to the neglect of other 487 
pathogens. The findings of this review can highlight pathogens and locations where 488 
these dogmas should be questioned. The relative lack of studies reporting robust 489 
diagnoses of illness caused by Leptospira spp. in Africa, for example, is likely to 490 
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reflect a lack of research effort and limited diagnostic capacity rather than a relative 491 
absence of clinical leptospirosis in the region (14). Similarly, recent studies indicate 492 
that the lack of studies investigating O. tsutsugamushi in Africa may be a reflection of 493 
a presumed absence of scrub typhus in Africa and a consequent failure to test for 494 
Orientia, rather than an absence of the pathogen itself, potentially allowing a 495 
substantial incidence of scrub typhus to go unrecognized (32,33). The findings of this 496 
review may help indicate potential gaps in what is looked for and can highlight 497 
pathogens and locations where these dogmas should be questioned. 498 
 499 
Figure 4 shows The majority of the comparison30 zoonotic causes of fever 500 
contributing data for this review were bacteria (56·7%). This proportion is greater 501 
than expected from the taxonomic distribution of all zoonotic pathogens, which 502 
comprise 30·1% bacteria
44
 and also contrasts with the taxonomic distribution of 503 
emerging zoonoses, which are dominated by viruses.
13
 This finding reinforces the 504 
clinical importance of endemic bacterial zoonoses. The comparisons between the 505 
number of articles that looked for, diagnosed, and contributed data for each of 36 506 
zoonoses mentioned in the 181 articles analyzed. These three metrics and their 507 
comparison provide several insights. First, revealing40 zoonoses reveals the range of 508 
zoonotic pathogens investigated and providing an indication of indicates the relative 509 
investigative effort used for each pathogen. The (figure 3). However, the figures for 510 
number of articles where a pathogen was looked for but not identified must be 511 
interpreted with caution given the high probability of reporting bias and likelihood 512 
that studies often omit mention of investigations for pathogens that are not 513 
subsequently found. Finally, forhow rarely negative results are reported. For several 514 
pathogens, the number (and/or proportion) of articles that reported a zoonotic 515 
diagnosis of a zoonoses but did not contribute further data for this are non-trivial. 516 
These articles report diagnosis of zoonoses but data were not extracted asanalysis 517 
(because the diagnostic approaches described dodid not meet study quality criteria. 518 
These results demonstrate) are substantial (figure 3). This demonstrates that for many, 519 
predominantly bacterial pathogens, suboptimal and/or non-standardized diagnostic 520 
tests or imprecise case definitions are in widespread use, highlighthighlighting the 521 
challenges of accurately quantifying disease prevalence and comparing studies.  522 
 523 
Unfortunately, several factors contribute to the ongoingPersistent challenges ofin the 524 
diagnosis of febrile patients. These include limited laboratory capacity, reliance on 525 
demonstration of seroconversion for confirmed diagnosis of many pathogens (with 526 
limited utility for management of acute cases), non-sustainable, unsustainable costs 527 
associated with more advanced diagnosticsdiagnostic technologies, and lack of simple 528 
and affordable tests for the accurate and timely diagnosis of several zoonotic 529 
pathogens. Linked to thisIn addition, the delays in patient presentation that are typical 530 
in many resource limited settings, lead to low magnitude bacteremiabacteraemia at 531 
presentation orand, presentation of patients during the immune phase of illness, 532 
factors that furtherall limit the sensitivity of culture or PCR-based diagnostic 533 
approaches when available. These challenges necessitate syndromic approaches to 534 
patient management and broad-spectrum treatment. One specific issue relates to 535 
tetracycline use. O. tsutsugamushi and rickettsioses, which thisThis study identified 536 
rickettsioses and O. tsutsugamushi as common causes of fever,. These would both 537 
benefit from treatment with tetracyclines, which are not currently included in the 538 
Integrated Management of Adolescent and Adult Illness (IMAI) algorithms for septic 539 
shock and severe respiratory distress without shock (34)..
45
 In light of the extensive 540 
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contribution of tetracycline-responsive infections to fever in malaria-endemic 541 
countries, revisions to clinical guidelines may be warranted to suggest the empirical 542 
use of tetracyclines in addition to beta-lactams in those scenarios where the infection 543 
with tetracycline-responsive pathogens could notcannot be excluded. 544 
 545 
The diversity of pathogens identified in this review add to the existing diagnostic 546 
challenges facing clinicians, laboratories, and health systems. To some extent, 547 
findings from existing aetiology studies can be extrapolated to inform practice in 548 
other similar countries and settings. This approach may be most valuable for 549 
pathogens with well described and stable epidemiology. However, where pathogens 550 
show wide spatial and temporal variability in incidence, more locally-specific 551 
research efforts will be needed to assess the relative contribution of different zoonoses 552 
to fever in different settings.  553 
 554 
The most common patient population in this review comprised people with 555 
undifferentiated febrile illness. Figure 6 illustrates the associations between different 556 
zoonoses and different clinical presentations. While some zoonotic pathogens were 557 
associated with specific clinical presentations in addition to fever (e.g. neurological, 558 
gastrointestinal, haemorrhagic clinical presentation) in some reports, almost all 559 
pathogens were also detected in undifferentiated populations. This suggests that 560 
zoonoses commonly linked with specific syndromes (e.g. Crimean-Congo 561 
haemorrhagic syndrome and JEV) still need to be considered in the differential 562 
diagnosis of undifferentiated fever, even in the absence of other specific clinical 563 
features. While documented associations between pathogens and specific clinical 564 
presentations may assist clinicians in the differential diagnosis of febrile illnesses, the 565 
impact of variation in when specific pathogens are tested for must also be 566 
remembered when interpreting these data.  567 
The findings of this review show that one or more zoonotic causes of fever are likely 568 
to present a threat to health in all of the countries included in this review. Only a 569 
small proportion of the febrile populations included in the study were defined as 570 
demographically restricted and most were not clinically differentiated. Even zoonoses 571 
commonly linked with specific syndromes (e.g., Crimean-Congo haemorrhagic fever 572 
virus and JEV) were diagnosed in undifferentiated populations and should thus be 573 
considered in the differential diagnosis of undifferentiated febrile illness. Within 574 
populations at risk, it is important that aetiologic studies are followed by 575 
epidemiologic risk factor studies to determine whether certain sub-groups are at 576 
higher risk for specific zoonotic diseases. Robust febrile illness surveillance systems 577 
help inform local epidemiology and febrile illness management, and are also essential 578 
for detection of disease outbreaks.
46
 579 
 580 
There are several important limitations to this study. We examined the contribution of 581 
zoonotic pathogens to febrile illness only in malaria-endemic countries and excluded 582 
articles not available in English from our analysis. ArticlesThe restriction of this 583 
review to English language texts will have reduced the probability that studies from 584 
French and Spanish speaking countries were only included and may partially account 585 
for some gaps, such as the 23 countries in the review if they included valid data on 586 
diagnosis of one or more zoonoses.Africa and 15 in the Americas for which no 587 
eligible studies were identified. Studies reporting the performance of tests resulting 588 
in all negative test results were thus excluded from the analysis.. This selection 589 
strategy was motivated by the inevitable influence of publication bias and 590 
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complexities inchallenges of systematically quantifying the non-reporting of either 591 
diagnostic test performance or the non-detection of specific pathogens. The findings 592 
of this study thus include only populations where zoonoses were identified. 593 
Biases in testing practices for different pathogens in different locations and with 594 
different clinical febrile presentations will influence the pathogens looked for, 595 
detected and reported. The application of diagnostic criteria that are strictly 596 
comparable across pathogens is not feasible.  in this study. The proportions of 597 
febrile illnesses attributable to each zoonotic pathogen (Figure 7) thus apply 598 
only for populations where the pathogen is known to be present.In this study, 599 
strict diagnostic criteria were applied, preferentially including diagnostic approaches 600 
with a high specificity, to minimize the influence of false positives within the 601 
analyses. The bias assessments for study representativeness and precision in the 602 
estimates of proportion of fevers attributable to a given pathogen both reveal that the 603 
majority of data points had medium or high risk of one or both types of bias. This 604 
emphasizes the need for cautious and essentially non-quantitative interpretation of the 605 
data extracted from these studies. Many studies with risk of precision bias due to 606 
smaller sample size tended to report the highest prevalences of disease attribution to a 607 
given pathogen (figure 5); and, interestingly, these studies were often also classified 608 
as high risk for representativeness bias. Figure 5 shows clear variation in risk of 609 
representativeness bias across pathogens, potentially linked to variation in clinical 610 
presentation. For example, the majority of data points for Japanese encephalitis virus 611 
and indeed all data points for Leishmania donovanii are classified as high risk of 612 
representativeness bias. This review focused on studies reporting diagnostic 613 
investigation of patient populations that were principally defined by fever (e.g. febrile 614 
populations some of whom had one or more zoonoses) and populations principally 615 
defined by a common aetiological diagnosis were excluded (e.g.,. populations defined 616 
by presence or suspicion of one or more zoonosis, some of whom were febrile). As a 617 
consequence, this systematicThis review therefore had relativelyan inherently low 618 
sensitivity for studies describing outbreaks, with just 9 included studies described 619 
as documenting disease outbreaks (but meeting all study criteria and thus 620 
retained).. This focus explains, for example, the absence of studies describing the 621 
2014-2016 Ebola West Africa outbreak amongst others. Our findings are therefore 622 
unlikely to capture the full extent. The design of this review did not allow explicit 623 
investigation of morbidity and mortality attributable to co-infections, either of 624 
zoonoses with malaria or of multiple zoonoses that cause outbreaks.. Co-infections 625 
are likely to be an important factor underlying both the distribution and prevalence of 626 
some zoonotic pathogens, including for example nontyphoidal Salmonella serovars.
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 627 
Serological diagnosis of acute infection based on testing of both acute and 628 
convalescent phase serum samplessera is central to the confirmed diagnosis of 629 
multiple pathogens included in the study: as. As a consequence, individuals who die 630 
prior to the collection of convalescent samples are unlikely to contribute data (in the 631 
absence of other valid confirmatory test options) and the proportionproportions of 632 
fevers attributable to pathogens with high probability of acute fatality will be under-633 
estimated and our findings may not fully capture the contribution of zoonoses in 634 
lethal febrile illnesses. Furthermore, no validity criteria regarding the timing of 635 
sample collection for acute and convalescent samples were imposed, leading 636 
potentially to false negative results (e.g., seroconversion not detected because of 637 
premature convalescent sampling). For these reasons, our findings are unlikely to 638 
capture the full extent of morbidity and mortality attributable to zoonoses. 639 
 640 
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The data compiled in this review demonstrate the need to consider multiple zoonoses 641 
among the potential causes of febrile illnesses in malaria-endemic countries. The 642 
diversity of pathogens identified and the geographic variation in their distribution 643 
indicates that differentDifferent zoonoses are likely to be important in different 644 
settings. Nonetheless, ourOur study provides a starting point for improving awareness 645 
of first the zoonoses that are known to contribute to febrile illness in different 646 
malaria-endemic regions and second the fever-causing zoonoses with widespread 647 
distribution that should also be considered in patient evaluation. The demonstration of 648 
major data gaps should also encourage a more open-minded approach when 649 
considering zoonoses as a potential cause of febrile illness. 650 
 651 
Greater research effort is needed to overcome the current paucity of evidence. In 652 
addition, untapped Continued efforts are needed to develop multi-pathogen 653 
diagnostics, ideally with formats appropriate for point of care use. To avoid 654 
perpetuation of self-fulfilling prophesies that can arise when only pathogens tested for 655 
(and detected) are assumed to be present, the development and evaluation of such 656 
diagnostics should be informed by data describing the pathogens present in specific 657 
settings and also the wider context. Untapped sources of information on the 658 
distribution and occurrence of fever-causing zoonoses almost certainly also exist, 659 
particularly in the animal health sector, and. One Health efforts to share data and 660 
knowledge between animal and human health sectors could help raise clinician 661 
awareness of locally- relevant zoonoses, inform history taking, and guide diagnostic 662 
and management decision making. Given the diversityControl of pathogens, 663 
continued effortsdisease in animal populations and prevention of transmission from 664 
animals to humans are also neededlikely to be the most effective ways to reduce 665 
human disease risk with many zoonoses, necessitating active engagement with 666 
populations at risk to develop multi-pathogen diagnostics. This is also important to 667 
avoid perpetuation of self-fulfilling prophesies that can arise when only pathogens 668 
tested for (and hence detected) are assumed to be present. While theresustainable 669 
disease control interventions. There are substantial challenges to clinicians and 670 
epidemiologists in revealing the true impacts of many zoonoses, the. The enormous 671 
global burden of febrile illness and scope for improvements in the diagnosis and 672 
treatment of zoonotic pathogens necessitatesnecessitate efforts to overcome these 673 
challenges and translate findings into important public health gains. 674 
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 676 
Research in Context 677 
Evidence before this study 678 
Fever is one of the most common drivers of healthcare seeking globally and there is 679 
growing awareness of the clinical importance of multiple causes of febrile illness. 680 
Zoonoses are known to be important, but many zoonoses remain systematically 681 
under-reported and there are large and persistent gaps in our understanding of the 682 
human health impacts of zoonoses globally. We conducted a systematic review to 683 
describe the occurrence and distribution of reported zoonotic causes of human febrile 684 
illness in malaria endemic countries.  685 
We reviewed studies identified in Medline and Embase databases that described 686 
testing of febrile populations for zoonotic pathogens, using a pre-defined list of 687 
eligible zoonotic pathogens and applying quality criteria for diagnostic tests. 688 
Literature searches were run using the OvidSP gateway and were limited to peer-689 
reviewed English language articles published in the period 2004 to 2016 inclusive, to 690 
span the period from the described peak of global malaria mortality in 2004 to 691 
present. The searches were last executed on 26 August 2016.  692 
Added value of this study 693 
This review reveals the widespread occurrence of zoonotic causes of febrile illness, 694 
with a diverse range of pathogens identified. Data were extracted on the zoonotic 695 
pathogens detected and the number of individuals tested and positive for each 696 
pathogen using diagnostics that met study inclusion criteria. We identified 181 697 
articles, from 46 countries and 7 WHO regions that described diagnosis of 29 698 
zoonoses in febrile people. The majority of zoonoses were bacterial. Our data identify 699 
substantial gaps in the current evidence base and highlight areas for future research 700 
investment.  701 
Implications of all the available evidence 702 
The principal implications of the study findings are that zoonotic pathogens are 703 
ubiquitous but sparsely reported and that many different zoonoses are likely to 704 
contribute to substantial under-documented clinical burdens across the regions 705 
included in this study. Given the crucial importance of knowledge of probable 706 
infecting pathogen to inform clinical management of febrile illness there is a clear 707 
need for further investigation of the zoonotic causes of febrile illness globally to 708 
generate data relevant to clinicians, epidemiologists and health policy makers. 709 
 710 
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Tables 1411 
 1412 
Table 1. Zoonoses included in the review, with details of species and serovars where 1413 
appropriate.  1414 
Pathogen Species, subspecies, and serovars excluded Pathogen 
type (13)  
Alphaviruses All species excluded with the exception of 
Eastern equine encephalitis virus (EEEV) 
complex, Venezuelan equine encephalitis (VEEV) 
complex, and Western equine encephalitis virus 
(WEEV) complex 
Virus 
Anaplasma spp. - Bacteria 
Aphthoviruses All species excluded with the exception of Foot-
and-mouth disease virus 
Virus 
Avulaviruses All species excluded with the exception of 
Newcastle disease virus 
Virus 
Babesia spp. - Protozoa 
Bacillus 
antrhracis 
- Bacteria 
Bartonella spp. B. bacilliformis and B. quintana Bacteria 
Borrelia spp. B. recurrentis Bacteria 
Bovine 
spongiform 
encephalopathy 
- Prion 
Brucella spp. - Bacteria 
Burkholderia 
spp. 
B. cepacia complex and B. psuedomallei Bacteria 
Campylobacter 
spp. 
- Bacteria 
Chlamydia spp. All species excluded with the exception of C. 
psittaci 
Bacteria 
Coxiella burnetii - Bacteria 
Cryptosporidium 
spp. 
C. hominis Protozoa 
Ebolavirus - Virus 
Echinococcus 
spp. 
- Helminth 
Ehrlichia spp. - Bacteria 
Enteroviruses All species excluded with the exception of Swine 
vesicular disease virus 
Virus 
Escherichia spp. All species excluded with the exception of Shiga-
toxin producing E. coli 
Bacteria 
Flaviviruses All species excluded with the exception of 
Japanese encephalitis virus (JEV), West Nile 
virus (WNV), and Tick-borne encephalitis 
viruses.  
Virus 
Francisella spp. All species excluded with the exception of F. 
tularensis 
Bacteria 
Hantavirus - Virus 
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Henipaviruses - Virus 
Lassa virus - Virus 
Leishmania spp. L. donovani if detected in India Protozoa 
Leptospira spp. - Bacteria 
Listeria spp. - Bacteria 
Lyssavirus All species excluded with the exception of rabies Virus 
Marburg virus - Virus 
Mycobacterium All species excluded with the exception of M. 
bovis and M. avis 
Bacteria 
Nairovirus All species excluded with the exception of 
Crimean-Congo hemorrhagic fever virus 
Virus 
Orthopox viruses All species excluded with the exception of 
Cowpox virus, Monkeypox virus, and Vaccinia 
virus 
Virus 
Pasteurella spp. - Bacteria 
Phleboviruses All species excluded with the exception of Rift 
Valley Fever virus 
Virus 
Rickettsia spp. All species excluded with the exception of R. 
prowazekii 
Bacteria 
Salmonella spp. All species, subspecies, and serovars excluded 
with the exception of nontyphoidal Salmonella 
serovars 
Bacteria 
Schistosoma spp. S. haematobium, S. intercalatum, and S. mekongi. Helminth 
Streptobacillus 
spp. 
- Bacteria 
Streptococcus 
spp. 
All species excluded with the exception of S. 
canis, S. suis, S. equi, and S. iniae 
Bacteria 
Taenia spp. - Helminth 
Toxocara - Helminth 
Toxoplasma 
gondii 
- Protozoa 
Trichinella spp. - Helminth 
Trypanosoma 
spp. 
All species excluded with the exception of T. 
brucei rhodesiense and T. cruzi 
Protozoa 
Varicelloviruses All species excluded with the exception of 
Pseudorabies virus 
Virus 
Vesiculoviruses All species excluded with the exception of 
Vesicular stomatitis virus 
Virus 
Yersinia spp. All species excluded with the exception of Y. 
pestis, Y. enterocolitica and Y. pseudotuberculosis 
Bacteria 
 1415 
  1416 
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Table 2: Inclusion and exclusion criteria for full text review 1417 
Outcome Criterion 
Inclusion:  Febrile population (≥ 2 people with a fever, defined as body 
temperature ≥ 38.0°C) 
 Diagnosis of one or more zoonotic pathogens from pre-
defined reference list of eligible aetiological agents (Table 1) 
 Diagnostic test criteria:  
i) Culture of the pathogen from sample(s) collected from an 
febrile person 
ii) Direct detection of the pathogen (e.g. by PCR based 
techniques) from sample(s) collected from a febrile person 
iii) Serological diagnosis of acute infection based on testing of 
both acute and convalescent phase serum samples and 
demonstration of seroconversion 
iv) Diagnosis of acute infection based on detection of pathogen-
specific IgM or antigens in a single serum sample only for 
selected pathogens, for which widely accepted case 
definitions deemed pathogen-specific IgM or antigens 
detection sufficiently accurate (see footnote
1
)  
v)  IgM detection in CSF (e.g. for JEV and WNV) 
 
Exclusion:  Failure to meet inclusion criteria described above  
 Lack of study detail e.g. number of people tested for each 
pathogen 
 Negative diagnostic test results in all patients  
 Study designed to evaluate diagnostic test and/or vaccine 
performance without presenting novel data on number or 
proportion of patients diagnosed with a study pathogen from 
a previously described population of febrile people.  
 Study described as a group of ≥ 2 people principally 
classified based on a shared (100% frequency) aetiological 
diagnosis. 
 Review 
1
The following were considered valid tests: Leptospira spp. agglutination titer of ≥ 1418 
800 by microscopic agglutination test in one serum specimen (35); detection of 1419 
Hantavirus-specific IgM in a serum sample (36); detection of virus-specific IgM 1420 
antibodies in serum with confirmatory virus-specific neutralizing antibodies for 1421 
Eastern equine encephalitis virus (EEEV), West Nile virus (WNV), Western equine 1422 
encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) (37); 1423 
identification of lyssavirus specific antibody by indirect fluorescent antibody test or 1424 
complete rabies virus neutralization at 1:5 dilution in the serum of an unvaccinated 1425 
person (38); detection of viral antigens in blood by enzyme-linked immunosorbent 1426 
assay for Ebola (39,40), Marburg (40,41), Lassa (40,42), and Crimean-Congo 1427 
hemorrhagic fever viruses (40); detection of Rift Valley fever antigens or IgM in 1428 
blood by enzyme-linked Immunosorbent assay (43); and IgM detection in CSF for 1429 
EEEV, Japanese encephalitis virus (JEV), rabies virus, WEEV, WNV and VEEV 1430 
(37,38,44). 1431 
 1432 
 1433 
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 1434 
Table 3: Characteristics and summary of extracted data for the 181 articles included in the review.  1435 
 1436 
First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Aarsland et al (2012)(45) Ethiopia 
2009-
2010 Borrelia spp. 102 2 
Aarsland et al (2012)(45) Ethiopia 
2009-
2010 Rickettsia (SFGR) 102 4 
Adurthi et al (2008)(46) India - Toxoplasma gondii 162 21 
Afifi et al (2005)(47) Egypt 
1999-
2003 Brucella spp. 9883 275 
Aguilar et al (2007)(48) Peru - 
Eastern equine 
encephalitis virus 153 2 
Akinyemi et al (2007)(49) Nigeria 
2004-
2005 
Salmonella (non-Typhi) 
serovars  235 16 
Akinyemi et al (2015)(50) Nigeria 
2010-
2011 
Salmonella (non-Typhi) 
serovars 135 2 
Alam et al (2013)(51) Pakistan 
2008-
2008 
Crimean-Congo 
haemorrhagic fever virus 44 16 
Albuquerque Filho et al 
(2011)(52) Brazil 
2009-
2009 Leptospira spp. 97 56 
Al-Emran et al (2016)(53) No Single Country - 
Salmonella (non-Typhi) 
serovars 10636 77 
Al-Emran et al (2016)(54) No Single Country 
2011-
2013 
Salmonella (non-Typhi) 
serovars 8161 28 
Ali et al (2007)(55) Pakistan 
2001-
2001 
Crimean-Congo 
haemorrhagic fever virus 10 3 
Andualem et al (2014)(56) Ethiopia 2010- Salmonella (non-Typhi) 270 7 
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First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
2011 serovars 
Anga et al (2010)(57) Papua New Guinea 
2007-
2008 
Japanese encephalitis 
virus 129 2 
Angelakis et al (2014)(58) No Single Country 
2008-
2012 Coxiella burnetii 1888 7 
Armien et al (2013)(59) Panama 
2006-
2010 Hantavirus 150 117 
Barua et al (2016)(60) India 
2010-
2012 Brucella spp. 102 18 
Bengre et al (2012)(61) India 
2009-
2011 Pasteurella spp. 50 1 
Biggs et al (2011)(62) 
United Republic of 
Tanzania 
2007-
2008 Leptospira spp. 831 70 
Biggs et al (2014)(63) 
United Republic of 
Tanzania 
2006-
2008 
Salmonella (non-Typhi) 
serovars 4106 163 
Blacksell et al (2006)(64) 
Lao People's 
Democratic Republic 
2001-
2003 Leptospira spp. 186 5 
Blacksell et al (2007)(65) Nepal 
2002-
2004 Orientia tsutsugamushi 103 5 
Blacksell et al (2007)(65) Nepal 
2002-
2004 Rickettsia (TGR) 103 9 
Blacksell et al (2010)(66) 
Lao People's 
Democratic Republic 
2003-
2007 Orientia tsutsugamushi 1030 101 
Blacksell et al (2010)(66) 
Lao People's 
Democratic Republic 
2003-
2007 Rickettsia (TGR) 1030 183 
Blacksell et al (2016)(67) Thailand 
2007-
2008 Orientia tsutsugamushi 135 22 
   Page 39 of 56 
First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Blacksell et al (2016)(68)  Thailand 
2006-
2007 Orientia tsutsugamushi 152 37 
Boisen et al (2015)(69) Sierra Leone 
2012-
2012 Lassa virus 53 29 
Boisen et al (2015)(69) Sierra Leone 
2012-
2012 West Nile virus 23 4 
Boonsilp et al (2011)(70) Thailand 
2001-
2002 Leptospira spp. 418 120 
Bottieau et al (2011)(71) No Single Country 
2000-
2006 Campylobacter spp. 512 47 
Brooks et al (2005)(72) Bangladesh 
2000-
2001 
Salmonella (non-Typhi) 
serovars 888 2 
Castillo Ore et al (2012)(73) Peru 
2007-
2010 Hantavirus 5174 9 
Chadha et al (2006)(74) India 
2001-
2001 Nipah virus 6 5 
Chandy et al (2005)(75) India 
2002-
2003 Hantavirus 152 23 
Chandy et al (2009)(76) India 
2005-
2007 Hantavirus 347 86 
Chansamouth et al (2016)(77) 
Lao People's 
Democratic Republic 
2006-
2010 Leptospira spp. 158 1 
Chansamouth et al (2016)(77) 
Lao People's 
Democratic Republic 
2006-
2010 Orientia tsutsugamushi 217 16 
Chansamouth et al (2016)(77) 
Lao People's 
Democratic Republic 
2006-
2010 Rickettsia (TGR) 217 15 
Chatterjee et al (2004)(78) India 1996- Japanese encephalitis 72 24 
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First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
1999 virus 
Chen et al (2014)(79) China 
2011-
2012 Hantavirus 85 33 
Chen et al (2014)(79) China 
2011-
2012 Orientia tsutsugamushi 85 1 
Chen et al (2014)(79) China 
2011-
2012 Rickettsia (TGR) 85 1 
Chheng et al (2013)(80) Cambodia 
2009-
2010 
Japanese encephalitis 
virus 107 6 
Chheng et al (2013)(80) Cambodia 
2009-
2010 Leptospira spp. 1179 17 
Chheng et al (2013)(80) Cambodia 
2009-
2010 Orientia tsutsugamushi 1179 17 
Chheng et al (2013)(80) Cambodia 
2009-
2010 Rickettsia (TGR) 1179 5 
Chheng et al (2013)(80) Cambodia 
2009-
2010 
Salmonella (non-Typhi) 
serovars 1180 1 
Chikeka et al (2016)(81) Nicaragua - Ehrlichia spp. 748 1 
Chinikar et al (2012)(82) 
Iran (Islamic Republic 
of) 
2008-
2009 West Nile virus 249 3 
Chiriboga et al (2015)(83) Ecuador 
2011-
2012 Leptospira spp. 210 132 
Chrispal et al (2010)(84) India 
2007-
2008 Hantavirus 398 1 
Ciftdogan et al (2011)(85) Turkey 
2003-
2008 Brucella spp. 92 3 
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First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Cohen et al (2007)(86) Thailand 
2002-
2003 Leptospira spp. 704 67 
Crump et al (2011)(5) 
United Republic of 
Tanzania 
2007-
2008 
Salmonella (non-Typhi) 
serovars 224 2 
Crump et al (2011)(87) 
United Republic of 
Tanzania 
2007-
2008 
Salmonella (non-Typhi) 
serovars 139 1 
Crump et al (2013)(12) 
United Republic of 
Tanzania 
2007-
2008 Brucella spp. 453 16 
Crump et al (2013)(12) 
United Republic of 
Tanzania 
2007-
2008 Coxiella burnetii 482 24 
Crump et al (2013)(12) 
United Republic of 
Tanzania 
2007-
2008 Leptospira spp. 453 40 
Crump et al (2013)(12) 
United Republic of 
Tanzania 
2007-
2008 Rickettsia (SFGR) 450 36 
Crump et al (2013)(12) 
United Republic of 
Tanzania 
2007-
2008 Rickettsia (TGR) 450 2 
Cruz et al (2012)(88) 
Bolivia (Plurinational 
State of) 
2008-
2009 Hantavirus 372 9 
D'Acremont et al (2014)(28) 
United Republic of 
Tanzania 
2008-
2008 
Salmonella (non-Typhi) 
serovars 424 1 
Dassanayake et al (2009)(89) Sri Lanka 
2007-
2008 Leptospira spp. 123 62 
Davies et al (2016)(90) Nigeria - 
Salmonella (non-Typhi) 
serovars 129 15 
Degarege et al (2012)(91) Ethiopia 
2010-
2011 Schistosoma mansoni 702 82 
Dong et al (2014)(92) China 2009- Salmonella (non-Typhi) 2529 3 
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First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
2011 serovars 
dos Santos et al (2012)(93) Brazil 
2009-
2010 Rickettsia (SFGR) 110 36 
Ehichioya et al (2012)(94) Nigeria 
2005-
2008 Lassa virus 451 2 
Eibach et al (2016)(95) Ghana 
2007-
2012 
Salmonella (non-Typhi) 
serovars 7172 215 
El-Mahallawy et al (2005)(96) Egypt 
1999-
1999 Listeria spp. 1135 1 
El-Mahallawy et al (2005)(96) Egypt 
1999-
1999 Pasteurella spp. 1135 6 
Elhelw et al (2014)(97) Egypt 
2008-
2009 Borrelia spp. 15 4 
Ellis et al (2006)(98) Thailand 
1999-
2002 
Japanese encephalitis 
virus 530 1 
Ellis et al (2006)(98) Thailand 
1999-
2002 Leptospira spp. 613 107 
Elyan et al (2014)(99) Afghanistan 
2008-
2010 West Nile virus 277 24 
Eremeeva et al (2013)(100) Guatemala 
2007-
2007 Rickettsia (SFGR) 17 1 
Fadeel et al (2006)(101) Egypt 
1999-
2003 Brucella spp. 1177 202 
Forshey et al (2010)(102) No Single Country 
2000-
2007 
Venezuelan equine 
encephalitis virus 13259 250 
Fotso Fotso et al (2015)(103) Algeria 
2012-
2012 Borrelia spp. 257 4 
   Page 43 of 56 
First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Gasem et al (2009)(104) Indonesia 
2005-
2006 Leptospira spp. 137 4 
Gasem et al (2009)(104) Indonesia 
2005-
2006 Rickettsia (TGR) 137 4 
Gordon et al (2010)(105) Malawi - 
Salmonella (non-Typhi) 
serovars 355 70 
Hailu et al (2006)(106) Ethiopia - Leishmania donovani 103 49 
Hamilton et al (2011)(107) Iraq 
2008-
2008 Coxiella burnetii 18 8 
Hem et al (2016)(108) Cambodia 
2007-
2009 Leptospira spp. 2044 17 
Hidalgo et al (2008)(109) Colombia 
2005-
2005 Rickettsia (TGR) 120 14 
Hidalgo et al (2013)(110) Colombia 
2010-
2011 Rickettsia (SFGR) 26 7 
Hidalgo et al (2013)(110) Colombia 
2010-
2011 Rickettsia (TGR) 26 2 
Ismail et al (2006)(111) Egypt 
1999-
2003 Leptospira spp. 886 141 
Jennings et al (2007)(112) Egypt 
2002-
2003 Brucella spp. 4490 115 
Joshi et al (2006)(113) Nepal 
1998-
2002 Leishmania donovani 996 284 
Joshi et al (2013)(114) India 
2007-
2007 
Japanese encephalitis 
virus 152 4 
Jung et al (2015)(115) Republic of Korea 
2009-
2013 Orientia tsutsugamushi 382 3 
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First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Kakoti et al (2013)(116) India 
2012-
2012 
Japanese encephalitis 
virus 223 49 
Kamal et al (2013)(117) Saudi Arabia 
2009-
2011 Brucella spp. 101 50 
Kendall et al (2010)(118) Bangladesh 
2001-
2001 Leptospira spp. 78 7 
Kibuuka et al (2015)(119) Uganda 
2012-
2012 
Salmonella (non-Typhi) 
serovars 250 11 
Klempa et al (2010)(120) Guinea 
2001-
2005 Hantavirus 717 8 
Kocher et al (2016)(121) Peru 
2013-
2014 
Venezuelan equine 
encephalitis virus 2054 22 
Koizumi et al (2009)(122) Sri Lanka 
2008-
2008 Leptospira spp. 107 3 
Kosoy et al (2010)(123) Thailand 
2002-
2003 Bartonella spp. 261 14 
Kuchuloria et al (2014)(124) Georgia 
2008-
2011 
Crimean-Congo 
haemorrhagic fever virus 537 3 
Kuchuloria et al (2014)(124) Georgia 
2008-
2011 Hantavirus 537 2 
Kuchuloria et al (2016)(125) Georgia 
2008-
2011 
Crimean-Congo 
haemorrhagic fever virus 537 3 
Kuchuloria et al (2016)(125) Georgia 
2008-
2011 Hantavirus 537 2 
Kuloglu et al (2012)(126) Turkey 
2003-
2009 Rickettsia (SFGR) 126 97 
Kumar et al (2014)(127)  India 2011- Orientia tsutsugamushi 199 48 
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Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
2012 
Kumar et al (2014)(128) India 
2009-
2010 West Nile virus 105 27 
Kumar et al (2015)(129) India - 
Japanese encephalitis 
virus 108 54 
LaRocque et al (2005)(130) Bangladesh 
2001-
2001 Leptospira spp. 359 63 
Ley et al (2009)(131)  
United Republic of 
Tanzania 
2008-
2009 
Salmonella (non-Typhi) 
serovars 1680 49 
Libraty et al (2007)(132) Thailand 
1994-
1999 Leptospira spp. 812 14 
Liu et al (2007)(133) China 
2002-
2004 Hantavirus 130 49 
Liu et al (2007)(133) China 
2002-
2004 Orientia tsutsugamushi 130 46 
Liu et al (2016)(134) China 
2014-
2014 Rickettsia (SFGR) 733 56 
Mahende et al (2014)(135) 
United Republic of 
Tanzania 
2013-
2013 
Salmonella (non-Typhi) 
serovars 808 2 
Maina et al (2012)(136) Kenya 
2008-
2010 Rickettsia (SFGR) 699 50 
Manock et al (2009)(137) Ecuador 
2001-
2004 Brucella spp. 275 4 
Manock et al (2009)(137) Ecuador 
2001-
2004 Coxiella burnetii 33 15 
Manock et al (2009)(137) Ecuador 
2001-
2004 Rickettsia (SFGR) 214 6 
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publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Manock et al (2009)(137) Ecuador 
2001-
2004 Rickettsia (TGR) 255 8 
Manock et al (2009)(137) Ecuador 
2001-
2004 
Venezuelan equine 
encephalitis virus 229 2 
Matthias et al (2008)(138) Peru 
2003-
2006 Leptospira spp. 881 45 
Maude et al (2015)(139) Bangladesh 
2012-
2012 Orientia tsutsugamushi 300 1 
Maude et al (2015)(139) Bangladesh 
2012-
2012 Rickettsia (TGR) 300 2 
Mayxay et al (2013)(140) 
Lao People's 
Democratic Republic 
2008-
2010 Leptospira spp. 1932 137 
Mayxay et al (2013)(140) 
Lao People's 
Democratic Republic 
2008-
2010 Orientia tsutsugamushi 1871 170 
Mayxay et al (2013)(140) 
Lao People's 
Democratic Republic 
2008-
2010 Rickettsia (SFGR) 1849 2 
Mayxay et al (2013)(140) 
Lao People's 
Democratic Republic 
2008-
2010 Rickettsia (TGR) 1849 12 
Mazyad et al (2007)(141) Egypt 
2006-
2006 Coxiella burnetii 150 5 
McGready et al (2010)(142) Thailand 
2004-
2006 Leptospira spp. 203 5 
McGready et al (2010)(142) Thailand 
2004-
2006 Orientia tsutsugamushi 203 11 
McGready et al (2010)(142) Thailand 
2004-
2006 Rickettsia (TGR) 203 14 
Mediannikov et al (2010)(143) Senegal 2008- Rickettsia (SFGR) 204 8 
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publication and reference Country 
Study 
Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
2009 
Mediannikov et al (2013)(144) No Single Country 
2010-
2012 Rickettsia (SFGR) 2612 321 
Mediannikov et al (2014)(145) Senegal 
2010-
2011 Borrelia spp. 1566 115 
Meremo et al (2012)(146) 
United Republic of 
Tanzania - 
Salmonella (non-Typhi) 
serovars 346 12 
Metanat et al (2014)(147) 
Iran (Islamic Republic 
of) 
2011-
2011 Coxiella burnetii 105 23 
Moon et al (2013)(148) Mozambique 
2012-
2012 
Salmonella (non-Typhi) 
serovars 258 28 
Morrison et al (2008)(149) Peru 
2005-
2006 
Venezuelan equine 
encephalitis virus 1136 34 
Mourembou et al (2015)(150) Gabon 
2011-
2012 Rickettsia (SFGR) 793 8 
Mourembou et al (2015)(151) Gabon 
2013-
2014 Rickettsia (SFGR) 410 42 
Mourembou et al (2016)(152) Gabon - 
Salmonella (non-Typhi) 
serovars 410 3 
Mtove et al (2010)(153) 
United Republic of 
Tanzania 
2008-
2009 
Salmonella (non-Typhi) 
serovars 1502 45 
Mtove et al (2011)(154) 
United Republic of 
Tanzania 
2006-
2010 
Salmonella (non-Typhi) 
serovars 6836 232 
Mtove et al (2011)(155) 
United Republic of 
Tanzania 
2009-
2010 
Salmonella (non-Typhi) 
serovars 965 1 
Mueller et al (2014)(156) Cambodia 
2008-
2010 Leptospira spp. 1193 112 
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Period Pathogen 
Number of 
Individuals Tested 
Number of 
Individuals Positive 
Mueller et al (2014)(156) Cambodia 
2008-
2010 Orientia tsutsugamushi 1193 47 
Mueller et al (2014)(156) Cambodia 
2008-
2010 Rickettsia spp. 1193 2 
Mukhtar et al (2015)(157) Sudan 
2012-
2014 Leishmania donovani 285 191 
Murdoch et al (2004)(158) Nepal 
2001-
2001 Leptospira spp. 26 11 
Murray et al (2011)(159) Egypt 
2005-
2007 Leptospira spp. 2441 47 
Nadjm et al (2010)(160) 
United Republic of 
Tanzania - 
Salmonella (non-Typhi) 
serovars 3639 160 
Nadjm et al (2012)(161) 
United Republic of 
Tanzania 
2007-
2007 
Salmonella (non-Typhi) 
serovars 198 5 
Naheed et al (2008)(162) Bangladesh 
2003-
2004 Campylobacter spp. 867 1 
Nandagopal et al (2012)(163) India 
2008-
2009 Brucella spp. 301 3 
Natarajaseenivasan et al 
(2004)(164) India 
2000-
2000 Leptospira spp. 29 7 
Natarajaseenivasan et al 
(2012)(165) India 
2009-
2009 Leptospira spp. 75 71 
Ndip et al (2004)(166) Cameroon 
2003-
2003 Rickettsia (SFGR) 118 7 
Ndip et al (2009)(167) Cameroon 
2003-
2003 Ehrlichia spp. 118 12 
Njeru et al (2016)(168) Kenya 2014- Coxiella burnetii 448 10 
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2015 
Nordstrand et al (2007)(169) Togo 
2002-
2004 Borrelia spp. 237 21 
Onyango et al (2008)(170) Kenya 
2004-
2005 
Salmonella (non-Typhi) 
serovars 20 18 
Onyango et al (2009)(171) Kenya 
2004-
2005 
Salmonella (non-Typhi) 
serovars 40 20 
Paris et al (2011)(172) Thailand 
2007-
2008 Orientia tsutsugamushi 138 26 
Park et al (2016)(173) No Single Country 
2010-
2014 
Salmonella (non-Typhi) 
serovars 13431 73 
Parola et al (2011)(174) Senegal 
2008-
2009 Borrelia spp. 206 27 
Peters et al (2004)(175) Malawi 
2000-
2000 
Salmonella (non-Typhi) 
serovars 352 44 
Phimda et al (2007)(176) Thailand 
2003-
2005 Leptospira spp. 296 55 
Phimda et al (2007)(176) Thailand 
2003-
2005 Orientia tsutsugamushi 230 34 
Pradhan et al (2012)(177) Nepal 
2006-
2007 Rickettsia (TGR) 1039 22 
Pradhan et al (2012)(177) Nepal 
2006-
2007 
Salmonella (non-Typhi) 
serovars 1039 2 
Prakash et al (2012)(178) India 
2006-
2008 Rickettsia (SFGR) 58 34 
Preziosi et al (2015)(179) Mozambique 
2011-
2014 
Salmonella (non-Typhi) 
serovars 841 10 
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Rafizah et al (2013)(180) Malaysia - Leptospira spp. 999 53 
Rao et al (2005)(181) India - Leptospira spp. 70 2 
Rasul et al (2012)(182) Bangladesh 
2007-
2009 
Japanese encephalitis 
virus 130 2 
Ratmanov et al (2013)(183) Senegal 
2008-
2011 Coxiella burnetii 874 4 
Rayamajhi et al (2006)(184) Nepal 
2000-
2001 
Japanese encephalitis 
virus 117 54 
Rayamajhi et al (2007)(185) Nepal 
2000-
2001 
Japanese encephalitis 
virus 94 54 
Rayamajhi et al (2011)(186) Nepal 
2006-
2008 
Japanese encephalitis 
virus 86 19 
Reller et al (2011)(187) 
United Republic of 
Tanzania - Borrelia spp. 310 13 
Reller et al (2012)(188) Sri Lanka 
2007-
2007 Orientia tsutsugamushi 883 17 
Reller et al (2012)(188) Sri Lanka 
2007-
2007 Rickettsia (SFGR) 883 108 
Reller et al (2012)(188) Sri Lanka 
2007-
2007 Rickettsia (TGR) 883 61 
Reller et al (2014) (189) Nicaragua 
2008-
2009 Leptospira spp. 748 17 
Richards et al (2010)(190) Kenya 
2006-
2008 Rickettsia (SFGR) 163 6 
Rijal et al (2004)(191) Nepal 
2000-
2002 Leishmania donovani 261 155 
   Page 51 of 56 
First author, year of 
publication and reference Country 
Study 
Period Pathogen 
Number of 
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Rutvisuttinunt et al (2014)(192) Nepal 
2009-
2010 West Nile virus 2046 14 
Saisongkorh et al (2004)(193) Thailand - Orientia tsutsugamushi 36 9 
Sarih et al (2009)(194) Morocco 
2005-
2006 Borrelia spp. 127 23 
Sarkar et al (2012)(195) India 
2010-
2010 
Japanese encephalitis 
virus 135 36 
Schoepp et al (2014)(196) Sierra Leone 
2006-
2008 Lassa virus 253 7 
Schoepp et al (2014)(196) Sierra Leone 
2006-
2008 Rift Valley fever virus 253 5 
Shukla et al (2012)(197) India 
2009-
2010 West Nile virus 105 27 
Singh et al (2009)(198) Nepal 
2003-
2004 
Japanese encephalitis 
virus 107 19 
Singh et al (2014)(199) India 
2008-
2011 
Japanese encephalitis 
virus 1410 10 
Sinyange et al (2016)(200) Zambia 
2015-
2015 Yersinia pestis 12 6 
Socolovschi et al (2010)(201) Senegal 
2008-
2009 Rickettsia (SFGR) 134 8 
Sokhna et al (2013)(202) Senegal 
2011-
2012 Bartonella spp. 440 23 
Sokhna et al (2013)(202) Senegal 
2011-
2012 Borrelia spp. 440 35 
Sokhna et al (2013)(202) Senegal 
2011-
2012 Coxiella burnetii 440 2 
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Sokhna et al (2013)(202) Senegal 
2011-
2012 Rickettsia (SFGR) 440 28 
Sonthayanon et al (2006)(203) Thailand 
2000-
2001 Orientia tsutsugamushi 722 183 
Sothmann et al (2015)(204) Ghana 
2012-
2012 
Salmonella (non-Typhi) 
serovars 2306 24 
Sow et al (2016)(205) Senegal 
2009-
2013 Rift Valley fever virus 13845 1 
Stremlau et al (2015)(206) Nigeria - Lassa virus 195 104 
Suharti et al (2009)(207) Indonesia 
1995-
1996 Hantavirus 60 5 
Suputtamongkol et al 
(2009)(208) Thailand 
2000-
2003 Orientia tsutsugamushi 1663 192 
Suputtamongkol et al 
(2009)(208) Thailand 
2000-
2003 Rickettsia (TGR) 1663 18 
Suputthamongkol et al 
(2005)(209) Thailand 
1999-
2000 Hantavirus 115 8 
Suttinont et al (2006)(210) Thailand 
2001-
2002 Leptospira spp. 845 293 
Swami et al (2008)(211) India 
2003-
2005 
Japanese encephalitis 
virus 40 9 
Taraphdar et al (2012)(212) India 
2010-
2010 
Japanese encephalitis 
virus 58 23 
Tezcan et al (2006)(213) Turkey 
1996-
2004 
Salmonella (non-Typhi) 
serovars 621 1 
Thipmontree et al (2014)(214) Thailand 
2001-
2012 Leptospira spp. 726 118 
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Thompson et al (2015)(215) Nepal 
2008-
2011 Hantavirus 125 2 
Thompson et al (2015)(215) Nepal 
2008-
2011 Rickettsia (TGR) 125 21 
Tigoi et al (2015)(216) Kenya 
2009-
2012 West Nile virus 379 47 
Wiersinga et al (2015)(217) Gabon 
2012-
2013 
Salmonella (non-Typhi) 
serovars 941 5 
Wuthiekanun et al (2007)(218) Thailand 
2001-
2002 Leptospira spp. 989 83 
Zhang et al (2011)(219) China 
2004-
2006 
Anaplasma 
phagocytophilum 26 8 
Zhang et al (2013)(220) China 
2009-
2010 
Anaplasma 
phagocytophilum 421 46 
Zhou et al (2013)(221) China 
2012-
2013 Babesia microti 449 10 
Zimmerman et al (2008)(222) Nepal 
2001-
2001 Rickettsia (TGR) 756 50 
 1437 
 1438 
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 1439 
Table 4: Summary of number of studies from each global region represented in the study 1440 
dataset  1441 
 1442 
WHO Region Number (%) of malaria endemic 
countries contributing data 
Number (%) of 
studies contributing 
data (n=174
1
) 
Africa 17 of 44 (38·6%) 56  (32·2%) 
Americas 8 of 23 (34·8%) 16  (9·2%) 
Eastern Mediterranean 8 of 14 (57%) 17  (9·8%) 
Europe 2 of 9 (22·2%) 5  (2·9%) 
South-East Asia 6 of 10 (60·0%) 63  (36·2%) 
Western Pacific 6 of 10 (60·0%) 17  (9·8%) 
1
Table includes data from 174 of 181 articles included in the review, excluding 7 articles 1443 
reporting data from multiple countries excluded for this analysis. 1444 
 1445 
  1446 
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Figures 1447 
 1448 
Figure 1: Flow diagram of records and articles assessed for the review. 1449 
Among the 46 articles excluded because the full text was not accessible in English, the 1450 
breakdown of languages was as follows: French (13 articles); Spanish (11 articles); Turkish 1451 
(9 articles); Mandarin (6 articles); Portuguese (2 articles); Hebrew (2 articles); Arabic (1 1452 
article); Danish (1 article) and Russian (1 article). 1453 
 1454 
Figure 2: Map illustrating the malaria-endemic countries included in the study and number of 1455 
articles contributing data for each country. (indicated by colour shading).  1456 
 1457 
Figure 3: Barchart showing the number of articles contributing data for each country included 1458 
in the study, displayed by country and WHO region.  1459 
 1460 
Figure 4Figure 3: Barchart showing the number of articles that looked for, reported diagnosis 1461 
of and contributed data for each zoonosis. of 40, 31 and 30 zoonoses respectively.  1462 
These data were tabulated for all pathogenszoonoses (n=40) and articles included in the 1463 
review. (n=244). Bar colour indicates pathogen type and shading differentiates studies that i) 1464 
contribute data meeting study diagnostic criteria (left hand bar sections with darkest 1465 
shading),, n=30 pathogens indicated by *), ii) report diagnosis with approaches that do not 1466 
meet study diagnostic criteria (central bar sections with partial shadinglighter shading, n=31 1467 
pathogens that comprised the 30 with extracted data and Escherichia coli), iii) report looking 1468 
for but not diagnosing a zoonosis (right hand bar section with lightest shading, n=40 1469 
pathogens, also including Burkholderia spp. Tick borne encephalitis virus, Marburg virus, 1470 
Rabies virus, Newcastle Disease virus, Mycobacterium bovis, Francisella tularensis, Ebola 1471 
virus and Cryptosporidium parvum).  1472 
 1473 
Figure 4: Proportion of fevers attributed to each zoonosis.  1474 
The plot includes one data point per study and pathogen combination. The different panels 1475 
include data from different WHO regions. Point colour indicates the coding for the risk of 1476 
bias for the representativeness of the febrile population and point size is proportional to the 1477 
number of individuals tested. Points are jittered on the x axis and shaded to visualize 1478 
overlapping points. 1479 
Figure 5: Barchart showing number of articles from each global region contributing data for 1480 
each of 29 zoonoses. 1481 
Plot panels indicate the WHO defined global region and bar colour indicates type of pathogen 1482 
 1483 
Figure 6 1484 
Figure 5: Venn diagram illustrating the associations between febrile population clinical 1485 
presentation and pathogens identified. Circles are scaled to the number of pathogens detected 1486 
in each type of patient population. Undifferentiated, shown in green, 22 pathogens; febrile 1487 
neurological, shown in blue, 5 pathogens; febrile gastrointestinal, shown in pink, 2 1488 
pathogens; febrile haemmorhagic, shown in orange, 4 pathogens, Leishmania donavanii, 1489 
Toxoplasma gondii, Rickettsia spp., and Yersinia pestis are not represented as they were only 1490 
detected in febrile populations classified as mixed.  1491 
 1492 
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Figure 7: Proportion of fevers attributed to each zoonosis. Circles are scaled to the number of 1493 
pathogens detected in each type of febrile population. Undifferentiated, shown in green, 23 1494 
pathogens (including pathogens also seen in other populations); febrile neurological, shown 1495 
in red, four pathogens; febrile gastrointestinal, shown in blue, two pathogens; febrile 1496 
respiratory, shown in purple, one pathogen, febrile haemorrhagic, shown in yellow, seven 1497 
pathogens. Five pathogens are not represented in the figure as they were only detected in 1498 
febrile populations classified as co-morbid (Listeria spp., Pasteurella spp. and Toxoplasma 1499 
gondii) or in febrile populations with a specific febrile aetiology suspected (Leishmania 1500 
donavani, and Yersinia pestis).  1501 
 1502 
The plot includes one data point per study and pathogen combination. Point colour indicates 1503 
pathogen type and point size is proportional to the number of individuals tested. Points are 1504 
jittered on the x axis and shaded to visualize overlapping points. 1505 
 1506 
